0000099302 TRANSCAT INC false --03-30 Q2 2025 1 2 3 4 565 544 0.50 0.50 30,000,000 30,000,000 9,199,277 9,199,277 8,839,299 8,839,299 0.1 0.1 0.01 3 0 150 100 100 5 5 10 0 3 3 5 5 3 2 11 15 false false false false Operating expense allocations between segments are based on actual amounts, a percentage of revenues, headcount, and management’s estimates. United States includes Puerto Rico. Revenues are attributed to the countries based on the destination of a product shipment or the location where service is rendered. 00000993022024-03-312024-09-28 xbrli:shares 00000993022024-10-31 thunderdome:item iso4217:USD 0000099302us-gaap:ServiceMember2024-06-302024-09-28 0000099302us-gaap:ServiceMember2023-06-252023-09-23 0000099302us-gaap:ServiceMember2024-03-312024-09-28 0000099302us-gaap:ServiceMember2023-03-262023-09-23 0000099302us-gaap:DistributionServiceMember2024-06-302024-09-28 0000099302us-gaap:DistributionServiceMember2023-06-252023-09-23 0000099302us-gaap:DistributionServiceMember2024-03-312024-09-28 0000099302us-gaap:DistributionServiceMember2023-03-262023-09-23 00000993022024-06-302024-09-28 00000993022023-06-252023-09-23 00000993022023-03-262023-09-23 iso4217:USDxbrli:shares 00000993022024-09-28 00000993022024-03-30 00000993022023-03-25 00000993022023-09-23 0000099302us-gaap:CommonStockMember2023-03-25 0000099302us-gaap:AdditionalPaidInCapitalMember2023-03-25 0000099302us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-25 0000099302us-gaap:RetainedEarningsMember2023-03-25 0000099302us-gaap:CommonStockMember2023-03-262023-06-24 0000099302us-gaap:AdditionalPaidInCapitalMember2023-03-262023-06-24 0000099302us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-262023-06-24 0000099302us-gaap:RetainedEarningsMember2023-03-262023-06-24 00000993022023-03-262023-06-24 0000099302us-gaap:CommonStockMember2023-06-24 0000099302us-gaap:AdditionalPaidInCapitalMember2023-06-24 0000099302us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-24 0000099302us-gaap:RetainedEarningsMember2023-06-24 00000993022023-06-24 0000099302us-gaap:CommonStockMember2023-06-252023-09-23 0000099302us-gaap:AdditionalPaidInCapitalMember2023-06-252023-09-23 0000099302us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-252023-09-23 0000099302us-gaap:RetainedEarningsMember2023-06-252023-09-23 0000099302us-gaap:CommonStockMember2023-09-23 0000099302us-gaap:AdditionalPaidInCapitalMember2023-09-23 0000099302us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-23 0000099302us-gaap:RetainedEarningsMember2023-09-23 0000099302us-gaap:CommonStockMember2024-03-30 0000099302us-gaap:AdditionalPaidInCapitalMember2024-03-30 0000099302us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-30 0000099302us-gaap:RetainedEarningsMember2024-03-30 0000099302us-gaap:CommonStockMember2024-03-312024-06-29 0000099302us-gaap:AdditionalPaidInCapitalMember2024-03-312024-06-29 0000099302us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-312024-06-29 0000099302us-gaap:RetainedEarningsMember2024-03-312024-06-29 00000993022024-03-312024-06-29 0000099302us-gaap:CommonStockMember2024-06-29 0000099302us-gaap:AdditionalPaidInCapitalMember2024-06-29 0000099302us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-29 0000099302us-gaap:RetainedEarningsMember2024-06-29 00000993022024-06-29 0000099302us-gaap:CommonStockMember2024-06-302024-09-28 0000099302us-gaap:AdditionalPaidInCapitalMember2024-06-302024-09-28 0000099302us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-302024-09-28 0000099302us-gaap:RetainedEarningsMember2024-06-302024-09-28 0000099302us-gaap:CommonStockMember2024-09-28 0000099302us-gaap:AdditionalPaidInCapitalMember2024-09-28 0000099302us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-28 0000099302us-gaap:RetainedEarningsMember2024-09-28 xbrli:pure 0000099302us-gaap:TransferredAtPointInTimeMember2024-06-302024-09-28 0000099302us-gaap:TransferredAtPointInTimeMember2023-06-252023-09-23 0000099302us-gaap:TransferredAtPointInTimeMember2024-03-312024-09-28 0000099302us-gaap:TransferredAtPointInTimeMember2023-03-262023-09-23 0000099302us-gaap:TransferredOverTimeMember2024-06-302024-09-28 0000099302us-gaap:TransferredOverTimeMember2023-06-252023-09-23 0000099302us-gaap:TransferredOverTimeMember2024-03-312024-09-28 0000099302us-gaap:TransferredOverTimeMember2023-03-262023-09-23 0000099302us-gaap:ForeignExchangeContractMember2024-09-28 0000099302trns:DistributionSegmentMember2024-03-30 0000099302trns:ServiceSegmentMember2024-03-30 0000099302trns:DistributionSegmentMember2024-03-312024-09-28 0000099302trns:ServiceSegmentMember2024-03-312024-09-28 0000099302trns:DistributionSegmentMember2024-09-28 0000099302trns:ServiceSegmentMember2024-09-28 0000099302us-gaap:RevolvingCreditFacilityMember2021-07-07 0000099302us-gaap:LetterOfCreditMember2021-07-07 0000099302trns:The2018TermLoanMember2021-07-07 0000099302us-gaap:RevolvingCreditFacilityMembersrt:MaximumMember2024-09-28 0000099302us-gaap:RevolvingCreditFacilityMember2024-09-28 0000099302trns:The2018TermLoanMember2024-09-28 0000099302trns:The2018TermLoanMember2024-03-312024-09-28 0000099302us-gaap:RevolvingCreditFacilityMember2024-03-312024-09-28 0000099302us-gaap:RevolvingCreditFacilityMember2023-03-262024-03-30 0000099302trns:The2021PlanMember2024-06-29 utr:Y 0000099302trns:PerformancebasedRestrictedStockUnitsMember2024-03-312024-09-28 0000099302trns:October2018Membertrns:PerformancebasedRestrictedStockUnitsMember2024-09-28 0000099302trns:March2022Membertrns:PerformancebasedRestrictedStockUnitsMember2024-09-28 0000099302trns:May2022FirstIssuanceMembertrns:PerformancebasedRestrictedStockUnitsMember2024-09-28 0000099302trns:May2022SecondIssuanceMembertrns:PerformancebasedRestrictedStockUnitsMember2024-09-28 0000099302trns:August2022IssuanceMembertrns:PerformancebasedRestrictedStockUnitsMember2024-09-28 0000099302trns:May2023FirstIssuanceMembertrns:PerformancebasedRestrictedStockUnitsMember2024-09-28 0000099302trns:May2023SecondIssuanceMembertrns:PerformancebasedRestrictedStockUnitsMember2024-09-28 0000099302trns:May2023ThirdIssuanceMembertrns:PerformancebasedRestrictedStockUnitsMember2024-09-28 0000099302trns:April2024FirstIssuanceMembertrns:PerformancebasedRestrictedStockUnitsMember2024-09-28 0000099302trns:April2024SecondIssuanceMembertrns:PerformancebasedRestrictedStockUnitsMember2024-09-28 0000099302trns:May2024FirstIssuanceMembertrns:PerformancebasedRestrictedStockUnitsMember2024-09-28 0000099302trns:May2024SecondIssuanceMembertrns:PerformancebasedRestrictedStockUnitsMember2024-09-28 0000099302trns:May2024ThirdIssuanceMembertrns:PerformancebasedRestrictedStockUnitsMember2024-09-28 0000099302trns:May2024FourthIssuanceMembertrns:PerformancebasedRestrictedStockUnitsMember2024-09-28 0000099302trns:July2024Membertrns:PerformancebasedRestrictedStockUnitsMember2024-09-28 0000099302trns:September2024FirstIssuanceMembertrns:PerformancebasedRestrictedStockUnitsMember2024-09-28 0000099302trns:September2024SecondIssuanceMembertrns:PerformancebasedRestrictedStockUnitsMember2024-09-28 0000099302trns:September2024ThirdIssuanceMembertrns:PerformancebasedRestrictedStockUnitsMember2024-09-28 0000099302us-gaap:RestrictedStockUnitsRSUMember2024-03-312024-09-28 0000099302us-gaap:RestrictedStockUnitsRSUMember2023-03-262023-09-23 0000099302us-gaap:RestrictedStockUnitsRSUMember2024-09-28 0000099302trns:PerformancebasedRestrictedStockUnitsMember2024-09-28 0000099302us-gaap:EmployeeStockOptionMember2024-03-312024-09-28 0000099302us-gaap:EmployeeStockOptionMembersrt:MinimumMember2024-03-312024-09-28 0000099302us-gaap:EmployeeStockOptionMembersrt:MaximumMember2024-03-312024-09-28 0000099302us-gaap:EmployeeStockOptionMember2024-06-302024-09-28 0000099302us-gaap:EmployeeStockOptionMember2023-06-252023-09-23 0000099302us-gaap:EmployeeStockOptionMember2023-03-262023-09-23 0000099302us-gaap:EmployeeStockOptionMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2024-03-312024-09-28 0000099302us-gaap:EmployeeStockOptionMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2024-03-312024-09-28 0000099302us-gaap:EmployeeStockOptionMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2023-03-262023-09-23 0000099302us-gaap:EmployeeStockOptionMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2023-03-262023-09-23 0000099302trns:IndividualEmployeeMember2023-03-262023-09-23 0000099302srt:DirectorMember2023-03-262023-09-23 0000099302us-gaap:EmployeeStockOptionMember2024-09-28 0000099302us-gaap:OperatingSegmentsMembertrns:ServiceSegmentMember2024-06-302024-09-28 0000099302us-gaap:OperatingSegmentsMembertrns:ServiceSegmentMember2023-06-252023-09-23 0000099302us-gaap:OperatingSegmentsMembertrns:ServiceSegmentMember2024-03-312024-09-28 0000099302us-gaap:OperatingSegmentsMembertrns:ServiceSegmentMember2023-03-262023-09-23 0000099302us-gaap:OperatingSegmentsMembertrns:DistributionSegmentMember2024-06-302024-09-28 0000099302us-gaap:OperatingSegmentsMembertrns:DistributionSegmentMember2023-06-252023-09-23 0000099302us-gaap:OperatingSegmentsMembertrns:DistributionSegmentMember2024-03-312024-09-28 0000099302us-gaap:OperatingSegmentsMembertrns:DistributionSegmentMember2023-03-262023-09-23 0000099302country:US2024-06-302024-09-28 0000099302country:US2023-06-252023-09-23 0000099302country:US2024-03-312024-09-28 0000099302country:US2023-03-262023-09-23 0000099302country:CA2024-06-302024-09-28 0000099302country:CA2023-06-252023-09-23 0000099302country:CA2024-03-312024-09-28 0000099302country:CA2023-03-262023-09-23 0000099302trns:OtherInternationalMember2024-06-302024-09-28 0000099302trns:OtherInternationalMember2023-06-252023-09-23 0000099302trns:OtherInternationalMember2024-03-312024-09-28 0000099302trns:OtherInternationalMember2023-03-262023-09-23 0000099302trns:BecnelRentalToolsLlcMembersrt:MaximumMember2024-04-152024-04-15 0000099302trns:BecnelRentalToolsLlcMember2024-04-152024-04-15 0000099302trns:BecnelRentalToolsLlcMember2024-04-15 0000099302trns:BecnelRentalToolsLlcMember2024-09-28 0000099302trns:BecnelRentalToolsLlcMemberus-gaap:MeasurementInputDiscountRateMember2024-04-15 0000099302trns:BecnelRentalToolsLlcMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-04-15 0000099302trns:BecnelRentalToolsLlcMemberus-gaap:MeasurementInputPriceVolatilityMember2024-04-15 0000099302trns:BecnelRentalToolsLlcMembertrns:RevenueTargetAchievementMember2024-04-152024-04-15 0000099302trns:BecnelRentalToolsLlcMemberus-gaap:CustomerRelatedIntangibleAssetsMember2024-04-15 0000099302trns:BecnelRentalToolsLlcMemberus-gaap:TrademarksAndTradeNamesMember2024-04-15 0000099302trns:BecnelRentalToolsLlcMember2024-04-152024-09-28 0000099302trns:AxiomMember2023-08-082023-08-08 0000099302trns:AxiomMember2023-08-08 0000099302trns:AxiomMemberus-gaap:CustomerRelatedIntangibleAssetsMember2023-08-08 0000099302trns:AxiomMember2024-03-312024-09-28 0000099302trns:SteriqualIncMember2023-07-122023-07-12 0000099302trns:SteriqualIncMember2024-06-302024-09-28 0000099302trns:SteriqualIncMember2023-12-232023-12-23 0000099302trns:SteriqualIncMember2023-07-12 0000099302trns:SteriqualIncMemberus-gaap:CustomerRelatedIntangibleAssetsMember2023-07-12 0000099302trns:SteriqualIncMemberus-gaap:NoncompeteAgreementsMember2023-07-12 0000099302trns:SteriqualIncMembertrns:SalesBacklogMember2023-07-12 0000099302trns:SteriqualIncMember2024-03-312024-09-28 0000099302trns:TICMSIncMember2023-03-272023-03-27 0000099302trns:TICMSIncMember2023-03-27 0000099302trns:TICMSIncMember2023-03-262023-06-24 0000099302trns:TICMSIncMemberus-gaap:CustomerRelatedIntangibleAssetsMember2023-03-27 0000099302trns:TICMSIncMemberus-gaap:NoncompeteAgreementsMember2023-03-27 0000099302trns:TICMSIncMember2024-03-312024-09-28 0000099302trns:NEXAMember2024-03-312024-09-28 0000099302trns:AxiomMember2024-03-312024-09-28 0000099302trns:SteriqualIncMember2024-03-312024-09-28 0000099302us-gaap:SubsequentEventMember2024-10-302024-10-30
 

 

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________

 

FORM 10-Q

(Mark one)

  Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended: September 28, 2024

 

or

 

  Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the transition period from to                  

Commission File Number: 000-03905         

 

TRANSCAT, INC.

(Exact name of registrant as specified in its charter)

 

Ohio

16-0874418

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

 

35 Vantage Point Drive, Rochester, New York 14624

(Address of principal executive offices) (Zip Code)

 

(585) 352-7777

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.50 par value

TRNS

Nasdaq Global Market

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☑ Yes No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☑ Yes No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☑

Accelerated filer ☐

Non-accelerated filer ☐

Smaller reporting company

Emerging growth company

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No ☑

 

The number of shares of common stock, par value $0.50 per share, of the registrant outstanding as of October 31, 2024 was9,199,277.

     

  

 
   

Page(s)

PART I.

FINANCIAL INFORMATION

 
     

Item 1.

Consolidated Financial Statements:

 
     
 

Statements of Income for the Second Quarter and Six Months Ended September 28, 2024 and September 23, 2023

1

     
 

Statements of Comprehensive Income for the Second Quarter and Six Months Ended September 28, 2024 and September 23, 2023

2

     
 

Balance Sheets as of September 28, 2024 and March 30, 2024

3

     
 

Statements of Cash Flows for the Six Months Ended September 28, 2024 and September 23, 2023

4

     
 

Statements of Changes in Shareholders' Equity for the Second Quarter and Six Months Ended September 28, 2024 and September 23, 2023

5

     
 

Notes to Consolidated Financial Statements

6

     

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

19

     

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

31

     

Item 4.

Controls and Procedures

31

     

PART II.

OTHER INFORMATION

 
     

Item 6.

Exhibits

33

     

SIGNATURES

35

 

 

 

PART I. FINANCIAL INFORMATION

 

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

 

TRANSCAT, INC.

CONSOLIDATED STATEMENTS OF INCOME

(In Thousands, Except Per Share Amounts)

 

  

(Unaudited)

  

(Unaudited)

 
  

Second Quarter Ended

  

Six Months Ended

 
  

September 28,

  

September 23,

  

September 28,

  

September 23,

 
  

2024

  

2023

  

2024

  

2023

 
                 

Service Revenue

 $44,083  $41,431  $87,861  $81,284 

Distribution Revenue

  23,743   21,373   46,672   42,118 

Total Revenue

  67,826   62,804   134,533   123,402 
                 

Cost of Service Revenue

  29,492   27,347   58,387   54,229 

Cost of Distribution Revenue

  17,128   15,332   32,285   30,338 

Total Cost of Revenue

  46,620   42,679   90,672   84,567 
                 

Gross Profit

  21,206   20,125   43,861   38,835 
                 

Selling, Marketing and Warehouse Expenses

  8,181   6,856   15,982   13,325 

General and Administrative Expenses

  9,290   11,626   19,045   19,227 

Total Operating Expenses

  17,471   18,482   35,027   32,552 
                 

Operating Income

  3,735   1,643   8,834   6,283 
                 

Interest Expense

  76   890   128   1,704 

Interest Income

  (286)  -   (598)  - 

Other Expense (Income)

  232   (49)  363   15 

Total Interest and Other Expense (Income), net

  22   841   (107)  1,719 
                 

Income Before Provision For Income Taxes

  3,713   802   8,941   4,564 

Provision for Income Taxes

  427   342   1,247   1,155 
                 

Net Income

 $3,286  $460  $7,694  $3,409 
                 

Basic Earnings Per Share

 $0.36  $0.06  $0.84  $0.44 

Average Shares Outstanding

  9,160   7,819   9,107   7,732 
                 

Diluted Earnings Per Share

 $0.35  $0.06  $0.83  $0.43 

Average Shares Outstanding

  9,282   7,948   9,222   7,840 

 

See accompanying notes to consolidated financial statements.

 

 

 

 

TRANSCAT, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In Thousands)

 

  

(Unaudited)

  

(Unaudited)

 
  

Second Quarter Ended

  

Six Months Ended

 
  

September 28,

  

September 23,

  

September 28,

  

September 23,

 
  

2024

  

2023

  

2024

  

2023

 

Net Income

 $3,286  $460  $7,694  $3,409 
                 

Other Comprehensive (Loss) / Income :

                

Currency Translation Adjustment

  381   (352)  221   124 

Other, net of tax effects of $1 and $2 for the second quarter ended September 28, 2024 and September 23, 2023, respectively; and $3 and $4 for the six months ended September 28, 2024 and September 23, 2023, respectively

  5   6   10   12 

Total Other Comprehensive Income / (Loss)

  386   (346)  231   136 
                 

Comprehensive Income

 $3,672  $114  $7,925  $3,545 

 

See accompanying notes to consolidated financial statements.

 

 

 

TRANSCAT, INC.

CONSOLIDATED BALANCE SHEETS

(In Thousands, Except Share and Per Share Amounts)

 

  

(Unaudited)

  

(Audited)

 
  

September 28,

  

March 30,

 
  

2024

  

2024

 

ASSETS

        

Current Assets:

        

Cash and Cash Equivalents

 $23,815  $19,646 

Marketable Securities

  -   15,533 

Accounts Receivable, less allowance for credit losses of $565 and $544 as of September 28, 2024 and March 30, 2024, respectively

  48,933   47,779 

Other Receivables

  628   506 

Inventory, net

  15,549   17,418 

Prepaid Expenses and Other Current Assets

  6,241   4,276 

Total Current Assets

  95,166   105,158 

Property and Equipment, net

  47,493   38,944 

Goodwill

  138,127   105,585 

Intangible Assets, net

  24,362   19,987 

Right to Use Assets, net

  17,309   16,823 

Other Assets

  1,096   1,055 

Total Assets

 $323,553  $287,552 
         

LIABILITIES AND SHAREHOLDERS' EQUITY

        

Current Liabilities:

        

Accounts Payable

 $13,043  $11,495 

Accrued Compensation and Other Current Liabilities

  11,092   19,665 

Current Portion of Long-Term Debt

  2,386   2,339 

Total Current Liabilities

  26,521   33,499 

Long-Term Debt

  612   1,817 

Deferred Tax Liabilities, net

  9,297   9,291 

Lease Liabilities

  14,661   14,873 

Other Liabilities

  3,705   2,903 

Total Liabilities

  54,796   62,383 
         

Shareholders' Equity:

        

Common Stock, par value $0.50 per share, 30,000,000 shares authorized; 9,199,277 and 8,839,299 shares issued and outstanding as of September 28, 2024 and March 30, 2024, respectively

  4,600   4,420 

Capital in Excess of Par Value

  178,986   141,624 

Accumulated Other Comprehensive Loss

  (718)  (949)

Retained Earnings

  85,889   80,074 

Total Shareholders' Equity

  268,757   225,169 

Total Liabilities and Shareholders' Equity

 $323,553  $287,552 

 

See accompanying notes to consolidated financial statements.

 

 

 

TRANSCAT, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Thousands)

 

   

(Unaudited)

 
   

Six Months Ended

 
   

September 28,

   

September 23,

 
   

2024

   

2023

 

Cash Flows from Operating Activities:

               

Net Income

  $ 7,694     $ 3,409  

Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities:

               

Net Loss on Disposal of Property and Equipment

    43       11  

Deferred Income Taxes

    6       23  

Depreciation and Amortization

    8,513       6,078  

Provision for Accounts Receivable and Inventory Reserves

    108       347  

Stock-Based Compensation Expense

    1,623       2,171  

Changes in Assets and Liabilities, net of acquisitions:

               

Accounts Receivable and Other Receivables

    1,746       2,384  

Inventory

    2,597       3,376  

Prepaid Expenses and Other Current Assets

    (1,918 )     465  

Accounts Payable

    1,525       (3,969 )

Accrued Compensation and Other Current Liabilities

    (6,178 )     1,677  

Net Cash Provided by Operating Activities

    15,759       15,972  
                 

Cash Flows from Investing Activities:

               

Purchase of Property and Equipment

    (7,633 )     (5,444 )

Business Acquisitions, net of cash acquired

    (15,858 )     (12,882 )

Sales of Marketable Securities

    15,533       -  

Net Cash Used in Investing Activities

    (7,958 )     (18,326 )
                 

Cash Flows from Financing Activities:

               

Repayment of Revolving Credit Facility, net

    -       5,288  

Repayments of Term Loan

    (1,158 )     (1,112 )

Issuance of Common Stock, net of direct costs

    838       384  

Repurchase of Common Stock

    (3,026 )     (2,247 )

Net Cash (Used in)/Provided by Financing Activities

    (3,346 )     2,313  
                 

Effect of Exchange Rate Changes on Cash and Cash Equivalents

    (286 )     (244 )
                 

Net Increase/(Decrease) in Cash and Cash Equivalents

    4,169       (285 )

Cash and Cash Equivalents at Beginning of Period

    19,646       1,531  

Cash and Cash Equivalents at End of Period

  $ 23,815     $ 1,246  
                 

Supplemental Disclosure of Cash Flow Activity:

               

Cash (received)/paid during the period for:

               

Interest

  $ (462 )   $ 1,680  

Income Taxes, net

  $ 5,534     $ 1,099  

Supplemental Disclosure of Non-Cash Investing and Financing Activities:

               

Common stock issued for acquisitions

  $ 35,479     $ 34,769  

Assets acquired and liabilities assumed in business combinations:

               

Accrued holdback and contingent consideration related to acquisitions

  $ 1,306     $ 4,589  

Contingent consideration treated as equity related to acquisitions

  $ 750     $ -  

Balance Sheet Reclassification of Property and Equipment, net to Inventory

  $ 692     $ 494  

 

See accompanying notes to consolidated financial statements.

 

 

TRANSCAT, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY

(In Thousands, Except Par Value Amounts)

(Unaudited)

 

                   

Capital

                         
   

Common Stock

   

In

   

Accumulated

                 
   

Issued

   

Excess

   

Other

                 
   

$0.50 Par Value

   

of Par

   

Comprehensive

   

Retained

         
   

Shares

   

Amount

   

Value

   

(Loss)

   

Earnings

   

Total

 

Balance as of March 25, 2023

    7,562     $ 3,781     $ 27,886     $ (1,200 )   $ 69,163     $ 99,630  

Issuance of Common Stock

    82       42       6,988       -       -       7,030  

Repurchase of Common Stock

    (3 )     (2 )     (86 )     -       (213 )     (301 )

Stock-Based Compensation

    2       1       929       -       -       930  

Other Comprehensive Income

    -       -       -       482       -       482  

Net Income

    -       -       -       -       2,949       2,949  

Balance as of June 24, 2023

    7,643     $ 3,822     $ 35,717     $ (718 )   $ 71,899     $ 110,720  

Issuance of Common Stock

    313       156       27,967       -       -       28,123  

Repurchase of Common Stock

    (22 )     (11 )     (593 )     -       (1,342 )     (1,946 )

Stock-Based Compensation

    44       22       1,219       -       -       1,241  

Other Comprehensive Loss

    -       -       -       (346 )     -       (346 )

Net Income

    -       -       -       -       460       460  

Balance as of September 23, 2023

    7,978     $ 3,989     $ 64,310     $ (1,064 )   $ 71,017     $ 138,252  

 

                   

Capital

                         
   

Common Stock

   

In

   

Accumulated

                 
   

Issued

   

Excess

   

Other

                 
   

$0.50 Par Value

   

of Par

   

Comprehensive

   

Retained

         
   

Shares

   

Amount

   

Value

   

(Loss)

   

Earnings

   

Total

 

Balance as of March 30, 2024

    8,839     $ 4,420     $ 141,624     $ (949 )   $ 80,074     $ 225,169  

Issuance of Common Stock

    302       151       32,888       -       -       33,039  

Contingent Consideration Classified as Equity

    -       -       750       -       -       750  

Repurchase of Common Stock

    (13 )     (7 )     (652 )     -       (961 )     (1,620 )

Stock-Based Compensation

    16       8       689       -       -       697  

Other Comprehensive Loss

    -       -       -       (155 )     -       (155 )

Net Income

    -       -       -       -       4,408       4,408  

Balance as of June 29, 2024

    9,144     $ 4,572     $ 175,299     $ (1,104 )   $ 83,521     $ 262,288  

Issuance of Common Stock

    53       26       3,251       -       -       3,277  

Repurchase of Common Stock

    (11 )     (5 )     (483 )     -       (918 )     (1,406 )

Stock-Based Compensation

    13       7       919       -       -       926  

Other Comprehensive Income

    -       -       -       386       -       386  

Net Income

    -       -       -       -       3,286       3,286  

Balance as of September 28, 2024

    9,199     $ 4,600     $ 178,986     $ (718 )   $ 85,889     $ 268,757  

 

See accompanying notes to consolidated financial statements.

 

 

TRANSCAT, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

 

NOTE 1 GENERAL

 

Description of Business: Transcat, Inc. (“Transcat,” “we,” “us,” “our” or the “Company”) is a leading provider of accredited calibration services, cost control and optimization services, and distribution and rental of value-added professional grade handheld test, measurement and control instrumentation. The Company is focused on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceutical, biotechnology, medical device and other FDA-regulated businesses. Additional industries served include industrial manufacturing; energy and utilities, including oil and gas; chemical manufacturing; FAA-regulated businesses, including aerospace and defense and other industries that require accuracy in their processes, confirmation of the capabilities of their equipment, and for which the risk of failure is very costly.

 

Basis of Presentation: Transcat’s unaudited Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the Securities and Exchange Commission (“SEC”). Accordingly, the Consolidated Financial Statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of the Company’s management, all adjustments considered necessary for a fair presentation (consisting of normal recurring adjustments) have been included. The results for the interim periods are not necessarily indicative of what the results will be for the fiscal year. The accompanying Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements as of and for the fiscal year ended  March 30, 2024 (“fiscal year 2024”) contained in the Company’s Annual Report on Form 10-K for fiscal year 2024 filed with the SEC.

 

Use of Estimates: The preparation of Transcat’s Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States ("GAAP") requires that the Company make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions are used for, but not limited to, allowance for credit losses and returns, inventory reserves, estimated levels of achievement for performance-based restricted stock units, fair value of stock options, depreciable lives of fixed assets, estimated lives of intangible assets, fair value of the goodwill reporting units, and the valuation of assets acquired, liabilities assumed and consideration transferred in business acquisitions. Future events and their effects cannot be predicted with certainty; accordingly, accounting estimates require the exercise of judgment. The accounting estimates used in the preparation of the Consolidated Financial Statements may change as new events occur, as more experience is acquired, as additional information is obtained and as the operating environment changes. Actual results could differ from those estimates. Such changes and refinements in estimation methodologies are reflected in reported results of operations in the period in which the changes are made and, if material, their effects are disclosed in the Notes to the Consolidated Financial Statements.

 

Cash and Cash Equivalents:  Cash equivalents consist of highly liquid investments with an original maturity when purchased of three months or less and are stated at cost, which approximates fair value.

 

Marketable Securities: Marketable securities consist of highly liquid investments with an original maturity when purchased of more than three months and are stated at fair value on the Consolidated Balance Sheets.  These securities are considered trading securities. Earnings on the marketable securities are included in interest income in the Consolidated Statements of Income.

 

Revenue Recognition:  Distribution non-rental revenue is recorded when an order’s title and risk of loss transfers to the customer, which is generally upon shipment. Distribution rental revenue is recognized over time using the time-elapsed output method as this portrays the transfer of control to the customer. The Company recognizes the majority of its Service revenue based upon when the calibration or other activity is performed and then shipped and/or delivered to the customer. The majority of the Company’s revenue generating activities have a single performance obligation and are recognized at the point in time when control transfers and/or our obligation has been fulfilled. Some Service revenue is generated from managing customers’ calibration programs in which the Company recognizes revenue over time using the time-elapsed output method as this portrays the transfer of control to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for product shipped or services performed. Sales taxes and other taxes billed and collected from customers are excluded from revenue. The Company generally invoices its customers for freight, shipping, and handling charges. Freight billed to customers is included in revenue. Shipping and handling is not included in revenue. Provisions for customer returns are provided for in the period the related revenue is recorded based upon historical data.

   

6

 

Under Accounting Standards Codification ("ASC") Topic 606, Revenue from Contracts with Customers, we use judgments that could potentially impact both the timing of our satisfaction of performance obligations. Such judgments include considerations in determining our transaction prices and when our performance obligations are satisfied for our standard product sales that include general payment terms that are between net 30 and 90 days.

 

Revenue recognized from prior period performance obligations for the second quarter of the fiscal year ending March 29, 2025 (“fiscal year 2025”) was immaterial. As of September 28, 2024, the Company had no unsatisfied performance obligations for contracts with an original expected duration of greater than one year. Pursuant to ASC Topic 606, the Company applied the practical expedient with respect to disclosure of the deferral and future expected timing of revenue recognition for transaction price allocated to remaining performance obligations. Deferred revenue, unbilled revenue and deferred contract costs recorded on our Consolidated Balance Sheets as of September 28, 2024 and March 30, 2024 were immaterial. See Note 4 for disaggregated revenue information.

 

  

% of Total Net Sales

 
  

Second Quarter Ended

  

Six Months Ended

 
  

September 28,

  

September 23,

  

September 28,

  

September 23,

 
  

2024

  

2023

  

2024

  

2023

 

Point-in-Time

  86.6%  90.4%  86.1%  90.5%

Over Time - Output Method

  13.4%  9.6%  13.9%  9.5%

Total

  100.0%  100.0%  100.0%  100.0%

 

Fair Value of Financial Instruments:  Transcat has determined the fair value of debt and other financial instruments using a valuation hierarchy. The hierarchy, which prioritizes the inputs used in measuring fair value, consists of three levels. Level 1 uses observable inputs such as quoted prices in active markets; Level 2 uses inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, which is defined as unobservable inputs in which little or no market data exists, requires the Company to develop its own assumptions. The carrying amount of debt on the Consolidated Balance Sheets approximates fair value due to variable interest rate pricing on a portion of the debt with the balance bearing an interest rate approximating current market rates, and the carrying amounts for cash and cash equivalents, marketable securities, accounts receivable and accounts payable approximate fair value due to their short-term nature. Investment assets, which fund the Company’s non-qualified deferred compensation plan, consist of mutual funds and are valued based on Level 1 inputs.  At each of September 28, 2024 and March 30, 2024, investment assets totaled $0.1 million, and are included as a component of other assets (non-current) on the Consolidated Balance Sheets.

 

Stock-Based Compensation:  The Company measures the cost of services received in exchange for all equity awards granted, including stock options and restricted stock units, based on the fair market value of the award as of the grant date. The Company records compensation cost related to unvested equity awards by recognizing, on a straight-line basis, the unamortized grant date fair value over the remaining service period for awards expected to vest. Excess tax benefits for share-based award activity are reflected in the Consolidated Statements of Income as a component of the provision for income taxes. Excess tax benefits are realized benefits from tax deductions for exercised awards in excess of the deferred tax asset attributable to stock-based compensation costs for such awards. The Company did not capitalize any stock-based compensation costs as part of an asset. The Company estimates forfeiture rates based on its historical experience. During the first six months of fiscal year 2025 and fiscal year 2024, the Company recorded non-cash stock-based compensation cost of $1.6 million and $2.2 million, respectively, in the Consolidated Statements of Income.

 

Foreign Currency Translation and Transactions:  The accounts of Cal OpEx Limited (d/b/a Transcat Ireland), an Irish company, and Transcat Canada Inc., both of which are wholly-owned subsidiaries of the Company, are maintained in their local currencies, the Euro and the Canadian dollar, respectively, and have been translated to U.S. dollars. Accordingly, the amounts representing assets and liabilities have been translated at the period-end rates of exchange and related revenue and expense accounts have been translated at an average rate of exchange during the period. Gains and losses arising from translation of Cal OpEx Limited’s and Transcat Canada Inc.’s financial statements into U.S. dollars are recorded directly to the accumulated other comprehensive loss component of shareholders’ equity.

 

7

 

Transcat records foreign currency gains and losses on business transactions denominated in foreign currency. The net foreign currency was a net loss of $0.4 million for the first six months of fiscal year 2025 and a net gain of less than $0.1 million for the first six months of fiscal year 2024. The Company continually utilizes short-term foreign exchange forward contracts to reduce the risk that its future earnings denominated in Canadian dollars would be adversely affected by changes in currency exchange rates. The Company does not apply hedge accounting and therefore the net change in the fair value of the contracts, which totaled a gain of less than $0.1 million during each of the first six months of fiscal years 2025 and 2024, was recognized as a component of Interest and Other Expenses, net in the Consolidated Statements of Income. The change in the fair value of the contracts is offset by the change in fair value on the underlying accounts receivables denominated in Canadian dollars being hedged. On September 28, 2024, the Company had a foreign exchange contract, which matured in October 2024, outstanding in the notional amount of $2.5 million. This contract was subsequently renewed and remains in place. The Company does not use hedging arrangements for speculative purposes.

 

Earnings Per Share: Basic earnings per share of the Company's common stock, par value $0.50 per share ("common stock"), are computed based on the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share of common stock reflect the assumed conversion of stock options, unvested restricted stock units using the treasury stock method and contingent consideration classified as equity in periods in which they have a dilutive effect. In computing the per share effect of assumed conversion, proceeds received from the exercise of options and unvested restricted stock units are considered to have been used to purchase shares of common stock at the average market prices during the period, and the resulting net additional shares of common stock are included in the calculation of average shares of common stock outstanding.

 

For the second quarter of fiscal year 2025, the net additional common stock equivalents had a ($0.01) effect on the calculation of diluted earnings per share.   For the second quarter of fiscal year 2024, the net additional common stock equivalents had no effect on the calculation of diluted earnings per share.  For the first six months of each of fiscal years 2025 and 2024, the net additional common stock equivalents had a ($0.01) effect on the calculation of diluted earnings per share. The average shares outstanding used to compute basic and diluted earnings per share are as follows (amounts in thousands):

 

  

Second Quarter Ended

  

Six Months Ended

 
  

September 28,

  

September 23,

  

September 28,

  

September 23,

 
  

2024

  

2023

  

2024

  

2023

 

Average Shares Outstanding – Basic

  9,160   7,819   9,107   7,732 

Effect of Dilutive Common Stock Equivalents

  122   129   115   108 

Average Shares Outstanding – Diluted

  9,282   7,948   9,222   7,840 

Anti-dilutive Common Stock Equivalents

  31   31   41   37 

 

Goodwill and Intangible Assets: Goodwill represents the excess of the purchase price over the fair values of the underlying net assets of an acquired business. The Company tests goodwill for impairment for each reporting unit on an annual basis during the fourth quarter of its fiscal year, or immediately if conditions indicate that such impairment could exist. The Company is permitted, but not required, to qualitatively assess indicators of a reporting unit’s fair value to determine whether it is necessary to perform the two-step goodwill impairment test. If a quantitative test is deemed necessary, a discounted cash flow analysis is prepared to estimate fair value.

 

Intangible assets, namely customer base and covenants not to compete, represent an allocation of purchase price to identifiable intangible assets of an acquired business. Intangible assets are evaluated for impairment when events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. The allocation of goodwill and intangible assets by segment for the fiscal year 2025 additions are preliminary.  A summary of changes in the Company’s goodwill and intangible assets is as follows (amounts in thousands):

 

  

Goodwill

  

Intangible Assets

 
  

Distribution

  

Service

  

Total

  

Distribution

  

Service

  

Total

 

Net Book Value as of March 30, 2024

 $38,216  $67,369  $105,585  $6,993  $12,994  $19,987 

Additions

  21,685   10,847   32,532   5,360   2,680   8,040 

Amortization

  -   -   -   (1,443)  (2,222)  (3,665)

Currency Translation Adjustment

  -   10   10   -   -   - 

Net Book Value as of September 28, 2024

 $59,901  $78,226  $138,127  $10,910  $13,452  $24,362 

 

8

 

Other Liabilities: A summary of other current and non-current liabilities is as follows (amounts in thousands):

 

  

(Unaudited)

  

(Audited)

 
  

September 28,

  

March 30,

 
  

2024

  

2024

 

Current Liabilities:

        

Accrued Payroll and Employee Benefits

 $4,982  $5,508 

Accrued Incentives

  1,277   4,182 

Current Portion of Lease Liabilities

  3,201   2,510 

Accrued Acquisition Holdbacks

  514   2,577 

Accrued Sales Tax

  652   813 

Accrued Contingent Consideration

  -   529 

Income Taxes Payable

     2,926 

Other Current Liabilities

  466   620 

Accrued Compensation and Other Current Liabilities

 $11,092  $19,665 
         

Non-Current Liabilities:

        

Postretirement Benefit Obligation

 $1,132  $1,134 

Accrued Acquisition Holdbacks

  1,647   1,647 

Accrued Contingent Consideration

  806   - 

Other Non-Current Liabilities

  120   122 

Other Liabilities

 $3,705  $2,903 

 

Recent Accounting Guidance Not Yet Adopted:  In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280).  The ASU requires disclosures, on an annual and interim basis, of significant segment expenses and other segment items that are regularly provided to the Chief Operating Decision Maker ("CODM") as well as the title and position of the CODM. ASU 2023-07 is effective for annual periods beginning in fiscal 2025 and interim periods in fiscal year 2026 with early adoption permitted.  The adoption of this ASU is expected to impact the Company's financial statement disclosures but have no material impact on our results of operations, cash flows or financial condition.

 

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures.  The ASU expands the income tax disclosure requirements, principally related to the rate reconciliation table and income taxes paid.  ASU 2023-09 is effective for annual periods beginning in fiscal 2026, with early adoption permitted.  The adoption of the ASU is not expected to have a material impact on the Company’s financial statement disclosures.

 

9

 
 

NOTE 2 LONG-TERM DEBT

 

On July 7, 2021, the Company entered into the Second Amended and Restated Credit Facility Agreement (the “Credit Agreement”) with Manufacturers and Traders Trust Company (“M&T”), that amended and restated in its entirety the Company’s prior credit agreement with M&T.

 

The Credit Agreement provides for a revolving credit commitment (the “revolving credit facility”) of $80.0 million through June 2026, with a letter of credit subfacility of $10.0 million. The Company's 2018 term loan, with an original principal amount of $15.0 million (the "2018 Term Loan"), is also provided for under the Credit Agreement.

 

The Credit Agreement allows the Company to use up to $50.0 million under the revolving credit facility for acquisitions in any single fiscal year. The Credit Agreement restricts the Company's ability to complete acquisitions of businesses with a principal place of business located in the United Kingdom or the European Union to an aggregate purchase price of $40.0 million during the term of the Credit Agreement, if the acquisition is financed directly or indirectly with the revolving credit facility.

 

Under the Credit Agreement, the Company may make restricted payments up to $25.0 million in the aggregate over the term of the Credit Agreement and $10.0 million in any single fiscal year to repurchase shares and pay dividends.

 

As of September 28, 2024, $80.0 million was available for borrowing under the revolving credit facility.  As of September 28, 2024, there were no amounts outstanding under the revolving credit facility. 

 

As of September 28, 2024, $3.0 million was outstanding on the 2018 Term Loan, of which $2.4 million was included in current liabilities on the Consolidated Balance Sheets with the remainder included in long-term debt. The 2018 Term Loan requires total amortizing repayments (principal plus interest) of $0.2 million per month through its maturity date in December 2025.

 

Interest and Other Costs: Effective July 1, 2023, interest on outstanding borrowings under the revolving credit facility accrue, at Transcat’s election, at either the variable Daily Simple SOFR or a fixed rate for a designated period at the SOFR corresponding to such period (subject to a 0.25% floor), in each case, plus a margin.  Unused fees accrue based on the average daily amount of unused credit available on the revolving credit facility. Interest rate margins and unused fees are determined on a quarterly basis based upon the Company’s calculated leverage ratio. The Company’s interest rate for the revolving credit facility for the first six months of fiscal year 2025 was 7.1%.  Interest on outstanding borrowings under the 2018 Term Loan accrue at a fixed rate of 3.90% over the term of the loan. 

 

Covenants: The Credit Agreement has certain covenants with which the Company must comply, including a fixed charge ratio covenant, which prohibits the Company's fixed charge ratio from being less than 1.15 to 1.00, and a leverage ratio covenant, which prohibits the Company's leverage ratio from exceeding 3.00 to 1.00. The Company was in compliance with all loan covenants and requirements during the first six months of fiscal year 2025. The Company's leverage ratio, as defined in the Credit Agreement, was 0.08 at September 28, 2024, compared with 0.10 at March 30, 2024.

 

Other Terms: The Company has pledged all of its U.S. tangible and intangible personal property, the equity interests of its U.S.-based subsidiaries, and a majority of the common stock of Transcat Canada Inc. as collateral security for the loans made under the revolving credit facility.

 

10

 
 

NOTE 3 STOCK-BASED COMPENSATION

 

In September 2021, the Transcat, Inc. 2021 Stock Incentive Plan (the “2021 Plan”) was approved by shareholders and became effective. The 2021 Plan replaced the Transcat, Inc. 2003 Incentive Plan (the “2003 Plan”). Shares available for grant under the 2021 Plan include any shares remaining available for issuance under the 2003 Plan and any shares that are subject to outstanding awards under the 2003 Plan that are subsequently canceled, expired, forfeited, or otherwise not issued or are settled in cash. The 2021 Plan provides for, among other awards, grants of restricted stock units and stock options to directors, officers and key employees at the fair market value at the date of grant.  At September 28, 2024, 0.6 million shares of common stock were available for future grant under the 2021 Plan.

 

The Company receives an excess tax benefit related to restricted stock vesting and stock options exercised and redeemed. The discrete tax benefits related to share-based compensation and stock option activity during the first six months of fiscal year 2025 and fiscal year 2024 were $1.1 million and $0.6 million, respectively.

 

Restricted Stock Units:  The Company grants time-based and performance-based restricted stock units as a component of executive and key employee compensation. Expense for restricted stock unit grants is recognized on a straight-line basis for the service period of the stock award based upon fair value of the award on the date of grant. The fair value of the restricted stock unit grants is the quoted market price for the Company’s common stock on the date of grant. These restricted stock units are either time vested, or vest following the third fiscal year from the date of grant subject to cumulative diluted earnings per share or cumulative Adjusted EBITDA targets over the eligible period.

 

Compensation cost ultimately recognized for performance-based restricted stock units will equal the grant date fair market value of the unit that coincides with the actual outcome of the performance conditions. On an interim basis, the Company records compensation cost based on the estimated level of achievement of the performance conditions. The expense relating to the time vested restricted stock units is recognized on a straight-line basis over the requisite service period for the entire award.

 

The following table summarizes the non-vested restricted stock units outstanding as of September 28, 2024 (in thousands, except per unit data):

 

       

Total

   

Grant Date

 

Estimated

       

Number

   

Fair

 

Level of

Date

 

Measurement

 

of Units

   

Value

 

Achievement at

Granted

 

Period

 

Outstanding

   

Per Unit

 

September 28, 2024

October 2018

 

October 2018 – September 2028

  5     $ 20.81  

Time Vested

March 2022

 

March 2022 – March 2025

  1     $ 76.31  

Time Vested

May 2022

 

May 2022 – March 2025

  9     $ 63.17  

Time Vested

May 2022

 

May 2022 – March 2025

  8     $ 63.17  

0% of target level

August 2022

 

August 2022 – August 2025

  1     $ 78.04  

Time Vested

May 2023

 

May 2023 – March 2026

  8     $ 89.70  

150% of target level

May 2023

 

May 2023 – March 2026

  8     $ 89.70  

Time Vested

May 2023

 

May 2023 – May 2026

  13     $ 89.70  

Time Vested

April 2024

 

April 2024 - April 2027

  2     $ 107.13  

Time Vested

April 2024

 

April 2024 - April 2027

  1     $ 108.04  

Time Vested

May 2024

 

May 2024 - May 2027

  1     $ 119.45  

Time Vested

May 2024

 

May 2024 - May 2027

  1     $ 124.12  

Time Vested

May 2024

 

May 2024 - March 2027

  9     $ 124.12  

100% of target level

May 2024

 

May 2024 - March 2027

  10     $ 124.12  

Time Vested

July 2024

 

July 2024 - July 2027

  1     $ 116.91  

Time Vested

September 2024

 

September 2024 - September 2025

  6     $ 120.66  

Time Vested

September 2024

 

September 2024 - September 2027

  1     $ 123.33  

100% of target level

September 2024

 

September 2024 - September 2027

  1     $ 123.33  

Time Vested

 

11

 

Total expense relating to restricted stock units, based on grant date fair value and the achievement criteria, was $0.9 million and $1.5 million in the first six months of fiscal year 2025 and fiscal year 2024, respectively. As of September 28, 2024, unearned compensation, to be recognized over the grants’ respective service periods, totaled $5.0 million based on estimated achievement levels as of September 28, 2024.  If the maximum performance levels were achieved, the unearned compensation could be a maximum of $6.4 million.

 

Stock Options:  The Company grants stock options to employees and directors with an exercise price equal to the quoted market price of the Company’s stock at the date of the grant. The fair value of stock options is estimated using the Black-Scholes option pricing formula that requires assumptions for expected volatility, expected dividends, the risk-free interest rate and the expected term of the option. Expense for stock options is recognized on a straight-line basis over the requisite service period for each award. Options vest either immediately or over a period of up to five years using a straight-line basis and expire either five years or ten years from the date of grant.

 

We calculate the fair value of the stock options granted using the Black-Scholes model. The following weighted-average assumptions were used to value options granted during the first six months of fiscal year 2025 and fiscal year 2024:

 

   

Second Quarter Ended

   

Six Months Ended

 
   

September 28,

   

September 23,

   

September 28,

   

September 23,

 
   

2024

   

2023

   

2024

   

2023

 
                                 

Risk-Free Interest Rate

    4.09 %     4.38 %     4.35 %     3.82 %

Volatility Factor

    40.70 %     36.87 %     40.98 %     37.04 %

Expected Term (in Years)

    4.00       6.27       4.00       6.22  

Annual Dividend Rate

    0.00 %     0.00 %     0.00 %     0.00 %

 

We calculate expected volatility for stock options by taking an average of historical volatility over the expected term. The computation of expected term was determined based on safe harbor rules, giving consideration to the contractual terms of the stock-based awards and vesting schedules. The interest rate for periods within the contractual life of the award is based on the U.S. Treasury yield in effect at the time of grant. We assume no expected dividends. Under FASB ASC Topic 718, Compensation – Stock Compensation, the Company has elected to account for forfeitures as they occur.

 

During the first six months of fiscal year 2025, the Company granted options for 10,000 shares of common stock in the aggregate to Company employees that vest over three years.

 

During the first six months of fiscal year 2024, the Company granted options for 7,000 shares of common stock in the aggregate to Company employees that vest over three years, an option for 10,000 shares of common stock to a Company employee that vests over five years and an option for 10,000 shares of common stock to a Company director that vests over five years.

 

The expense related to all stock option awards was $0.7 million in the first six months of fiscal year 2025 and $0.6 million in the first six months of fiscal year 2024.

 

12

 

The following table summarizes the Company’s options as of and for the first six months ended September 28, 2024 (in thousands, except price per option data and years):

 

           

Weighted

   

Weighted

         
           

Average

   

Average

         
   

Number

   

Exercise

   

Remaining

   

Aggregate

 
   

Of

   

Price Per

   

Contractual

   

Intrinsic

 
   

Options

   

Option

   

Term (in years)

   

Value

 

Outstanding as of March 30, 2024

    234     $ 63.43                  

Granted

    10     $ 112.93                  

Exercised

    (25 )   $ 23.02                  

Forfeited

    (12 )   $ 63.04                  

Outstanding as of September 28, 2024

    207     $ 70.67       6     $ 10,522  

Exercisable as of September 28, 2024

    72     $ 58.95       6     $ 2,838  

 

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price on the last trading day of the second quarter of fiscal year 2025 and the exercise price, multiplied by the number of in-the-money stock options) that would have been received by the option holders had all holders exercised their options on September 28, 2024. The amount of aggregate intrinsic value will change based on the fair market value of the Company’s common stock.

 

Total unrecognized compensation cost related to non-vested stock options as of September 28, 2024 was $2.1 million, which is expected to be recognized over a period of three years. The aggregate intrinsic value of stock options exercised during the first six months of fiscal year 2025 was $2.4 million and during the first six months of fiscal year 2024 was $0.3 million. Cash received from the exercise of options in the first six months of fiscal year 2025 was $0.6 million and during the first six months of fiscal year 2024 was $0.1 million.

 

13

 
 

NOTE 4 SEGMENT INFORMATION

 

The basis for determining our operating segments is the manner in which financial information is used in monitoring our operations. Transcat has two reportable segments: Service and Distribution. Through our Service segment, we offer calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting and other related services. Through our Distribution segment, we sell and rent national and proprietary brand instruments to customers globally. The Company has no inter-segment sales. We believe that reporting performance at the operating income level is the best indicator of segment performance. The following table presents segment and geographic data for the second quarter and first six months of fiscal year 2025 and fiscal year 2024 (dollars in thousands):

 

   

Second Quarter Ended

   

Six Months Ended

 
   

September 28,

   

September 23,

   

September 28,

   

September 23,

 
   

2024

   

2023

   

2024

   

2023

 

Revenue:

                               

Service

  $ 44,083     $ 41,431     $ 87,861     $ 81,284  

Distribution

    23,743       21,373       46,672       42,118  

Total

    67,826       62,804       134,533       123,402  
                                 

Gross Profit:

                               

Service

    14,591       14,084       29,474       27,055  

Distribution

    6,615       6,041       14,387       11,780  

Total

    21,206       20,125       43,861       38,835  
                                 

Operating Expenses:

                               

Service (1)

    10,887       13,342       21,680       23,121  

Distribution (1)

    6,584       5,140       13,347       9,431  

Total

    17,471       18,482       35,027       32,552  
                                 

Operating Income:

                               

Service

    3,704       742       7,794       3,934  

Distribution

    31       901       1,040       2,349  

Total

    3,735       1,643       8,834       6,283  
                                 

Unallocated Amounts:

                               

Interest and Other (Income)/Expense, net

    22       841       (107 )     1,719  

Provision for Income Taxes

    427       342       1,247       1,155  

Total

    449       1,183       1,140       2,874  
                                 

Net Income

  $ 3,286     $ 460     $ 7,694     $ 3,409  
                                 

Geographic Data:

                               

Revenues to Unaffiliated Customers (2)

                               

United States (3)

  $ 62,492     $ 57,119     $ 123,232     $ 111,376  

Canada

    3,794       3,896       8,266       8,143  

Other International

    1,540       1,789       3,035       3,883  

Total

  $ 67,826     $ 62,804     $ 134,533     $ 123,402  

 

(1)

Operating expense allocations between segments are based on actual amounts, a percentage of revenues, headcount, and management’s estimates.

(2)

Revenues are attributed to the countries based on the destination of a product shipment or the location where service is rendered.

(3)

United States includes Puerto Rico.

 

14

 
 

NOTE 5 BUSINESS ACQUISITIONS

 

Becnel:  Effective  April 15, 2024, the Company acquired Becnel Rental Tools, LLC, a privately-held Louisiana limited liability company (“Becnel”), pursuant to an Agreement and Plan of Merger (the “Becnel agreement”), by and among the Company, Becnel and the other parties thereto. Becnel is an ISO 9001:2015 certified provider of rental tools and services primarily utilized in the decommissioning and maintenance of oil wells. This transaction aligned with a key component of the Company’s acquisition strategy of targeting businesses that expand the depth and breadth of the Company’s service and rental capabilities.

 

The  Becnel goodwill is primarily attributable to the workforce acquired, as well as operational synergies and other intangibles that do not qualify for separate recognition. The goodwill and intangible assets relating to the Becnel acquisition have preliminarily been allocated to both the Service and Distribution segment. Intangible assets related to the Becnel acquisition are being amortized for financial reporting purposes on an accelerated basis over the estimated useful life of up to eleven years and are deductible for tax purposes. Amortization of goodwill related to the Becnel acquisition is deductible for income tax purposes.

 

The total purchase price for Becnel was approximately $49.8 million consisting of up to $17.5 million in cash and the issuance of our common stock valued at $32.3 million. Pursuant to the Becnel agreement, the Company held back approximately $2.5 million of the purchase price for certain potential post-closing adjustments.  This includes $0.5 million withheld for ordinary post-closing adjustments and $2.0 million withheld that is subject to revenue target achievement. 

 

Pursuant to the Becnel agreement, the purchase price is subject to reduction by $2.0 million if certain revenue targets are not met through April 15, 2026.  As of April 15, 2024 and September 28, 2024, the estimated fair value of this contingent consideration, classified as Level 3 in the fair value hierarchy, was approximately $1.5 million and $1.6 million, respectively. This amount was calculated using a Geometric Brownian motion distribution that was then used in a Monte Carlo simulation model. Assumptions used in the Monte Carlo simulation model included: 1) discount rate of 11.00%, 2) risk-free interest rate of 5.00%, 3) asset volatility of 30.00%, and 4) forecasted revenue.  50% of this contingent consideration is payable in cash and 50% of this contingent consideration is payable in 9,283 shares of Transcat common stock.  The cash portion of the contingent consideration is classified as a liability and is recorded in other liabilities in the Consolidated Balance Sheets.  The stock portion of the contingent consideration is classified as equity and is recorded in shareholders equity in the Consolidated Balance Sheets.  The contingent consideration payout will either be $0 or $2.0 million depending on the revenue target achievement.

 

This cash portion of the contingent consideration is remeasured quarterly. If, as a result of remeasurement, the value of the cash portion of the contingent consideration changes, any charges or income will be included in the Company’s Consolidated Statements of Income. There was no impact from the remeasurement done during the first six months of fiscal year 2025.  Due to the uncertainty with utilizing these significant unobservable inputs for this Level 3 fair value measurement, materially higher or lower fair value measurements may be recognized at subsequent remeasurement periods.  The stock portion of the contingent consideration is remeasured quarterly.  If, as a result of the measurement, the value of the stock portion of the contingent consideration changes, any changes will be included in the Consolidated Balance Sheets as a component of shareholders equity. 

 

The purchase price allocation is subject to revision based upon our final review of tangible and intangible asset valuation assumptions, working capital adjustments, assets acquired, liabilities assumed and consideration transferred. The following is a summary of the preliminary purchase price allocation, in the aggregate, to the fair value, based on Level 3 inputs, of Becnel's assets and liabilities acquired on April 15, 2024 (in thousands):

 

Goodwill

 

$32,537

 

Intangible Assets – Customer Base & Contracts

    7,200  

Intangible Assets – Trademarks and Tradenames

    840  
        40,577  
         

Plus:

Cash

    214  
 

Accounts Receivable

    3,041  
 

Property and Equipment

    6,122  
 

Other Current Assets

    79  

Less:

Current Liabilities

    (210 )

Total Purchase Price

  $ 49,823  

 

From the date of acquisition through the end of the second quarter of fiscal year 2025, Becnel has contributed revenue of $4.7 million and an operating loss of $0.2 million, which includes the negative impact of amortization of the acquired intangible assets.

 

Axiom: Effective August 8, 2023, Transcat purchased all of the outstanding capital stock of Axiom Test Equipment, Inc. (“Axiom”), a privately-held California rental provider of electronic test equipment to customers across the United States. This transaction aligned with a key component of the Company’s acquisition strategy of targeting businesses that expand the depth and breadth of the Company’s Distribution capabilities.

 

The Axiom goodwill is primarily attributable to the workforce acquired, as well as operational synergies and other intangibles that do not qualify for separate recognition. All the goodwill and intangible assets relating to the Axiom acquisition has been allocated to the Distribution segment. Intangible assets related to the Axiom acquisition are being amortized for financial reporting purposes on an accelerated basis over the estimated useful life of up to twelve years and are not deductible for tax purposes. Amortization of goodwill related to the Axiom acquisition is not deductible for tax purposes.

 

15

 

The total purchase price for Axiom was approximately $38.7 million and was paid with $10.0 million in cash and the issuance of our common stock valued at $28.6 million. Pursuant to the asset purchase agreement, the Company held back approximately $3.9 million of the purchase price for certain potential post-closing adjustments.

 

The following is a summary of the purchase price allocation, in the aggregate, to the fair value, based on Level 3 inputs, of Axiom's assets and liabilities acquired on August 8, 2023 (in thousands):

 

Goodwill

  $ 26,758  

Intangible Assets – Customer Base & Contracts

    7,900  
        34,658  

Plus:

Cash

    161  
 

Accounts Receivable

    925  
 

Inventory

    1,796  
 

Other Current Assets

    40  
 

Property and Equipment

    4,965  

Less:

Current Liabilities

    (579 )
 

Deferred Tax Liability

    (3,242 )

Total Purchase Price

  $ 38,724  

 

During the first six months of fiscal year 2025, Axiom has contributed revenue of $4.7 million and operating income of $0.3 million, which includes the negative impact of amortization of the acquired intangible assets.

 

SteriQual: Effective July 12, 2023, Transcat purchased all of the outstanding capital stock of SteriQual, Inc. (“SteriQual”), a Florida based provider of expert consulting services to pharmaceutical, biopharmaceutical, medical device and diagnostic equipment manufacturers. This transaction aligned with a key component of the Company’s acquisition strategy of targeting businesses that expand the depth and breadth of the Company’s Service capabilities.

 

The SteriQual goodwill is primarily attributable to the workforce acquired, as well as operational synergies and other intangibles that do not qualify for separate recognition. All the goodwill and intangible assets relating to the SteriQual acquisition has been allocated to the Service segment. Intangible assets related to the SteriQual acquisition are being amortized for financial reporting purposes on an accelerated basis over the estimated useful life of up to fifteen years and are not deductible for tax purposes. Amortization of goodwill related to the SteriQual acquisition is not deductible for tax purposes.

 

The total purchase price for SteriQual was approximately $4.3 million and was paid by the issuance of our common stock.  Pursuant to the asset purchase agreement, the Company held back approximately $0.9 million of the purchase price for certain potential post-closing adjustments. Pursuant to the asset purchase agreement, the purchase price is subject to reduction by $0.5 million if certain revenue targets are not met through July 12, 2024. The revenue targets were not met and the remaining $0.4 million of the holdback was paid during the second quarter of fiscal year 2025. The purchase price was reduced to $3.8 million as of December 23, 2023 as the Company recorded a receivable in the amount of $0.5 million related to the revenue target contingent consideration. This receivable was recognized based on the facts and circumstances at the date of acquisition and is recognized as a component of goodwill and not recorded in the Consolidated Statement of Income. 

 

16

 

The following is a summary of the purchase price allocation, in the aggregate, to the fair value, based on Level 3 inputs, of SteriQual's assets and liabilities acquired on July 12, 2023 (in thousands):

 

Goodwill

  $ 2,175  

Intangible Assets – Customer Base & Contracts

    1,062  

Intangible Assets – Covenant Not to Compete

    392  

Intangible Assets – Sales Backlog

    95  
        3,724  

Plus:

Accounts Receivable

    666  

Less:

Current Liabilities

    (211 )
 

Deferred Tax Liability

    (395 )

Total Purchase Price

  $ 3,784  

 

During the first six months of fiscal year 2025, SteriQual has contributed revenue of $1.1 million and operating loss of $0.2 million, which includes the negative impact of amortization of the acquired intangible assets.

 

TIC-MS: Effective March 27, 2023, Transcat purchased all of the outstanding capital stock of TIC-MS, Inc. (“TIC-MS”), a Missouri based provider of calibration services. This transaction aligned with a key component of the Company’s acquisition strategy of targeting businesses that expand the depth and breadth of the Company’s Service capabilities.

 

The TIC-MS goodwill is primarily attributable to the workforce acquired, as well as operational synergies and other intangibles that do not qualify for separate recognition. All the goodwill and intangible assets relating to the TIC-MS acquisition has been allocated to the Service segment. Intangible assets related to the TIC-MS acquisition are being amortized for financial reporting purposes on an accelerated basis over the estimated useful life of up to fifteen years and are not deductible for tax purposes. Amortization of goodwill related to the TIC-MS acquisition is not deductible for tax purposes.

 

The total purchase price for TIC-MS was approximately $9.7 million and was paid with $2.9 million in cash, including $0.5 million placed in escrow for contingent consideration, certain post-closing adjustments and indemnification claims, if any, and the issuance of 77,387 shares of our common stock valued at $6.9 million. Pursuant to the asset purchase agreement, the purchase price was subject to reduction by up to $0.5 million if a key customer relationship is not retained through March 27, 2024.  This key customer relationship was retained and, in the first quarter of fiscal year 2025 the $0.5 million in escrow was released and paid.  

 

The following is a summary of the purchase price allocation, in the aggregate, to the fair value, based on Level 3 inputs, of TIC-MS's assets and liabilities acquired on March 27, 2023 (in thousands):

 

Goodwill

  $ 7,218  

Intangible Assets – Customer Base & Contracts

    2,303  

Intangible Assets – Covenant Not to Compete

    132  
        9,653  

Plus:

Accounts Receivable

    502  
 

Property and Equipment

    356  

Less:

Current Liabilities

    (124 )
 

Deferred Tax Liability

    (712 )

Total Purchase Price

  $ 9,675  

 

During the first six months of fiscal year 2025, TIC-MS has contributed revenue of $1.8 million and operating income of $0.9 million, which includes the negative impact of amortization of the acquired intangible assets.

  

17

  

The results of acquired businesses are included in Transcat’s consolidated operating results as of the dates the businesses were acquired. The following unaudited pro forma information presents the Company’s results of operations as if the acquisitions of Becnel, Axiom, SteriQual and TIC-MS had occurred at the beginning of fiscal year 2024. The pro forma results do not purport to represent what the Company’s results of operations actually would have been if the transactions had occurred at the beginning of the period presented or what the Company’s operating results will be in future periods.

  

   

(Unaudited)

   

(Unaudited)

 
   

Second Quarter Ended

   

Six Months Ended

 

(in thousands except per share information)

 

September 28, 2024

   

September 23, 2023

   

September 28, 2024

   

September 23, 2023

 
                                 

Total Revenue

  $ 67,826     $ 68,948     $ 134,533     $ 137,828  

Net Income

  $ 3,286     $ 435     $ 7,545     $ 2,879  

Basic Earnings Per Share

  $ 0.36     $ 0.06     $ 0.83     $ 0.37  

Diluted Earnings Per Share

  $ 0.35     $ 0.05     $ 0.82     $ 0.37  

 

Certain of the Company’s acquisition agreements include provisions for contingent consideration and other holdback amounts. The Company accrues for contingent consideration and holdback provisions based on their estimated fair value at the date of acquisition and at subsequent remeasurement periods, as applicable.  As of September 28, 2024, $0.5 million of other holdback amounts unpaid are reflected in current liabilities on the Consolidated Balance Sheets and $0.8 million of contingent consideration and $1.6 million of other holdback amounts unpaid are reflected in other liabilities on the Consolidated Balance Sheets. During the first six months of fiscal year 2025, $0.5 million was paid to settle the earn-out obligation due to Cal OpEx Limited (d/b/a NEXA Enterprise Asset Management)(“NEXA”) for calendar 2023.  This amount was paid in 4,320 shares of Transcat common stock. During the first six months of fiscal year 2025, $2.3 million was paid to settle a holdback due to Axiom.  This amount was paid in 26,379 shares of Transcat common stock.  During the first six months of fiscal year 2025, $0.4 million was paid to settle a holdback to SteriQual.  This amount was paid in 4,763 shares of Transcat common stock.  During the first six months of fiscal year 2024, no contingent consideration and $0.3 million of other holdback amounts were paid.

 

During the first six months of fiscal year 2025 and fiscal year 2024, acquisition costs of $0.4 million and $0.2 million, respectively, were recorded as incurred as general and administrative expenses in the Consolidated Statements of Income.

 

 

NOTE 6  SUBSEQUENT EVENT

 

On October 30, 2024, the Company entered into an asset purchase agreement with Wiscale, LLC, a Wisconsin limited liability company and subsidiary of Nesnah Ventures, LLC (the “Purchaser”), pursuant to which the Company sold the assets, and certain liabilities, of the Company’s United Scale & Engineering division which is engaged in the business of selling, renting and servicing weighing systems, scales and balances, including truck scales, and related parts to the Purchaser. The aggregate consideration received by the Company for the sale was $1.1 million, subject to customary closing adjustments.

 

 

 

 

 

 

ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Forward-Looking Statements. This report contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to expectations, estimates, beliefs, assumptions and predictions of future events and are identified by words such as “anticipate,” “believes,” “estimates,” “expects,” “potential,” “outlook,” “seek,” “strategy,” “target,” “could,” "can," “may,” “will,” “would,” and other similar words. Forward-looking statements are not statements of historical fact and thus are subject to risks, uncertainties and other factors that could cause actual results to differ materially from historical results or those expressed in such forward-looking statements. You should evaluate forward-looking statements in light of important risk factors and uncertainties that may affect our operating and financial results and our ability to achieve our financial objectives. These factors include, but are not limited to, general economic conditions applicable to our business, inflationary impacts and changes in interest rates, the highly competitive nature of the industries in which we compete and in the nature of our two business segments, the concentration of Service segment customers in the life science and other FDA-regulated and industrial manufacturing industries, the significant competition we face in our Distribution segment, any impairment of our goodwill or intangible assets, tariffs and trade relations, our ability to successfully complete and integrate business acquisitions, cybersecurity risks, the risk of significant disruptions in our information technology systems, our ability to recruit, train and retain quality employees, skilled technicians and senior management, fluctuations in our operating results, our ability to achieve or maintain adequate utilization and pricing rates for our technical service providers, the prices we are able to charge for our services in our Service segment, competition in the rental market, our ability to adapt our technology, reliance on our enterprise resource planning system, technology updates, supply chain delays or disruptions, the risks related to current and future indebtedness, foreign currency rate fluctuations, risks related to our intellectual property, geopolitical events, adverse weather events or other catastrophes, natural disasters or widespread public health crises, the volatility of our stock price, the relatively low trading volume of our common stock, changes in tax rates, changes in accounting standards, legal requirements and listing standards, and legal and regulatory risks related to our international operations. These risk factors and uncertainties are more fully described by us under the heading “Risk Factors” in our reports filed with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended March 30, 2024. You should not place undue reliance on our forward-looking statements, which speak only as of the date they are made. Except as required by law, we undertake no obligation to update, correct or publicly announce any revisions to any of the forward-looking statements contained in this report, whether as a result of new information, future events or otherwise.

 

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

 

There have been no material changes to our critical accounting policies and estimates from the information provided in our Annual Report on Form 10-K for the fiscal year ended March 30, 2024.

 

RESULTS OF OPERATIONS

 

Executive Summary

 

During our second quarter of fiscal year 2025, we had consolidated revenue of $67.8 million. This represented an increase of $5.0 million or 8.0% versus the second quarter of fiscal year 2024. This increase was primarily due to acquisitions, demand in our Service segment’s highly-regulated end markets and increased rental sales, which includes incremental revenue from acquisitions.  See Note 5 – “Business Acquisitions” to our unaudited consolidated financial statements in this report for more information about the impact of our acquisitions.

 

Our second quarter of fiscal year 2025 gross profit was $21.2 million. This was an increase of $1.1 million or 5.4% versus the second quarter of fiscal year 2024. In addition, consolidated gross margin was 31.3%, a decrease of 70 basis points versus the second quarter of fiscal year 2024. This decrease was due to lower margins from NEXA and Becnel.

 

Total operating expenses were $17.5 million in the second quarter of fiscal year 2025, a decrease of $1.0 million or 5.5% when compared to the prior fiscal year second quarter. Included in operating expenses during the second quarter of fiscal year 2025 were incremental operating expenses from the acquisitions of Becnel, Axiom and SteriQual, investments in technology and higher incentive-based employee costs due to higher sales.  Included in operating expenses during the second quarter of fiscal year 2024 was a $2.8 million non-cash charge related to the amended NEXA earn-out agreement.  As a percentage of total revenue, operating expenses were 25.8% in the second quarter of fiscal year 2025, down 360 basis points from 29.4% in the second quarter of fiscal year 2024. Operating income was $3.7 million, an increase of $2.1 million, or 127.3% and operating margin increased from 2.6% to 5.5% in the second quarter of fiscal year 2025.

 

Net income was $3.3 million in the second quarter of fiscal year 2025 versus $0.5 million in the second quarter of fiscal year 2024. The increase was primarily due to higher operating income and lower interest expense.

 

 

The following table presents, for the second quarter and for the first six months of fiscal year 2025 and fiscal year 2024, the components of our Consolidated Statements of Income:

 

   

(Unaudited)

   

(Unaudited)

 
   

Second Quarter Ended

   

Six Months Ended

 
   

September 28,

   

September 23,

   

September 28,

   

September 23,

 
   

2024

   

2023

   

2024

   

2023

 

As a Percentage of Total Revenue:

                               

Service Revenue

    65.0 %     66.0 %     65.3 %     65.9 %

Distribution Revenue

    35.0 %     34.0 %     34.7 %     34.1 %

Total Revenue

    100.0 %     100.0 %     100.0 %     100.0 %
                                 

Gross Profit Percentage:

                               

Service Gross Profit

    33.1 %     34.0 %     33.5 %     33.3 %

Distribution Gross Profit

    27.9 %     28.3 %     30.8 %     28.0 %

Total Gross Profit

    31.3 %     32.0 %     32.6 %     31.5 %
                                 

Selling, Marketing and Warehouse Expenses

    12.1 %     10.9 %     11.9 %     10.8 %

General and Administrative Expenses

    13.7 %     18.5 %     14.2 %     15.6 %

Total Operating Expenses

    25.8 %     29.4 %     26.0 %     26.4 %
                                 

Operating Income

    5.5 %     2.6 %     6.6 %     5.1 %
                                 

Interest and Other (Income)/Expense, net

    0.0 %     1.3 %     (0.1 )%     1.4 %
                                 

Income Before Provision for Income Taxes

    5.5 %     1.3 %     6.6 %     3.7 %

Provision for Income Taxes

    0.6 %     0.6 %     0.9 %     0.9 %
                                 

Net Income

    4.8 %     0.7 %     5.7 %     2.8 %

 

Second QUARTER ENDED September 28, 2024 COMPARED TO Second QUARTER ENDED September 23, 2023 (dollars in thousands):

 

Revenue:

 

   

Second Quarter Ended

   

Change

 
   

September 28,

   

September 23,

                 
   

2024

   

2023

   

$

      %

Revenue:

                               

Service

  $ 44,083     $ 41,431     $ 2,652       6.4 %

Distribution

    23,743       21,373       2,370       11.1 %

Total

  $ 67,826     $ 62,804     $ 5,022       8.0 %

 

Total revenue was $67.8 million, an increase of $5.0 million, or 8.0%, in our fiscal year 2025 second quarter compared to the prior fiscal year second quarter.

 

Service revenue, which accounted for 65.0% and 66.0% of our total revenue in the second quarter of fiscal years 2025 and 2024, respectively, increased $2.7 million or 6.4% from the second quarter of fiscal year 2024 to the second quarter of fiscal year 2025. This year-over-year increase included $0.8 million in revenue from the acquisition of Becnel, and also included organic revenue growth of 4.4% driven by end-market demand and continued market share gains.

 

 

Our fiscal years 2025 and 2024 Service revenue growth, in relation to prior fiscal year quarter comparisons, was as follows:

 

   

FY 2025

   

FY 2024

 
   

Q2

   

Q1

   

Q4

   

Q3

   

Q2

   

Q1

 

Service Revenue Growth

    6.4 %     9.8 %     17.5 %     15.4 %     17.5 %     17.6 %

 

The lower growth in Service revenue during the second quarter of fiscal year 2025 was primarily due to a decline in our NEXA cost control and optimization services business as compared to the prior year quarter. We expect to fully integrate NEXA’s sales and marketing into our existing process to drive anticipated revenue growth. Within any fiscal year, while we add new customers, we also have customers from the prior fiscal year whose service orders may not repeat for any number of factors. Among those factors are variations in the timing of periodic calibrations and other services, customer capital expenditures and customer outsourcing decisions. Because the timing of Service segment orders can vary on a quarter-to-quarter basis, we believe trailing twelve-month information provides a better indication of the progress of this segment.

 

The following table presents the trailing twelve-month Service segment revenue for the first and second quarter of fiscal year 2025 and each quarter in fiscal year 2024 as well as the trailing twelve-month revenue growth as a comparison to that of the prior fiscal year period:

 

   

FY 2025

   

FY 2024

 
   

Q2

   

Q1

   

Q4

   

Q3

   

Q2

   

Q1

 

Trailing Twelve-Month:

                                               

Service Revenue

  $ 176,006     $ 173,450     $ 169,525     $ 162,556     $ 157,024     $ 150,860  

Service Revenue Growth

    12.1 %     15.0 %     17.0 %     16.3 %     17.1 %     17.6 %

 

Our strategy has been to focus our investments in the core electrical, temperature, pressure, physical/dimensional and radio frequency/microwave calibration disciplines. We expect to subcontract approximately 13% to 15% of our Service revenue to third-party vendors for calibration beyond our chosen scope of capabilities. We continually evaluate our outsourcing needs and make capital investments, as deemed necessary, to add more in-house capabilities and reduce the need for third-party vendors. Capability expansion through business acquisitions is another way that we seek to reduce the need for outsourcing. The following table presents the source of our Service revenue and the percentage of Service revenue derived from each source for the first and second quarter of fiscal year 2025 and for each quarter during fiscal year 2024:

 

   

FY 2025

   

FY 2024

 
   

Q2

   

Q1

   

Q4

   

Q3

   

Q2

   

Q1

 

Percent of Service Revenue:

                                               

In-House

    86.6 %     86.9 %     87.0 %     86.2 %     85.8 %     87.3 %

Outsourced

    12.3 %     12.0 %     11.9 %     12.6 %     13.0 %     11.6 %

Freight Billed to Customers

    1.1 %     1.1 %     1.1 %     1.2 %     1.2 %     1.1 %
      100.0 %     100.0 %     100.0 %     100.0 %     100.0 %     100.0 %

 

 

Our Distribution revenue accounted for 35.0% of our total revenue in the second quarter of fiscal year 2025 and 34.0% of our total revenue in the second quarter of fiscal year 2024. During the second quarter of fiscal year 2025, Distribution segment revenue was $23.7 million which was an increase of $2.3 million or 11.1%.  This increase was due to $2.0 million of incremental revenue from the acquisitions of Axiom and Becnel, incremental rental revenue, offset by slower demand for our non-rental products.

 

The following table presents the quarterly historical trend of Distribution revenue in fiscal years 2025 and 2024 compared to the prior year fiscal quarter:

 

   

FY 2025

   

FY 2024

 
   

Q2

   

Q1

   

Q4

   

Q3

   

Q2

   

Q1

 

Distribution Revenue Growth (Decline)

    11.1 %     10.5 %     8.4 %     10.4 %     0.9 %     (0.2 )%

 

The Distribution segment revenue increase for the second quarter of fiscal year 2025 versus the second quarter of fiscal year 2024 was due to revenue from the acquisitions of Axiom and Becnel and increases in traditional rental products.

 

Distribution revenue orders include orders for instruments that we routinely stock in our inventory, customized products, and other products ordered less frequently, which we do not stock. Product backorders are the total dollar value of orders received for which revenue has not yet been recognized. Pending product shipments are primarily backorders, but also include products that are requested to be calibrated in our service centers prior to shipment, orders required by the customer to be shipped complete or at a future date, and other orders awaiting final credit or management review prior to shipment. Management uses pending product shipments and backorders as measures of our future business performance and financial performance within the distribution segment.

 

The following table presents our total pending product shipments and the percentage of total pending product shipments that were backorders at the end of the first and second quarter of fiscal year 2025 and each quarter of fiscal year 2024:

 

   

FY 2025

   

FY 2024

 
   

Q2

   

Q1

   

Q4

   

Q3

   

Q2

   

Q1

 

Total Pending Product Shipments

  $ 4,102     $ 4,713     $ 5,079     $ 4,652     $ 6,332     $ 7,109  

% of Pending Product

                                               

Shipments that were Backorders

    84.7 %     78.4 %     88.8 %     82.0 %     87.4 %     85.0 %

 

Our total pending product shipments at the end of the second quarter of fiscal year 2025 were $4.1 million, a decrease of $2.2 million versus the end of the second quarter of fiscal year 2024 and a decrease of $1.0 million since March 30, 2024. The decrease in pending product shipments and backorders was a result of improved fulfillment of existing orders.

 

Gross Profit:

 

   

Second Quarter Ended

   

Change

 
   

September 28,

   

September 23,

                 
   

2024

   

2023

   

$

      %

Gross Profit:

                               

Service

  $ 14,591     $ 14,084     $ 507       3.6 %

Distribution

    6,615       6,041       574       9.5 %

Total

  $ 21,206     $ 20,125     $ 1,081       5.4 %

  

Total gross profit for the second quarter of fiscal year 2025 was $21.2 million, an increase of $1.1 million or 5.4% versus the second quarter of fiscal year 2024. Total gross margin was 31.3% in the second quarter of fiscal year 2025, down from 32.0% in the second quarter of fiscal year 2024, a 70 basis point decrease.

 

Service gross profit in the second quarter of fiscal year 2025 increased $0.5 million, or 3.6%, from the second quarter of fiscal year 2024. Service gross margin was 33.1% in the second quarter of fiscal year 2025, a 90 basis point decrease versus the 34.0% in the second quarter of fiscal year 2024. This decrease in Service gross margin was the result of lower than expected revenue and lower margins from NEXA.

 

 

The following table presents the quarterly historical trend of our Service gross margin as a percent of Service revenue:

 

   

FY 2025

   

FY 2024

 
   

Q2

   

Q1

   

Q4

   

Q3

   

Q2

   

Q1

 

Service Gross Margin

    33.1 %     34.0 %     35.7 %     32.5 %     34.0 %     32.5 %

 

Our Distribution gross margin includes net sales less the direct cost of inventory sold and the direct costs of equipment rental revenues, primarily depreciation expense for the fixed assets in our rental equipment pool, as well as the impact of rebates and cooperative advertising income we receive from vendors, freight billed to customers, freight expenses and direct shipping costs. In general, our Distribution gross margin can vary based upon the mix of products sold, price discounting, and the timing of periodic vendor rebates offered and cooperative advertising programs from suppliers.

 

The following table reflects the quarterly historical trend of our Distribution gross margin as a percent of Distribution revenue:

 

   

FY 2025

   

FY 2024

 
   

Q2

   

Q1

   

Q4

   

Q3

   

Q2

   

Q1

 

Distribution Gross Margin

    27.9 %     33.9 %     30.3 %     31.5 %     28.3 %     27.7 %

  

Distribution segment gross margin was 27.9% in the second quarter of fiscal year 2025 versus 28.3% in the second quarter of fiscal year 2024, a 40 basis point decrease. The decrease in Distribution gross margin was due to lower revenue and margins from Becnel which were impacted by hurricanes in the Gulf of Mexico.

 

Operating Expenses:

 

   

Second Quarter Ended

   

Change

 
   

September 28,

   

September 23,

                 
   

2024

   

2023

   

$

      %

Operating Expenses:

                               

Selling, Marketing and Warehouse

  $ 8,181     $ 6,856     $ 1,325       19.3 %

General and Administrative

    9,290       11,626       (2,336 )     (20.1 )%

Total

  $ 17,471     $ 18,482     $ (1,011 )     (5.5 )%

 

Total operating expenses were $17.5 million in the second quarter of fiscal year 2025 versus $18.5 million during the second quarter of fiscal year 2024. The year-over-year increase in selling, marketing and warehouse expenses is due to increased expenses related to recent acquisitions and higher incentive-based employee costs due to higher sales. The decrease in general and administrative expenses is due to the reduction in the non-cash charge related to the NEXA earn-out in the second quarter of fiscal year 2024 offset by incremental expenses related to acquired companies, increased payroll costs for new employees and continued investments in technology.

 

As a percentage of total revenue, operating expenses were 25.8% in the second quarter of fiscal year 2025 and 29.4% in the second quarter of fiscal year 2024, a decrease of 360 basis points.

 

Income Taxes:

 

   

Second Quarter Ended

   

Change

 
   

September 28,

   

September 23,

                 
   

2024

   

2023

   

$

      %

Provision for Income Taxes

  $ 427     $ 342     $ 85       24.9 %

  

Our effective tax rate for the second quarter of fiscal years 2025 and 2024 was 11.5% and 42.6%, respectively. The tax provision is impacted by higher operating income and lower interest expense. The decrease in effective tax rate is due to the increase in our discrete items.  Our quarterly provision for income taxes is affected by discrete items that may occur in any given period but are not consistent from year to year. The discrete benefits related to share-based compensation activity in the second quarter of fiscal years 2025 and 2024 was $0.6 million and less than $0.1 million, respectively.

 

 

Net Income:

 

   

Second Quarter Ended

   

Change

 
   

September 28,

   

September 23,

                 
   

2024

   

2023

   

$

      %

Net Income

  $ 3,286     $ 460     $ 2,826       614.3 %

 

Net income for the second quarter of fiscal year 2025 increased from the second quarter of fiscal year 2024 primarily due to higher operating income and lower interest expense.

 

Adjusted EBITDA:

 

Total Adjusted EBITDA, a non-GAAP measure, for the second quarter of fiscal year 2025 was $8.9 million, a decrease of $0.5 million or 5.0% versus the second quarter of fiscal year 2024. See “Non-GAAP Financial Measures” below for a description of the non-GAAP measures we use and a reconciliation to the most directly comparable GAAP measures. As a percentage of revenue, Adjusted EBITDA decreased to 13.1% for the second quarter of fiscal year 2025 from 14.9% for the second quarter of fiscal year 2024. The decrease in Adjusted EBITDA during the second quarter of fiscal year 2025 was primarily driven by increases in operating income and depreciation and amortization expense, offset by the decrease in the NEXA earn-out adjustment.

 

Six Months Ended September 28, 2024 COMPARED TO Six Months Ended September 23, 2023 (dollars in thousands):

 

Revenue:

 

   

Six Months Ended

   

Change

 

(dollars in thousands)

 

September 28,

   

September 23,

                 
   

2024

   

2023

   

$

      %

Revenue:

                               

Service

  $ 87,861     $ 81,284     $ 6,577       8.1 %

Distribution

    46,672       42,118       4,554       10.8 %

Total

  $ 134,533     $ 123,402     $ 11,131       9.0 %

 

Service revenue, which accounted for 65.3% and 65.9% of our total revenue in the first six months of fiscal years 2025 and 2024, respectively, increased $11.1 million or 9.0% from the first six months of fiscal year 2024 to the first six months of fiscal year 2025. This year-over-year increase included $2.2 million in revenue from the acquisitions of SteriQual and Becnel, and also included organic revenue growth of 5.4% driven by end-market demand and continued market share gains.

 

Distribution revenue, which accounted for 34.7% and 34.1% of our total revenue in the first six months of fiscal years 2025 and 2024, respectively, increased $4.6 million, or 10.8%, from the first six months of fiscal year 2024 to the first six months of fiscal year 2025. This year-over-year increase is primarily due to $3.8 million of incremental revenue from the acquisitions of Axiom and Becnel, and increases in rental revenue offset by slower demand for our non-rental products.

 

 

Gross Profit:

 

   

Six Months Ended

   

Change

 

(dollars in thousands)

 

September 28,

   

September 23,

                 
   

2024

   

2023

   

$

      %

Gross Profit:

                               

Service

  $ 29,474     $ 27,055     $ 2,419       8.9 %

Distribution

    14,387       11,780       2,607       22.1 %

Total

  $ 43,861     $ 38,835     $ 5,026       12.9 %

 

Total gross profit for the first six months of fiscal year 2025 was $43.9 million, an increase of $5.0 million or 12.9% versus the first six months of fiscal year 2024. Total gross margin was 32.6% in the first six months of fiscal year 2025, up from 31.5% in the first six months of fiscal year 2024, a 110 basis point increase. This increase in gross margin was primarily due to increased revenue in our Service segment, which allows us to leverage our fixed costs, continued technician productivity improvements, and a favorable sales mix driven by increases in rental revenue in the Distribution segment.

 

Operating Expenses:

 

   

Six Months Ended

   

Change

 

(dollars in thousands)

 

September 28,

   

September 23,

                 
   

2024

   

2023

   

$

      %

Operating Expenses:

                               

Selling, Marketing and Warehouse

  $ 15,982     $ 13,325     $ 2,657       19.9 %

General and Administrative

    19,045       19,227       (182 )     (0.9 )%

Total

  $ 35,027     $ 32,552     $ 2,475       7.6 %

 

Total operating expenses were $35.0 million in the first six months of fiscal year 2025 versus $32.6 million during the first six months of fiscal year 2024, an increase of $2.5 million or 7.6%. The year-over-year increase in selling, marketing and warehouse expenses is due to increased expenses related to recent acquisitions and higher incentive-based employee costs due to higher sales. The decrease in general and administrative expenses is due to the decrease in the non-cash charge related to the NEXA earn-out, offset by incremental expenses related to acquired companies, increased payroll costs for new employees and continued investments in technology.

 

As a percentage of total revenue, operating expenses were 26.0% in the first six months of fiscal year 2025 and 26.4% in the first six months of fiscal year 2024, a decrease of 40 basis points.

 

Income Taxes:

 

   

Six Months Ended

   

Change

 

(dollars in thousands)

 

September 28,

   

September 23,

                 
   

2024

   

2023

   

$

      %

Provision for Income Taxes

  $ 1,247     $ 1,155     $ 92       8.0 %

 

Our effective tax rate for the first six months of fiscal years 2025 and 2024 was 13.9% and 25.3%, respectively.  The tax provision is impacted by higher operating income and lower interest expense. The decrease in effective tax rate is due to the increase in our discrete items.  Our quarterly provision for income taxes is affected by discrete items that may occur in any given period but are not consistent from year to year. The discrete benefits related to share-based compensation activity in the first six months of fiscal years 2025 and 2024 was $1.1 million and $0.6 million, respectively.

 

 

Net Income:

 

   

Six Months Ended

   

Change

 
   

September 28,

   

September 23,

                 
   

2024

   

2023

   

$

      %

Net Income

  $ 7,694     $ 3,409     $ 4,285       125.7 %

 

Net income for the first six months of fiscal year 2025 was $7.7 million, an increase of $4.3 million versus the first six months of fiscal year 2024. The year-over-year increase in net income was primarily due to higher operating income and lower interest expense, net.

 

Adjusted EBITDA:

 

Total Adjusted EBITDA, a non-GAAP measure, for the first six months of fiscal year 2025 was $19.1 million, an increase of $1.3 million or 7.1% versus the first six months of fiscal year 2024. See “Non-GAAP Financial Measures” below for a description of the non-GAAP measures we use and a reconciliation to the most directly comparable GAAP measures.  The increase in Adjusted EBITDA during the first six months of fiscal year 2025 was primarily driven by increases in operating income and depreciation and amortization expense offset by the reduction in the NEXA earn-out adjustment.  As a percentage of revenue, Adjusted EBITDA decreased to 14.2% for the first six months of fiscal year 2025 from 14.4% for the first six months of fiscal year 2024, driven by the reduction in the NEXA earn-out adjustment.

 

Non-GAAP Financial Measures

 

Adjusted EBITDA

 

In addition to reporting net income, a GAAP measure, we present Adjusted EBITDA (earnings before interest, income taxes, depreciation and amortization, non-cash stock compensation expense, acquisition related transaction expenses, and other expense), which is a non-GAAP measure. Our management believes Adjusted EBITDA is an important measure of our operating performance because it allows management, investors and others to evaluate and compare the performance of our core operations from period to period by removing the impact of the capital structure (interest), tangible and intangible asset base (depreciation and amortization), taxes, stock-based compensation expense and other items, which is not always commensurate with the reporting period in which it is included. As such, our management uses Adjusted EBITDA as a measure of performance when evaluating our business segments and as a basis for planning and forecasting. Adjusted EBITDA is also commonly used by rating agencies, lenders and other parties to evaluate our credit worthiness.

 

Adjusted EBITDA is not a measure of financial performance under GAAP and is not calculated through the application of GAAP. As such, it should not be considered as a substitute or alternative for the GAAP measure of net income and, therefore, should not be used in isolation of, but in conjunction with, the GAAP measure. Adjusted EBITDA, as presented, may produce results that vary from the GAAP measure and may not be comparable to a similarly defined non-GAAP measure used by other companies.

 

   

Second Quarter Ended

   

Six Months Ended

 

(dollars in thousands)

 

September 28,

   

September 23,

   

September 28,

   

September 23,

 
   

2024

   

2023

   

2024

   

2023

 

Net Income

  $ 3,286     $ 460     $ 7,694     $ 3,409  

+ Interest (Income) Expense

    (210 )     890       (470 )     1,704  

+ Other Expense (Income)

    232       (49 )     363       15  

+ Tax Provision

    427       342       1,247       1,155  

Operating Income

    3,735       1,643       8,834       6,283  

+ Depreciation & Amortization

    4,399       3,269       8,512       6,059  

+ Transaction Expense

    33       328       467       513  

+ Acquisition Earn-Out Adjustment

    -       2,800       -       2,800  

+ Other (Expense) Income

    (232 )     49       (363 )     (15 )

+ Non-cash Stock Compensation

    926       1,241       1,623       2,171  

Adjusted EBITDA

  $ 8,861     $ 9,330     $ 19,073     $ 17,811  

 

 

Adjusted Diluted Earnings Per Share

 

In addition to reporting Diluted Earnings Per Share, a GAAP measure, we present Adjusted Diluted Earnings Per Share (net income plus acquisition related amortization expense, acquisition related transaction expenses, acquisition related stock-based compensation and acquisition amortization of backlog; divided by the average diluted shares outstanding during the period), which is a non-GAAP measure. Our management believes Adjusted Diluted Earnings Per Share is an important measure of our operating performance because it provides a basis for comparison of our business operations between current, past and future periods by excluding items that we do not believe are indicative of our core operating performance.

 

Adjusted Diluted Earnings Per Share is not a measure of financial performance under GAAP and is not calculated through the application of GAAP. As such, it should not be considered as a substitute or alternative for the GAAP measure of Diluted Earnings Per Share and, therefore, should not be used in isolation of, but in conjunction with, the GAAP measure. Adjusted Diluted Earnings Per Share, as presented, may produce results that vary from the GAAP measure and may not be comparable to a similarly defined non-GAAP measure used by other companies.

 

   

Second Quarter Ended

   

Six Months Ended

 
   

September 28,

   

September 23,

   

September 28,

   

September 23,

 
   

2024

   

2023

   

2024

   

2023

 

Net Income

  $ 3,286     $ 460     $ 7,694     $ 3,409  

+ Amortization of Intangible Assets

    1,888       1,416       3,637       2,509  

+ Acquisition Amortization of Backlog

    4       19       28       19  

+ Acquisition Deal Costs

    33       328       467       513  

+ Acquisition Stock Expense

    130       274       364       456  

+ Income Tax Effect @ 25%

    (514 )     (509 )     (1,124 )     (874 )

+ Acquisition Earn-Out Adjustment

            2,800               2,800  

Adjusted Net Income

    4,827       4,788       11,066       8,832  
                                 

Average Diluted Shares Outstanding

    9,282       7,948       9,222       7,840  
                                 

Diluted Earnings Per Share – GAAP

  $ 0.35     $ 0.06     $ 0.83     $ 0.43  
                                 

Adjusted Diluted Earnings Per Share

  $ 0.52     $ 0.60     $ 1.20     $ 1.13  

 

LIQUIDITY AND CAPITAL RESOURCES

 

We expect that foreseeable liquidity and capital resource requirements will be met through cash and cash equivalents, anticipated cash flows from operations and borrowings from our revolving credit facility. We believe that these sources of financing will be adequate to meet our future requirements.

 

Under our Second Amended and Restated Credit Facility Agreement (the “Credit Agreement”) with Manufacturers and Traders Trust Company (“M&T”), we have access to a revolving credit commitment (the “Revolving Credit Commitment”) of $80.0 million through June 2026, with a letter of credit subfacility of $10.0 million. Our 2018 term loan, with an original principal amount of $15.0 million (the “2018 Term Loan”), is also provided for under the Credit Agreement.

 

The Credit Agreement allows us to use up to $50.0 million under the Revolving Credit Commitment for acquisitions in any single fiscal year. The Credit Agreement restricts our ability to complete acquisitions of businesses with a principal place of business located in the United Kingdom or the European Union to an aggregate purchase price of $40.0 million during the term of the Credit Agreement, if the acquisition is financed directly or indirectly with the Revolving Credit Commitment. Under the Credit Agreement, we may make restricted payments up to $25.0 million in the aggregate over the term of the Credit Agreement and $10.0 million in any single fiscal year to repurchase shares and pay dividends.

 

 

Effective July 1, 2023, interest on outstanding borrowings under the revolving credit facility accrue, at our election, at either the variable Daily Simple SOFR or a fixed rate for a designated period at the SOFR corresponding to such period (subject to a 0.25% floor), in each case, plus a margin. Unused fees accrue based on the average daily amount of unused credit available on the revolving credit facility. Interest rate margins and unused fees are determined on a quarterly basis based upon our calculated leverage ratio. Our interest rate for the revolving credit facility for the first six months of fiscal year 2025 was 7.1%. Interest on outstanding borrowings under the 2018 Term Loan accrue at a fixed rate of 3.90% over the term of the loan. 

 

The Credit Agreement has certain covenants with which we must comply, including a fixed charge ratio covenant, which prohibits our fixed charge coverage ratio from being less than 1.15 to 1.00, and a leverage ratio covenant, which prohibits our leverage ratio from exceeding 3.00 to 1.00. We were in compliance with all loan covenants and requirements during the first six months of fiscal year 2025. Our leverage ratio, as defined in the Credit Agreement, was 0.08 at September 28, 2024, compared with 0.10 at March 30, 2024.

 

As of September 28, 2024, $80.0 million was available for borrowing under the revolving credit facility.  As of September 28, 2024, there were no amounts outstanding under the revolving credit facility.  During the first six months of fiscal year 2025 , we used $15.9 million, drawn from cash and cash equivalents on hand for a business acquisition.  During the first six months of fiscal year 2024, we used $12.9 million, drawn from the revolving credit facility for business acquisitions. 

 

As of September 28, 2024, $3.0 million was outstanding on the 2018 Term Loan, of which $2.4 million was included in current liabilities on the Consolidated Balance Sheets with the remainder included in long-term debt. The 2018 Term Loan requires total repayments (principal plus interest) of $0.2 million per month through December 2025.

 

Cash Flows: The following table is a summary of our Consolidated Statements of Cash Flows (dollars in thousands):

 

   

Six Months Ended

 
   

September 28,

   

September 23,

 
   

2024

   

2023

 

Cash Provided by (Used in):

               

Operating Activities

  $ 15,759     $ 15,972  

Investing Activities

  $ (7,958 )   $ (18,326 )

Financing Activities

  $ (3,346 )   $ 2,313  

 

Operating Activities: Net cash provided by operating activities was $15.8 million during the first six months of fiscal year 2025 compared to $16.0 million of net cash provided by operating activities during the first six months of fiscal year 2024. The year-over-year decrease in cash provided by operating activities was primarily the result of changes in net working capital (defined as current assets less current liabilities). The significant working capital fluctuations were as follows:

 

 

Receivables: Accounts receivable increased $1.2 million during the first six months of fiscal year 2025 inclusive of $3.1 million of accounts receivable acquired during the period. During the first six months of fiscal year 2024, accounts receivable decreased $0.3 million inclusive of $2.1 million of accounts receivable acquired during the period. The year-over-year variation reflects changes in the timing of collections. The following table illustrates our “days sales outstanding” as of September 28, 2024 and September 23, 2023 (dollars in thousands):

 

   

September 28,

   

September 23,

 
   

2024

   

2023

 

Net Sales, for the last two fiscal months

  $ 49,548     $ 45,032  

Accounts Receivable, net

  $ 48,933     $ 44,382  

Days Sales Outstanding

    59       59  

 

 

 

Inventory: Our inventory strategy includes making appropriate large quantity, high dollar purchases with key manufacturers for various reasons, including maximizing on-hand availability of key products, expanding the number of SKUs stocked in anticipation of customer demand, reducing backorders for products with long lead times and optimizing vendor purchase and sales volume discounts. As a result, inventory levels may vary from quarter-to-quarter based on the timing of these large orders in relation to our quarter end. Our inventory balance decreased $1.9 million during the first six months of fiscal year 2025. Our inventory balance decreased by $1.2 million during the first six months of fiscal year 2024 inclusive of $1.7 million of inventory acquired during the period.

 

 

Accounts Payable: Changes in accounts payable may or may not correlate with changes in inventory balances at any given quarter end due to the timing of vendor payments for inventory, as well as the timing of payments for outsourced Service vendors and capital expenditures.  Accounts payable increased $1.5 million during the first six months of fiscal year 2025.  Accounts payable decreased $3.3 million during the first six months of fiscal year 2024. The variances are largely due to the timing of inventory and capital expenditures and other payments in the respective periods.

 

 

Accrued Compensation and Other Current Liabilities: Accrued compensation and other current liabilities include, among other things, amounts paid to employees for non-equity performance-based compensation. At the end of any particular period, the amounts accrued for such compensation may vary due to many factors including changes in expected performance levels, the performance measurement period, and timing of payments to employees.  During the first six months of fiscal year 2025, accrued compensation and other current liabilities decreased by $8.6 million, inclusive of $0.2 million from assumed liabilities, contingent consideration and purchase price holdbacks from acquisition transactions. During the first six months of fiscal year 2024, accrued compensation and other current liabilities increased by $3.1 million, inclusive of $3.5 million from assumed liabilities, contingent consideration and purchase price holdbacks from acquisition transactions. The change from the first six months of fiscal year 2024 was largely due to the inclusion of the acquisition related transactions, partially offset by the timing of income taxes paid.

 

 

Investing Activities: During the first six months of fiscal years 2025 and 2024, we invested $7.6 million and $5.4 million, respectively, in capital expenditures that was used primarily for customer-driven expansion of Service segment capabilities and our rental business.

 

During the first six months of fiscal years 2025 and 2024, we used $15.9 million and $12.9 million, respectively, for business acquisitions.

 

During the first six months of fiscal year 2024, we paid $0.3 million of other holdbacks related to business acquisitions.

 

Financing Activities: During the first six months of fiscal year 2025, $0.8 million in cash was generated from the issuance of common stock.  In addition, we used $1.2 million for scheduled repayments of our term loan and $3.0 million for the “net” awarding of certain share awards to cover employee tax-withholding obligations for share award and stock option activity in fiscal year 2025, which are shown as a repurchase of shares of our common stock.

 

During the first six months of fiscal year 2024, $5.3 million was borrowed from our revolving line of credit and $0.4 million in cash was generated from the issuance of common stock. In addition, we used $1.1 million for scheduled repayments of our term loan and $2.2 million for the “net” awarding of certain share awards to cover employee tax-withholding obligations for share award and stock option activity in fiscal year 2024, which are shown as a repurchase of shares of our common stock.    

 

 

OUTLOOK

 

We are very proud of the consistent results the Transcat team has delivered year in and year out over an extended period of time.  That said, it goes without saying we are disappointed with the NEXA-impacted aggregated results in fiscal year 2025 second quarter. We experienced isolated revenue challenges in the NEXA services channel in the quarter but believe the swift actions our team is already taking will rectify the situation as we continue to execute on our highly successful core growth strategy.

 

We expect fiscal year 2025 organic Service revenue growth to be in the mid-single digits when normalized for the extra week in fiscal 2024 and gross margin expansion. We anticipate a return to high single digit organic growth by the second quarter of fiscal year 2026.

 

Automation of our calibration processes and focus on productivity remain key enablers of margin expansion. We have demonstrated the ability to leverage these tools to improve our operational efficiency, which has become visible in our financial performance over time.

 

We continue to work our robust acquisition pipeline and are pleased with the potential flow of opportunities.

 

We expect our income tax rate to range between 21% and 23% for full fiscal year 2025. This estimate includes federal, various state, Canadian and Irish income taxes and reflects the discrete tax accounting associated with share-based payment awards. 

 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

INTEREST RATES

 

Our exposure to changes in interest rates results from our borrowing activities.  During the first six months of fiscal year 2025, we had no borrowings under our revolving credit facility.  In the event interest rates were to move by 1%, our yearly interest expense would increase or decrease by approximately $0.4 million assuming borrowings of approximately $40 million under our revolving credit facility.  As of September 28, 2024, $80.0 million was available for borrowing under the revolving credit facility.  As of September 28, 2024, there were no amounts outstanding under the revolving credit facility. As described above under “Liquidity and Capital Resources,” we also have a $15.0 million (original principal) term loan. The 2018 Term Loan is considered a fixed interest rate loan. As of September 28, 2024, $3.0 million was outstanding under the 2018 Term Loan and was included in long-term debt and current portion of long-term debt on the Consolidated Balance Sheets. The 2018 Term Loan requires total (principal and interest) repayments of $0.2 million per month through December 2025.

 

Effective July 1, 2023, at our option, we may borrow from our revolving credit facility at the variable one-month Daily Simple SOFR or at a fixed rate for a designated period at the SOFR corresponding to such period (subject to a 0.25% floor), in each case, plus a margin. Our interest rate margin is determined on a quarterly basis based upon our calculated leverage ratio. Our interest rate during the first six months of fiscal year 2025 for our revolving credit facility was 7.1%. Interest on outstanding borrowings of the 2018 Term Loan accrued at a fixed rate of 3.90% over the term of the loan. On September 28, 2024, we had no hedging arrangements in place for our revolving credit facility to limit our exposure to movements in interest rates.  

 

FOREIGN CURRENCY

 

Approximately 90% of our total revenues for each of the first six months of fiscal year 2025 and 2024 were denominated in U.S. dollars, with the remainder denominated in Canadian dollars and Euros. A 10% change in the value of the Canadian dollar to the U.S. dollar and the Euro to the U.S. dollar would impact our revenue by approximately 1%. We monitor the relationship between the U.S. dollar and the Canadian dollar and the U.S. dollar and the Euro on a monthly basis and adjust sales prices for products and services sold in Canadian dollars or Euros as we believe to be appropriate.

 

We continually utilize short-term foreign exchange forward contracts to reduce the risk that future earnings denominated in Canadian dollars would be adversely affected by changes in currency exchange rates. We do not apply hedge accounting and therefore the net change in the fair value of the contracts, which totaled a loss of $0.1 million in both the first six months of fiscal years 2025 and 2024, respectively, was recognized as a component of Interest and Other Expense, net in the Consolidated Statements of Income. The change in the fair value of the contracts is offset by the change in fair value on the underlying accounts receivables denominated in Canadian dollars being hedged. On September 28, 2024, we had a foreign exchange contract, which matured in October 2024, outstanding in the notional amount of $2.5 million. The foreign exchange contract was renewed in October 2024 and continues to be in place. We do not use hedging arrangements for speculative purposes.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures. Our principal executive officer and our principal financial officer evaluated our disclosure controls and procedures (as defined in the Securities Exchange Act of 1934, as amended (the “Exchange Act”), Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this quarterly report. Disclosure controls and procedures are designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our principal executive officer and principal financial officer to allow timely decisions regarding required disclosure. Based on this evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were effective as of such date.

 

Changes in Internal Control over Financial Reporting. There has been no change in our internal control over financial reporting that occurred during the last fiscal quarter covered by this quarterly report (our second quarter of fiscal year 2025) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

 

 

PART II. OTHER INFORMATION

 

 

ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS. 

 

On August 8, 2024, we issued 26,379 shares of common stock to former shareholders of Axiom to settle a $2.3 million holdback and, on August 11, 2024, we issued 4,763 shares of common stock to the former shareholder of SteriQual to settle a $0.4 million holdback. The shares were issued pursuant to an exemption from registration in reliance upon Section 4(a)(2) of the Securities Act of 1933, as amended.

 

 

ITEM 6. EXHIBITS

 

INDEX TO EXHIBITS

 

Exhibit No.

 

Description

       
(3.1)   Articles of Incorporation and Bylaws
       
    3.1 Code of Regulations, as amended through September 11, 2024, are incorporated herein by reference from Exhibit 3.1 to the Company's Current Report on Form 8-K filed on September 13, 2024
       

(31)

 

Rule 13a-14(a)/15d-14(a) Certifications

       
   

31.1*

Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

       
   

31.2*

Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

       

(32)

 

Section 1350 Certifications

       
   

32.1**

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

       

 

 

       

(101)

 

Interactive Data File

       
101.INS*     Inline XBRL Instance Document
       
101.SCH*     Inline XBRL Taxonomy Extension Schema Document
       
101.CAL*     Inline XBRL Taxonomy Extension Calculation Linkbase Document
       
101.DEF*     Inline XBRL Taxonomy Extension Definition Linkbase Document
       
101.LAB*     Inline XBRL Taxonomy Extension Label Linkbase Document
       
101.PRE*     Inline XBRL Taxonomy Extension Presentation Linkbase Document
       
(104)     Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

*

Exhibit filed with this report.

**

Exhibit furnished with this report.

   

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  TRANSCAT, INC.  
     
     

Date: November 6, 2024

/s/ Lee D. Rudow

 
 

Lee D. Rudow

 
 

President and Chief Executive Officer

(Principal Executive Officer)

 
     
     

Date: November 6, 2024

/s/ Thomas L. Barbato

 
 

Thomas L. Barbato

 
 

Senior Vice President of Finance and Chief Financial Officer

(Principal Financial Officer)

 

 

 

35

Exhibit 31.1

 

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

 

I, Lee D. Rudow, President and Chief Executive Officer of Transcat, Inc., certify that:

 

 

1.

I have reviewed this quarterly report on Form 10-Q of Transcat, Inc.;

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

(a)

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

(b)

designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

(c)

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

(d)

disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

(a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

(b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

Date: November 6, 2024

/s/ Lee D. Rudow

 
 

Lee D. Rudow

 
 

President and Chief Executive Officer

(Principal Executive Officer)

 

 

 

Exhibit 31.2

 

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

 

I, Thomas L. Barbato, Senior Vice President of Finance and Chief Financial Officer of Transcat, Inc., certify that:

 

 

1.

I have reviewed this quarterly report on Form 10-Q of Transcat, Inc.;

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

(a)

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

(b)

designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

(c)

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

(d)

disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

(a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

(b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

Date: November 6, 2024

/s/ Thomas L. Barbato

 
 

Thomas L. Barbato

 
 

Senior Vice President of Finance and Chief Financial Officer

(Principal Financial Officer)

 

 

 

Exhibit 32.1

 

 

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with this quarterly report on Form 10-Q of Transcat, Inc., Lee D. Rudow, the Chief Executive Officer of Transcat, Inc. and Thomas L. Barbato, the Chief Financial Officer of Transcat, Inc. certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of their knowledge, that:

 

 

1.

This quarterly report on Form 10-Q for the second quarter ended September 28, 2024 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

2.

The information contained in this quarterly report on Form 10-Q for the second quarter ended September 28, 2024 fairly presents, in all material respects, the financial condition and results of operations of Transcat, Inc.

 

Date: November 6, 2024

/s/ Lee D. Rudow

 
 

Lee D. Rudow

 
 

President and Chief Executive Officer

(Principal Executive Officer)

 

 

Date: November 6, 2024

/s/ Thomas L. Barbato

 
 

Thomas L. Barbato

 
 

Senior Vice President of Finance and Chief Financial Officer

(Principal Financial Officer)

 

 

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to Transcat, Inc. and will be retained by Transcat, Inc. and furnished to the SEC or its staff upon request.

 

 
v3.24.3
Document And Entity Information - shares
6 Months Ended
Sep. 28, 2024
Oct. 31, 2024
Document Information [Line Items]    
Entity Central Index Key 0000099302  
Entity Registrant Name TRANSCAT INC  
Amendment Flag false  
Current Fiscal Year End Date --03-30  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2025  
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 28, 2024  
Document Transition Report false  
Entity File Number 000-03905  
Entity Incorporation, State or Country Code OH  
Entity Tax Identification Number 16-0874418  
Entity Address, Address Line One 35 Vantage Point Drive  
Entity Address, City or Town Rochester  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 14624  
City Area Code 585  
Local Phone Number 352-7777  
Title of 12(b) Security Common Stock, $0.50 par value  
Trading Symbol TRNS  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   9,199,277
v3.24.3
Consolidated Statements of Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Sep. 28, 2024
Sep. 23, 2023
Sep. 28, 2024
Sep. 23, 2023
Revenue [1] $ 67,826 $ 62,804 $ 134,533 $ 123,402
Cost of Revenue 46,620 42,679 90,672 84,567
Gross Profit 21,206 20,125 43,861 38,835
Selling, Marketing and Warehouse Expenses 8,181 6,856 15,982 13,325
General and Administrative Expenses 9,290 11,626 19,045 19,227
Total Operating Expenses 17,471 18,482 35,027 32,552
Operating Income 3,735 1,643 8,834 6,283
Interest Expense 76 890 128 1,704
Interest Income (286) 0 (598) 0
Other Expense (Income) 232 (49) 363 15
Total Interest and Other Expense (Income), net 22 841 (107) 1,719
Income Before Provision For Income Taxes 3,713 802 8,941 4,564
Provision for Income Taxes 427 342 1,247 1,155
Net Income $ 3,286 $ 460 $ 7,694 $ 3,409
Basic Earnings Per Share (in dollars per share) $ 0.36 $ 0.06 $ 0.84 $ 0.44
Average Shares Outstanding (in shares) 9,160 7,819 9,107 7,732
Diluted Earnings Per Share (in dollars per share) $ 0.35 $ 0.06 $ 0.83 $ 0.43
Average Shares Outstanding (in shares) 9,282 7,948 9,222 7,840
Service [Member]        
Revenue $ 44,083 $ 41,431 $ 87,861 $ 81,284
Cost of Revenue 29,492 27,347 58,387 54,229
Distribution Service [Member]        
Revenue 23,743 21,373 46,672 42,118
Cost of Revenue $ 17,128 $ 15,332 $ 32,285 $ 30,338
[1] Revenues are attributed to the countries based on the destination of a product shipment or the location where service is rendered.
v3.24.3
Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Sep. 28, 2024
Sep. 23, 2023
Sep. 28, 2024
Sep. 23, 2023
Net Income $ 3,286 $ 460 $ 7,694 $ 3,409
Other Comprehensive (Loss) / Income :        
Currency Translation Adjustment 381 (352) 221 124
Other, net of tax effects of $1 and $2 for the second quarter ended September 28, 2024 and September 23, 2023, respectively; and $3 and $4 for the six months ended September 28, 2024 and September 23, 2023, respectively 5 6 10 12
Total Other Comprehensive Income / (Loss) 386 (346) 231 136
Comprehensive Income $ 3,672 $ 114 $ 7,925 $ 3,545
v3.24.3
Consolidated Statements of Comprehensive Income (Unaudited) (Parentheticals) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Sep. 28, 2024
Sep. 23, 2023
Sep. 28, 2024
Sep. 23, 2023
Other, tax effect $ 1 $ 2 $ 3 $ 4
v3.24.3
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Sep. 28, 2024
Mar. 30, 2024
Current Assets:    
Cash and Cash Equivalents $ 23,815 $ 19,646
Marketable Securities 0 15,533
Accounts Receivable, less allowance for credit losses of $565 and $544 as of September 28, 2024 and March 30, 2024, respectively 48,933 47,779
Other Receivables 628 506
Inventory, net 15,549 17,418
Prepaid Expenses and Other Current Assets 6,241 4,276
Total Current Assets 95,166 105,158
Property and Equipment, net 47,493 38,944
Goodwill 138,127 105,585
Intangible Assets, net 24,362 19,987
Right to Use Assets, net 17,309 16,823
Other Assets 1,096 1,055
Total Assets 323,553 287,552
Current Liabilities:    
Accounts Payable 13,043 11,495
Accrued Compensation and Other Current Liabilities 11,092 19,665
Current Portion of Long-Term Debt 2,386 2,339
Total Current Liabilities 26,521 33,499
Long-Term Debt 612 1,817
Deferred Tax Liabilities, net 9,297 9,291
Lease Liabilities 14,661 14,873
Other Liabilities 3,705 2,903
Total Liabilities 54,796 62,383
Shareholders' Equity:    
Common Stock, par value $0.50 per share, 30,000,000 shares authorized; 9,199,277 and 8,839,299 shares issued and outstanding as of September 28, 2024 and March 30, 2024, respectively 4,600 4,420
Capital in Excess of Par Value 178,986 141,624
Accumulated Other Comprehensive Loss (718) (949)
Retained Earnings 85,889 80,074
Total Shareholders' Equity 268,757 225,169
Total Liabilities and Shareholders' Equity $ 323,553 $ 287,552
v3.24.3
Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($)
$ in Thousands
Sep. 28, 2024
Mar. 30, 2024
Accounts Receivable, allowance for doubtful accounts $ 565 $ 544
Common stock, par value (in dollars per share) $ 0.5 $ 0.5
Common stock, shares authorized (in shares) 30,000,000 30,000,000
Common stock, shares issued (in shares) 9,199,277 8,839,299
Common stock, shares outstanding (in shares) 9,199,277 8,839,299
v3.24.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Sep. 28, 2024
Sep. 23, 2023
Cash Flows from Operating Activities:    
Net Income $ 7,694 $ 3,409
Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities:    
Net Loss on Disposal of Property and Equipment 43 11
Deferred Income Taxes 6 23
Depreciation and Amortization 8,513 6,078
Provision for Accounts Receivable and Inventory Reserves 108 347
Stock-Based Compensation Expense 1,623 2,171
Changes in Assets and Liabilities, net of acquisitions:    
Accounts Receivable and Other Receivables 1,746 2,384
Inventory 2,597 3,376
Prepaid Expenses and Other Current Assets (1,918) 465
Accounts Payable 1,525 (3,969)
Accrued Compensation and Other Current Liabilities (6,178) 1,677
Net Cash Provided by Operating Activities 15,759 15,972
Cash Flows from Investing Activities:    
Purchase of Property and Equipment (7,633) (5,444)
Business Acquisitions, net of cash acquired (15,858) (12,882)
Sales of Marketable Securities 15,533 0
Net Cash Used in Investing Activities (7,958) (18,326)
Cash Flows from Financing Activities:    
Repayment of Revolving Credit Facility, net 0 5,288
Repayments of Term Loan (1,158) (1,112)
Issuance of Common Stock, net of direct costs 838 384
Repurchase of Common Stock (3,026) (2,247)
Net Cash (Used in)/Provided by Financing Activities (3,346) 2,313
Effect of Exchange Rate Changes on Cash and Cash Equivalents (286) (244)
Net Increase/(Decrease) in Cash and Cash Equivalents 4,169 (285)
Cash and Cash Equivalents at Beginning of Period 19,646 1,531
Cash and Cash Equivalents at End of Period 23,815 1,246
Supplemental Disclosure of Cash Flow Activity:    
Interest (462) 1,680
Income Taxes, net 5,534 1,099
Supplemental Disclosure of Non-Cash Investing and Financing Activities:    
Common stock issued for acquisitions 35,479 34,769
Assets acquired and liabilities assumed in business combinations:    
Accrued holdback and contingent consideration related to acquisitions 1,306 4,589
Contingent consideration treated as equity related to acquisitions 750 0
Balance Sheet Reclassification of Property and Equipment, net to Inventory $ 692 $ 494
v3.24.3
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Mar. 25, 2023 7,562        
Balance at Mar. 25, 2023 $ 3,781 $ 27,886 $ (1,200) $ 69,163 $ 99,630
Issuance of Common Stock (in shares) 82        
Issuance of Common Stock $ 42 6,988 0 0 7,030
Repurchase of Common Stock (in shares) (3)        
Repurchase of Common Stock $ (2) (86) 0 (213) (301)
Stock-Based Compensation (in shares) 2        
Stock-Based Compensation $ 1 929 0   930
Other Comprehensive Income 0 0 482 0 482
Net Income $ 0 0 0 2,949 2,949
Balance (in shares) at Jun. 24, 2023 7,643        
Balance at Jun. 24, 2023 $ 3,822 35,717 (718) 71,899 110,720
Balance (in shares) at Mar. 25, 2023 7,562        
Balance at Mar. 25, 2023 $ 3,781 27,886 (1,200) 69,163 99,630
Net Income         3,409
Balance (in shares) at Sep. 23, 2023 7,978        
Balance at Sep. 23, 2023 $ 3,989 64,310 (1,064) 71,017 138,252
Balance (in shares) at Jun. 24, 2023 7,643        
Balance at Jun. 24, 2023 $ 3,822 35,717 (718) 71,899 110,720
Issuance of Common Stock (in shares) 313        
Issuance of Common Stock $ 156 27,967 0 0 28,123
Repurchase of Common Stock (in shares) (22)        
Repurchase of Common Stock $ (11) (593) 0 (1,342) (1,946)
Stock-Based Compensation (in shares) 44        
Stock-Based Compensation $ 22 1,219 0   1,241
Other Comprehensive Income 0 0 (346) 0 (346)
Net Income $ 0 0 0 460 460
Balance (in shares) at Sep. 23, 2023 7,978        
Balance at Sep. 23, 2023 $ 3,989 64,310 (1,064) 71,017 138,252
Balance (in shares) at Mar. 30, 2024 8,839        
Balance at Mar. 30, 2024 $ 4,420 141,624 (949) 80,074 225,169
Issuance of Common Stock (in shares) 302        
Issuance of Common Stock $ 151 32,888 0 0 33,039
Repurchase of Common Stock (in shares) (13)        
Repurchase of Common Stock $ (7) (652) 0 (961) (1,620)
Stock-Based Compensation (in shares) 16        
Stock-Based Compensation $ 8 689 0   697
Other Comprehensive Income 0 0 (155) 0 (155)
Net Income 0 0 0 4,408 4,408
Contingent Consideration Classified as Equity $ 0 750 0 0 750
Balance (in shares) at Jun. 29, 2024 9,144        
Balance at Jun. 29, 2024 $ 4,572 175,299 (1,104) 83,521 262,288
Balance (in shares) at Mar. 30, 2024 8,839        
Balance at Mar. 30, 2024 $ 4,420 141,624 (949) 80,074 225,169
Net Income         7,694
Balance (in shares) at Sep. 28, 2024 9,199        
Balance at Sep. 28, 2024 $ 4,600 178,986 (718) 85,889 268,757
Balance (in shares) at Jun. 29, 2024 9,144        
Balance at Jun. 29, 2024 $ 4,572 175,299 (1,104) 83,521 262,288
Issuance of Common Stock (in shares) 53        
Issuance of Common Stock $ 26 3,251 0 0 3,277
Repurchase of Common Stock (in shares) (11)        
Repurchase of Common Stock $ (5) (483) 0 (918) (1,406)
Stock-Based Compensation (in shares) 13        
Stock-Based Compensation $ 7 919 0   926
Other Comprehensive Income 0 0 386 0 386
Net Income $ 0 0 0 3,286 3,286
Balance (in shares) at Sep. 28, 2024 9,199        
Balance at Sep. 28, 2024 $ 4,600 $ 178,986 $ (718) $ 85,889 $ 268,757
v3.24.3
Note 1 - General
6 Months Ended
Sep. 28, 2024
Notes to Financial Statements  
Significant Accounting Policies [Text Block]

NOTE 1 GENERAL

 

Description of Business: Transcat, Inc. (“Transcat,” “we,” “us,” “our” or the “Company”) is a leading provider of accredited calibration services, cost control and optimization services, and distribution and rental of value-added professional grade handheld test, measurement and control instrumentation. The Company is focused on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceutical, biotechnology, medical device and other FDA-regulated businesses. Additional industries served include industrial manufacturing; energy and utilities, including oil and gas; chemical manufacturing; FAA-regulated businesses, including aerospace and defense and other industries that require accuracy in their processes, confirmation of the capabilities of their equipment, and for which the risk of failure is very costly.

 

Basis of Presentation: Transcat’s unaudited Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the Securities and Exchange Commission (“SEC”). Accordingly, the Consolidated Financial Statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of the Company’s management, all adjustments considered necessary for a fair presentation (consisting of normal recurring adjustments) have been included. The results for the interim periods are not necessarily indicative of what the results will be for the fiscal year. The accompanying Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements as of and for the fiscal year ended  March 30, 2024 (“fiscal year 2024”) contained in the Company’s Annual Report on Form 10-K for fiscal year 2024 filed with the SEC.

 

Use of Estimates: The preparation of Transcat’s Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States ("GAAP") requires that the Company make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions are used for, but not limited to, allowance for credit losses and returns, inventory reserves, estimated levels of achievement for performance-based restricted stock units, fair value of stock options, depreciable lives of fixed assets, estimated lives of intangible assets, fair value of the goodwill reporting units, and the valuation of assets acquired, liabilities assumed and consideration transferred in business acquisitions. Future events and their effects cannot be predicted with certainty; accordingly, accounting estimates require the exercise of judgment. The accounting estimates used in the preparation of the Consolidated Financial Statements may change as new events occur, as more experience is acquired, as additional information is obtained and as the operating environment changes. Actual results could differ from those estimates. Such changes and refinements in estimation methodologies are reflected in reported results of operations in the period in which the changes are made and, if material, their effects are disclosed in the Notes to the Consolidated Financial Statements.

 

Cash and Cash Equivalents:  Cash equivalents consist of highly liquid investments with an original maturity when purchased of three months or less and are stated at cost, which approximates fair value.

 

Marketable Securities: Marketable securities consist of highly liquid investments with an original maturity when purchased of more than three months and are stated at fair value on the Consolidated Balance Sheets.  These securities are considered trading securities. Earnings on the marketable securities are included in interest income in the Consolidated Statements of Income.

 

Revenue Recognition:  Distribution non-rental revenue is recorded when an order’s title and risk of loss transfers to the customer, which is generally upon shipment. Distribution rental revenue is recognized over time using the time-elapsed output method as this portrays the transfer of control to the customer. The Company recognizes the majority of its Service revenue based upon when the calibration or other activity is performed and then shipped and/or delivered to the customer. The majority of the Company’s revenue generating activities have a single performance obligation and are recognized at the point in time when control transfers and/or our obligation has been fulfilled. Some Service revenue is generated from managing customers’ calibration programs in which the Company recognizes revenue over time using the time-elapsed output method as this portrays the transfer of control to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for product shipped or services performed. Sales taxes and other taxes billed and collected from customers are excluded from revenue. The Company generally invoices its customers for freight, shipping, and handling charges. Freight billed to customers is included in revenue. Shipping and handling is not included in revenue. Provisions for customer returns are provided for in the period the related revenue is recorded based upon historical data.

   

Under Accounting Standards Codification ("ASC") Topic 606, Revenue from Contracts with Customers, we use judgments that could potentially impact both the timing of our satisfaction of performance obligations. Such judgments include considerations in determining our transaction prices and when our performance obligations are satisfied for our standard product sales that include general payment terms that are between net 30 and 90 days.

 

Revenue recognized from prior period performance obligations for the second quarter of the fiscal year ending March 29, 2025 (“fiscal year 2025”) was immaterial. As of September 28, 2024, the Company had no unsatisfied performance obligations for contracts with an original expected duration of greater than one year. Pursuant to ASC Topic 606, the Company applied the practical expedient with respect to disclosure of the deferral and future expected timing of revenue recognition for transaction price allocated to remaining performance obligations. Deferred revenue, unbilled revenue and deferred contract costs recorded on our Consolidated Balance Sheets as of September 28, 2024 and March 30, 2024 were immaterial. See Note 4 for disaggregated revenue information.

 

  

% of Total Net Sales

 
  

Second Quarter Ended

  

Six Months Ended

 
  

September 28,

  

September 23,

  

September 28,

  

September 23,

 
  

2024

  

2023

  

2024

  

2023

 

Point-in-Time

  86.6%  90.4%  86.1%  90.5%

Over Time - Output Method

  13.4%  9.6%  13.9%  9.5%

Total

  100.0%  100.0%  100.0%  100.0%

 

Fair Value of Financial Instruments:  Transcat has determined the fair value of debt and other financial instruments using a valuation hierarchy. The hierarchy, which prioritizes the inputs used in measuring fair value, consists of three levels. Level 1 uses observable inputs such as quoted prices in active markets; Level 2 uses inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, which is defined as unobservable inputs in which little or no market data exists, requires the Company to develop its own assumptions. The carrying amount of debt on the Consolidated Balance Sheets approximates fair value due to variable interest rate pricing on a portion of the debt with the balance bearing an interest rate approximating current market rates, and the carrying amounts for cash and cash equivalents, marketable securities, accounts receivable and accounts payable approximate fair value due to their short-term nature. Investment assets, which fund the Company’s non-qualified deferred compensation plan, consist of mutual funds and are valued based on Level 1 inputs.  At each of September 28, 2024 and March 30, 2024, investment assets totaled $0.1 million, and are included as a component of other assets (non-current) on the Consolidated Balance Sheets.

 

Stock-Based Compensation:  The Company measures the cost of services received in exchange for all equity awards granted, including stock options and restricted stock units, based on the fair market value of the award as of the grant date. The Company records compensation cost related to unvested equity awards by recognizing, on a straight-line basis, the unamortized grant date fair value over the remaining service period for awards expected to vest. Excess tax benefits for share-based award activity are reflected in the Consolidated Statements of Income as a component of the provision for income taxes. Excess tax benefits are realized benefits from tax deductions for exercised awards in excess of the deferred tax asset attributable to stock-based compensation costs for such awards. The Company did not capitalize any stock-based compensation costs as part of an asset. The Company estimates forfeiture rates based on its historical experience. During the first six months of fiscal year 2025 and fiscal year 2024, the Company recorded non-cash stock-based compensation cost of $1.6 million and $2.2 million, respectively, in the Consolidated Statements of Income.

 

Foreign Currency Translation and Transactions:  The accounts of Cal OpEx Limited (d/b/a Transcat Ireland), an Irish company, and Transcat Canada Inc., both of which are wholly-owned subsidiaries of the Company, are maintained in their local currencies, the Euro and the Canadian dollar, respectively, and have been translated to U.S. dollars. Accordingly, the amounts representing assets and liabilities have been translated at the period-end rates of exchange and related revenue and expense accounts have been translated at an average rate of exchange during the period. Gains and losses arising from translation of Cal OpEx Limited’s and Transcat Canada Inc.’s financial statements into U.S. dollars are recorded directly to the accumulated other comprehensive loss component of shareholders’ equity.

 

Transcat records foreign currency gains and losses on business transactions denominated in foreign currency. The net foreign currency was a net loss of $0.4 million for the first six months of fiscal year 2025 and a net gain of less than $0.1 million for the first six months of fiscal year 2024. The Company continually utilizes short-term foreign exchange forward contracts to reduce the risk that its future earnings denominated in Canadian dollars would be adversely affected by changes in currency exchange rates. The Company does not apply hedge accounting and therefore the net change in the fair value of the contracts, which totaled a gain of less than $0.1 million during each of the first six months of fiscal years 2025 and 2024, was recognized as a component of Interest and Other Expenses, net in the Consolidated Statements of Income. The change in the fair value of the contracts is offset by the change in fair value on the underlying accounts receivables denominated in Canadian dollars being hedged. On September 28, 2024, the Company had a foreign exchange contract, which matured in October 2024, outstanding in the notional amount of $2.5 million. This contract was subsequently renewed and remains in place. The Company does not use hedging arrangements for speculative purposes.

 

Earnings Per Share: Basic earnings per share of the Company's common stock, par value $0.50 per share ("common stock"), are computed based on the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share of common stock reflect the assumed conversion of stock options, unvested restricted stock units using the treasury stock method and contingent consideration classified as equity in periods in which they have a dilutive effect. In computing the per share effect of assumed conversion, proceeds received from the exercise of options and unvested restricted stock units are considered to have been used to purchase shares of common stock at the average market prices during the period, and the resulting net additional shares of common stock are included in the calculation of average shares of common stock outstanding.

 

For the second quarter of fiscal year 2025, the net additional common stock equivalents had a ($0.01) effect on the calculation of diluted earnings per share.   For the second quarter of fiscal year 2024, the net additional common stock equivalents had no effect on the calculation of diluted earnings per share.  For the first six months of each of fiscal years 2025 and 2024, the net additional common stock equivalents had a ($0.01) effect on the calculation of diluted earnings per share. The average shares outstanding used to compute basic and diluted earnings per share are as follows (amounts in thousands):

 

  

Second Quarter Ended

  

Six Months Ended

 
  

September 28,

  

September 23,

  

September 28,

  

September 23,

 
  

2024

  

2023

  

2024

  

2023

 

Average Shares Outstanding – Basic

  9,160   7,819   9,107   7,732 

Effect of Dilutive Common Stock Equivalents

  122   129   115   108 

Average Shares Outstanding – Diluted

  9,282   7,948   9,222   7,840 

Anti-dilutive Common Stock Equivalents

  31   31   41   37 

 

Goodwill and Intangible Assets: Goodwill represents the excess of the purchase price over the fair values of the underlying net assets of an acquired business. The Company tests goodwill for impairment for each reporting unit on an annual basis during the fourth quarter of its fiscal year, or immediately if conditions indicate that such impairment could exist. The Company is permitted, but not required, to qualitatively assess indicators of a reporting unit’s fair value to determine whether it is necessary to perform the two-step goodwill impairment test. If a quantitative test is deemed necessary, a discounted cash flow analysis is prepared to estimate fair value.

 

Intangible assets, namely customer base and covenants not to compete, represent an allocation of purchase price to identifiable intangible assets of an acquired business. Intangible assets are evaluated for impairment when events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. The allocation of goodwill and intangible assets by segment for the fiscal year 2025 additions are preliminary.  A summary of changes in the Company’s goodwill and intangible assets is as follows (amounts in thousands):

 

  

Goodwill

  

Intangible Assets

 
  

Distribution

  

Service

  

Total

  

Distribution

  

Service

  

Total

 

Net Book Value as of March 30, 2024

 $38,216  $67,369  $105,585  $6,993  $12,994  $19,987 

Additions

  21,685   10,847   32,532   5,360   2,680   8,040 

Amortization

  -   -   -   (1,443)  (2,222)  (3,665)

Currency Translation Adjustment

  -   10   10   -   -   - 

Net Book Value as of September 28, 2024

 $59,901  $78,226  $138,127  $10,910  $13,452  $24,362 

 

Other Liabilities: A summary of other current and non-current liabilities is as follows (amounts in thousands):

 

  

(Unaudited)

  

(Audited)

 
  

September 28,

  

March 30,

 
  

2024

  

2024

 

Current Liabilities:

        

Accrued Payroll and Employee Benefits

 $4,982  $5,508 

Accrued Incentives

  1,277   4,182 

Current Portion of Lease Liabilities

  3,201   2,510 

Accrued Acquisition Holdbacks

  514   2,577 

Accrued Sales Tax

  652   813 

Accrued Contingent Consideration

  -   529 

Income Taxes Payable

     2,926 

Other Current Liabilities

  466   620 

Accrued Compensation and Other Current Liabilities

 $11,092  $19,665 
         

Non-Current Liabilities:

        

Postretirement Benefit Obligation

 $1,132  $1,134 

Accrued Acquisition Holdbacks

  1,647   1,647 

Accrued Contingent Consideration

  806   - 

Other Non-Current Liabilities

  120   122 

Other Liabilities

 $3,705  $2,903 

 

Recent Accounting Guidance Not Yet Adopted:  In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280).  The ASU requires disclosures, on an annual and interim basis, of significant segment expenses and other segment items that are regularly provided to the Chief Operating Decision Maker ("CODM") as well as the title and position of the CODM. ASU 2023-07 is effective for annual periods beginning in fiscal 2025 and interim periods in fiscal year 2026 with early adoption permitted.  The adoption of this ASU is expected to impact the Company's financial statement disclosures but have no material impact on our results of operations, cash flows or financial condition.

 

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures.  The ASU expands the income tax disclosure requirements, principally related to the rate reconciliation table and income taxes paid.  ASU 2023-09 is effective for annual periods beginning in fiscal 2026, with early adoption permitted.  The adoption of the ASU is not expected to have a material impact on the Company’s financial statement disclosures.

 

v3.24.3
Note 2 - Long-term Debt
6 Months Ended
Sep. 28, 2024
Notes to Financial Statements  
Long-Term Debt [Text Block]

NOTE 2 LONG-TERM DEBT

 

On July 7, 2021, the Company entered into the Second Amended and Restated Credit Facility Agreement (the “Credit Agreement”) with Manufacturers and Traders Trust Company (“M&T”), that amended and restated in its entirety the Company’s prior credit agreement with M&T.

 

The Credit Agreement provides for a revolving credit commitment (the “revolving credit facility”) of $80.0 million through June 2026, with a letter of credit subfacility of $10.0 million. The Company's 2018 term loan, with an original principal amount of $15.0 million (the "2018 Term Loan"), is also provided for under the Credit Agreement.

 

The Credit Agreement allows the Company to use up to $50.0 million under the revolving credit facility for acquisitions in any single fiscal year. The Credit Agreement restricts the Company's ability to complete acquisitions of businesses with a principal place of business located in the United Kingdom or the European Union to an aggregate purchase price of $40.0 million during the term of the Credit Agreement, if the acquisition is financed directly or indirectly with the revolving credit facility.

 

Under the Credit Agreement, the Company may make restricted payments up to $25.0 million in the aggregate over the term of the Credit Agreement and $10.0 million in any single fiscal year to repurchase shares and pay dividends.

 

As of September 28, 2024, $80.0 million was available for borrowing under the revolving credit facility.  As of September 28, 2024, there were no amounts outstanding under the revolving credit facility. 

 

As of September 28, 2024, $3.0 million was outstanding on the 2018 Term Loan, of which $2.4 million was included in current liabilities on the Consolidated Balance Sheets with the remainder included in long-term debt. The 2018 Term Loan requires total amortizing repayments (principal plus interest) of $0.2 million per month through its maturity date in December 2025.

 

Interest and Other Costs: Effective July 1, 2023, interest on outstanding borrowings under the revolving credit facility accrue, at Transcat’s election, at either the variable Daily Simple SOFR or a fixed rate for a designated period at the SOFR corresponding to such period (subject to a 0.25% floor), in each case, plus a margin.  Unused fees accrue based on the average daily amount of unused credit available on the revolving credit facility. Interest rate margins and unused fees are determined on a quarterly basis based upon the Company’s calculated leverage ratio. The Company’s interest rate for the revolving credit facility for the first six months of fiscal year 2025 was 7.1%.  Interest on outstanding borrowings under the 2018 Term Loan accrue at a fixed rate of 3.90% over the term of the loan. 

 

Covenants: The Credit Agreement has certain covenants with which the Company must comply, including a fixed charge ratio covenant, which prohibits the Company's fixed charge ratio from being less than 1.15 to 1.00, and a leverage ratio covenant, which prohibits the Company's leverage ratio from exceeding 3.00 to 1.00. The Company was in compliance with all loan covenants and requirements during the first six months of fiscal year 2025. The Company's leverage ratio, as defined in the Credit Agreement, was 0.08 at September 28, 2024, compared with 0.10 at March 30, 2024.

 

Other Terms: The Company has pledged all of its U.S. tangible and intangible personal property, the equity interests of its U.S.-based subsidiaries, and a majority of the common stock of Transcat Canada Inc. as collateral security for the loans made under the revolving credit facility.

 

v3.24.3
Note 3 - Stock-based Compensation
6 Months Ended
Sep. 28, 2024
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

NOTE 3 STOCK-BASED COMPENSATION

 

In September 2021, the Transcat, Inc. 2021 Stock Incentive Plan (the “2021 Plan”) was approved by shareholders and became effective. The 2021 Plan replaced the Transcat, Inc. 2003 Incentive Plan (the “2003 Plan”). Shares available for grant under the 2021 Plan include any shares remaining available for issuance under the 2003 Plan and any shares that are subject to outstanding awards under the 2003 Plan that are subsequently canceled, expired, forfeited, or otherwise not issued or are settled in cash. The 2021 Plan provides for, among other awards, grants of restricted stock units and stock options to directors, officers and key employees at the fair market value at the date of grant.  At September 28, 2024, 0.6 million shares of common stock were available for future grant under the 2021 Plan.

 

The Company receives an excess tax benefit related to restricted stock vesting and stock options exercised and redeemed. The discrete tax benefits related to share-based compensation and stock option activity during the first six months of fiscal year 2025 and fiscal year 2024 were $1.1 million and $0.6 million, respectively.

 

Restricted Stock Units:  The Company grants time-based and performance-based restricted stock units as a component of executive and key employee compensation. Expense for restricted stock unit grants is recognized on a straight-line basis for the service period of the stock award based upon fair value of the award on the date of grant. The fair value of the restricted stock unit grants is the quoted market price for the Company’s common stock on the date of grant. These restricted stock units are either time vested, or vest following the third fiscal year from the date of grant subject to cumulative diluted earnings per share or cumulative Adjusted EBITDA targets over the eligible period.

 

Compensation cost ultimately recognized for performance-based restricted stock units will equal the grant date fair market value of the unit that coincides with the actual outcome of the performance conditions. On an interim basis, the Company records compensation cost based on the estimated level of achievement of the performance conditions. The expense relating to the time vested restricted stock units is recognized on a straight-line basis over the requisite service period for the entire award.

 

The following table summarizes the non-vested restricted stock units outstanding as of September 28, 2024 (in thousands, except per unit data):

 

       

Total

   

Grant Date

 

Estimated

       

Number

   

Fair

 

Level of

Date

 

Measurement

 

of Units

   

Value

 

Achievement at

Granted

 

Period

 

Outstanding

   

Per Unit

 

September 28, 2024

October 2018

 

October 2018 – September 2028

  5     $ 20.81  

Time Vested

March 2022

 

March 2022 – March 2025

  1     $ 76.31  

Time Vested

May 2022

 

May 2022 – March 2025

  9     $ 63.17  

Time Vested

May 2022

 

May 2022 – March 2025

  8     $ 63.17  

0% of target level

August 2022

 

August 2022 – August 2025

  1     $ 78.04  

Time Vested

May 2023

 

May 2023 – March 2026

  8     $ 89.70  

150% of target level

May 2023

 

May 2023 – March 2026

  8     $ 89.70  

Time Vested

May 2023

 

May 2023 – May 2026

  13     $ 89.70  

Time Vested

April 2024

 

April 2024 - April 2027

  2     $ 107.13  

Time Vested

April 2024

 

April 2024 - April 2027

  1     $ 108.04  

Time Vested

May 2024

 

May 2024 - May 2027

  1     $ 119.45  

Time Vested

May 2024

 

May 2024 - May 2027

  1     $ 124.12  

Time Vested

May 2024

 

May 2024 - March 2027

  9     $ 124.12  

100% of target level

May 2024

 

May 2024 - March 2027

  10     $ 124.12  

Time Vested

July 2024

 

July 2024 - July 2027

  1     $ 116.91  

Time Vested

September 2024

 

September 2024 - September 2025

  6     $ 120.66  

Time Vested

September 2024

 

September 2024 - September 2027

  1     $ 123.33  

100% of target level

September 2024

 

September 2024 - September 2027

  1     $ 123.33  

Time Vested

 

Total expense relating to restricted stock units, based on grant date fair value and the achievement criteria, was $0.9 million and $1.5 million in the first six months of fiscal year 2025 and fiscal year 2024, respectively. As of September 28, 2024, unearned compensation, to be recognized over the grants’ respective service periods, totaled $5.0 million based on estimated achievement levels as of September 28, 2024.  If the maximum performance levels were achieved, the unearned compensation could be a maximum of $6.4 million.

 

Stock Options:  The Company grants stock options to employees and directors with an exercise price equal to the quoted market price of the Company’s stock at the date of the grant. The fair value of stock options is estimated using the Black-Scholes option pricing formula that requires assumptions for expected volatility, expected dividends, the risk-free interest rate and the expected term of the option. Expense for stock options is recognized on a straight-line basis over the requisite service period for each award. Options vest either immediately or over a period of up to five years using a straight-line basis and expire either five years or ten years from the date of grant.

 

We calculate the fair value of the stock options granted using the Black-Scholes model. The following weighted-average assumptions were used to value options granted during the first six months of fiscal year 2025 and fiscal year 2024:

 

   

Second Quarter Ended

   

Six Months Ended

 
   

September 28,

   

September 23,

   

September 28,

   

September 23,

 
   

2024

   

2023

   

2024

   

2023

 
                                 

Risk-Free Interest Rate

    4.09 %     4.38 %     4.35 %     3.82 %

Volatility Factor

    40.70 %     36.87 %     40.98 %     37.04 %

Expected Term (in Years)

    4.00       6.27       4.00       6.22  

Annual Dividend Rate

    0.00 %     0.00 %     0.00 %     0.00 %

 

We calculate expected volatility for stock options by taking an average of historical volatility over the expected term. The computation of expected term was determined based on safe harbor rules, giving consideration to the contractual terms of the stock-based awards and vesting schedules. The interest rate for periods within the contractual life of the award is based on the U.S. Treasury yield in effect at the time of grant. We assume no expected dividends. Under FASB ASC Topic 718, Compensation – Stock Compensation, the Company has elected to account for forfeitures as they occur.

 

During the first six months of fiscal year 2025, the Company granted options for 10,000 shares of common stock in the aggregate to Company employees that vest over three years.

 

During the first six months of fiscal year 2024, the Company granted options for 7,000 shares of common stock in the aggregate to Company employees that vest over three years, an option for 10,000 shares of common stock to a Company employee that vests over five years and an option for 10,000 shares of common stock to a Company director that vests over five years.

 

The expense related to all stock option awards was $0.7 million in the first six months of fiscal year 2025 and $0.6 million in the first six months of fiscal year 2024.

 

The following table summarizes the Company’s options as of and for the first six months ended September 28, 2024 (in thousands, except price per option data and years):

 

           

Weighted

   

Weighted

         
           

Average

   

Average

         
   

Number

   

Exercise

   

Remaining

   

Aggregate

 
   

Of

   

Price Per

   

Contractual

   

Intrinsic

 
   

Options

   

Option

   

Term (in years)

   

Value

 

Outstanding as of March 30, 2024

    234     $ 63.43                  

Granted

    10     $ 112.93                  

Exercised

    (25 )   $ 23.02                  

Forfeited

    (12 )   $ 63.04                  

Outstanding as of September 28, 2024

    207     $ 70.67       6     $ 10,522  

Exercisable as of September 28, 2024

    72     $ 58.95       6     $ 2,838  

 

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price on the last trading day of the second quarter of fiscal year 2025 and the exercise price, multiplied by the number of in-the-money stock options) that would have been received by the option holders had all holders exercised their options on September 28, 2024. The amount of aggregate intrinsic value will change based on the fair market value of the Company’s common stock.

 

Total unrecognized compensation cost related to non-vested stock options as of September 28, 2024 was $2.1 million, which is expected to be recognized over a period of three years. The aggregate intrinsic value of stock options exercised during the first six months of fiscal year 2025 was $2.4 million and during the first six months of fiscal year 2024 was $0.3 million. Cash received from the exercise of options in the first six months of fiscal year 2025 was $0.6 million and during the first six months of fiscal year 2024 was $0.1 million.

 

v3.24.3
Note 4 - Segment Information
6 Months Ended
Sep. 28, 2024
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]

NOTE 4 SEGMENT INFORMATION

 

The basis for determining our operating segments is the manner in which financial information is used in monitoring our operations. Transcat has two reportable segments: Service and Distribution. Through our Service segment, we offer calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting and other related services. Through our Distribution segment, we sell and rent national and proprietary brand instruments to customers globally. The Company has no inter-segment sales. We believe that reporting performance at the operating income level is the best indicator of segment performance. The following table presents segment and geographic data for the second quarter and first six months of fiscal year 2025 and fiscal year 2024 (dollars in thousands):

 

   

Second Quarter Ended

   

Six Months Ended

 
   

September 28,

   

September 23,

   

September 28,

   

September 23,

 
   

2024

   

2023

   

2024

   

2023

 

Revenue:

                               

Service

  $ 44,083     $ 41,431     $ 87,861     $ 81,284  

Distribution

    23,743       21,373       46,672       42,118  

Total

    67,826       62,804       134,533       123,402  
                                 

Gross Profit:

                               

Service

    14,591       14,084       29,474       27,055  

Distribution

    6,615       6,041       14,387       11,780  

Total

    21,206       20,125       43,861       38,835  
                                 

Operating Expenses:

                               

Service (1)

    10,887       13,342       21,680       23,121  

Distribution (1)

    6,584       5,140       13,347       9,431  

Total

    17,471       18,482       35,027       32,552  
                                 

Operating Income:

                               

Service

    3,704       742       7,794       3,934  

Distribution

    31       901       1,040       2,349  

Total

    3,735       1,643       8,834       6,283  
                                 

Unallocated Amounts:

                               

Interest and Other (Income)/Expense, net

    22       841       (107 )     1,719  

Provision for Income Taxes

    427       342       1,247       1,155  

Total

    449       1,183       1,140       2,874  
                                 

Net Income

  $ 3,286     $ 460     $ 7,694     $ 3,409  
                                 

Geographic Data:

                               

Revenues to Unaffiliated Customers (2)

                               

United States (3)

  $ 62,492     $ 57,119     $ 123,232     $ 111,376  

Canada

    3,794       3,896       8,266       8,143  

Other International

    1,540       1,789       3,035       3,883  

Total

  $ 67,826     $ 62,804     $ 134,533     $ 123,402  

 

(1)

Operating expense allocations between segments are based on actual amounts, a percentage of revenues, headcount, and management’s estimates.

(2)

Revenues are attributed to the countries based on the destination of a product shipment or the location where service is rendered.

(3)

United States includes Puerto Rico.

 

v3.24.3
Note 5 - Business Acquisitions
6 Months Ended
Sep. 28, 2024
Notes to Financial Statements  
Business Combination Disclosure [Text Block]

NOTE 5 BUSINESS ACQUISITIONS

 

Becnel:  Effective  April 15, 2024, the Company acquired Becnel Rental Tools, LLC, a privately-held Louisiana limited liability company (“Becnel”), pursuant to an Agreement and Plan of Merger (the “Becnel agreement”), by and among the Company, Becnel and the other parties thereto. Becnel is an ISO 9001:2015 certified provider of rental tools and services primarily utilized in the decommissioning and maintenance of oil wells. This transaction aligned with a key component of the Company’s acquisition strategy of targeting businesses that expand the depth and breadth of the Company’s service and rental capabilities.

 

The  Becnel goodwill is primarily attributable to the workforce acquired, as well as operational synergies and other intangibles that do not qualify for separate recognition. The goodwill and intangible assets relating to the Becnel acquisition have preliminarily been allocated to both the Service and Distribution segment. Intangible assets related to the Becnel acquisition are being amortized for financial reporting purposes on an accelerated basis over the estimated useful life of up to eleven years and are deductible for tax purposes. Amortization of goodwill related to the Becnel acquisition is deductible for income tax purposes.

 

The total purchase price for Becnel was approximately $49.8 million consisting of up to $17.5 million in cash and the issuance of our common stock valued at $32.3 million. Pursuant to the Becnel agreement, the Company held back approximately $2.5 million of the purchase price for certain potential post-closing adjustments.  This includes $0.5 million withheld for ordinary post-closing adjustments and $2.0 million withheld that is subject to revenue target achievement. 

 

Pursuant to the Becnel agreement, the purchase price is subject to reduction by $2.0 million if certain revenue targets are not met through April 15, 2026.  As of April 15, 2024 and September 28, 2024, the estimated fair value of this contingent consideration, classified as Level 3 in the fair value hierarchy, was approximately $1.5 million and $1.6 million, respectively. This amount was calculated using a Geometric Brownian motion distribution that was then used in a Monte Carlo simulation model. Assumptions used in the Monte Carlo simulation model included: 1) discount rate of 11.00%, 2) risk-free interest rate of 5.00%, 3) asset volatility of 30.00%, and 4) forecasted revenue.  50% of this contingent consideration is payable in cash and 50% of this contingent consideration is payable in 9,283 shares of Transcat common stock.  The cash portion of the contingent consideration is classified as a liability and is recorded in other liabilities in the Consolidated Balance Sheets.  The stock portion of the contingent consideration is classified as equity and is recorded in shareholders equity in the Consolidated Balance Sheets.  The contingent consideration payout will either be $0 or $2.0 million depending on the revenue target achievement.

 

This cash portion of the contingent consideration is remeasured quarterly. If, as a result of remeasurement, the value of the cash portion of the contingent consideration changes, any charges or income will be included in the Company’s Consolidated Statements of Income. There was no impact from the remeasurement done during the first six months of fiscal year 2025.  Due to the uncertainty with utilizing these significant unobservable inputs for this Level 3 fair value measurement, materially higher or lower fair value measurements may be recognized at subsequent remeasurement periods.  The stock portion of the contingent consideration is remeasured quarterly.  If, as a result of the measurement, the value of the stock portion of the contingent consideration changes, any changes will be included in the Consolidated Balance Sheets as a component of shareholders equity. 

 

The purchase price allocation is subject to revision based upon our final review of tangible and intangible asset valuation assumptions, working capital adjustments, assets acquired, liabilities assumed and consideration transferred. The following is a summary of the preliminary purchase price allocation, in the aggregate, to the fair value, based on Level 3 inputs, of Becnel's assets and liabilities acquired on April 15, 2024 (in thousands):

 

Goodwill

 

$32,537

 

Intangible Assets – Customer Base & Contracts

    7,200  

Intangible Assets – Trademarks and Tradenames

    840  
        40,577  
         

Plus:

Cash

    214  
 

Accounts Receivable

    3,041  
 

Property and Equipment

    6,122  
 

Other Current Assets

    79  

Less:

Current Liabilities

    (210 )

Total Purchase Price

  $ 49,823  

 

From the date of acquisition through the end of the second quarter of fiscal year 2025, Becnel has contributed revenue of $4.7 million and an operating loss of $0.2 million, which includes the negative impact of amortization of the acquired intangible assets.

 

Axiom: Effective August 8, 2023, Transcat purchased all of the outstanding capital stock of Axiom Test Equipment, Inc. (“Axiom”), a privately-held California rental provider of electronic test equipment to customers across the United States. This transaction aligned with a key component of the Company’s acquisition strategy of targeting businesses that expand the depth and breadth of the Company’s Distribution capabilities.

 

The Axiom goodwill is primarily attributable to the workforce acquired, as well as operational synergies and other intangibles that do not qualify for separate recognition. All the goodwill and intangible assets relating to the Axiom acquisition has been allocated to the Distribution segment. Intangible assets related to the Axiom acquisition are being amortized for financial reporting purposes on an accelerated basis over the estimated useful life of up to twelve years and are not deductible for tax purposes. Amortization of goodwill related to the Axiom acquisition is not deductible for tax purposes.

 

The total purchase price for Axiom was approximately $38.7 million and was paid with $10.0 million in cash and the issuance of our common stock valued at $28.6 million. Pursuant to the asset purchase agreement, the Company held back approximately $3.9 million of the purchase price for certain potential post-closing adjustments.

 

The following is a summary of the purchase price allocation, in the aggregate, to the fair value, based on Level 3 inputs, of Axiom's assets and liabilities acquired on August 8, 2023 (in thousands):

 

Goodwill

  $ 26,758  

Intangible Assets – Customer Base & Contracts

    7,900  
        34,658  

Plus:

Cash

    161  
 

Accounts Receivable

    925  
 

Inventory

    1,796  
 

Other Current Assets

    40  
 

Property and Equipment

    4,965  

Less:

Current Liabilities

    (579 )
 

Deferred Tax Liability

    (3,242 )

Total Purchase Price

  $ 38,724  

 

During the first six months of fiscal year 2025, Axiom has contributed revenue of $4.7 million and operating income of $0.3 million, which includes the negative impact of amortization of the acquired intangible assets.

 

SteriQual: Effective July 12, 2023, Transcat purchased all of the outstanding capital stock of SteriQual, Inc. (“SteriQual”), a Florida based provider of expert consulting services to pharmaceutical, biopharmaceutical, medical device and diagnostic equipment manufacturers. This transaction aligned with a key component of the Company’s acquisition strategy of targeting businesses that expand the depth and breadth of the Company’s Service capabilities.

 

The SteriQual goodwill is primarily attributable to the workforce acquired, as well as operational synergies and other intangibles that do not qualify for separate recognition. All the goodwill and intangible assets relating to the SteriQual acquisition has been allocated to the Service segment. Intangible assets related to the SteriQual acquisition are being amortized for financial reporting purposes on an accelerated basis over the estimated useful life of up to fifteen years and are not deductible for tax purposes. Amortization of goodwill related to the SteriQual acquisition is not deductible for tax purposes.

 

The total purchase price for SteriQual was approximately $4.3 million and was paid by the issuance of our common stock.  Pursuant to the asset purchase agreement, the Company held back approximately $0.9 million of the purchase price for certain potential post-closing adjustments. Pursuant to the asset purchase agreement, the purchase price is subject to reduction by $0.5 million if certain revenue targets are not met through July 12, 2024. The revenue targets were not met and the remaining $0.4 million of the holdback was paid during the second quarter of fiscal year 2025. The purchase price was reduced to $3.8 million as of December 23, 2023 as the Company recorded a receivable in the amount of $0.5 million related to the revenue target contingent consideration. This receivable was recognized based on the facts and circumstances at the date of acquisition and is recognized as a component of goodwill and not recorded in the Consolidated Statement of Income. 

 

The following is a summary of the purchase price allocation, in the aggregate, to the fair value, based on Level 3 inputs, of SteriQual's assets and liabilities acquired on July 12, 2023 (in thousands):

 

Goodwill

  $ 2,175  

Intangible Assets – Customer Base & Contracts

    1,062  

Intangible Assets – Covenant Not to Compete

    392  

Intangible Assets – Sales Backlog

    95  
        3,724  

Plus:

Accounts Receivable

    666  

Less:

Current Liabilities

    (211 )
 

Deferred Tax Liability

    (395 )

Total Purchase Price

  $ 3,784  

 

During the first six months of fiscal year 2025, SteriQual has contributed revenue of $1.1 million and operating loss of $0.2 million, which includes the negative impact of amortization of the acquired intangible assets.

 

TIC-MS: Effective March 27, 2023, Transcat purchased all of the outstanding capital stock of TIC-MS, Inc. (“TIC-MS”), a Missouri based provider of calibration services. This transaction aligned with a key component of the Company’s acquisition strategy of targeting businesses that expand the depth and breadth of the Company’s Service capabilities.

 

The TIC-MS goodwill is primarily attributable to the workforce acquired, as well as operational synergies and other intangibles that do not qualify for separate recognition. All the goodwill and intangible assets relating to the TIC-MS acquisition has been allocated to the Service segment. Intangible assets related to the TIC-MS acquisition are being amortized for financial reporting purposes on an accelerated basis over the estimated useful life of up to fifteen years and are not deductible for tax purposes. Amortization of goodwill related to the TIC-MS acquisition is not deductible for tax purposes.

 

The total purchase price for TIC-MS was approximately $9.7 million and was paid with $2.9 million in cash, including $0.5 million placed in escrow for contingent consideration, certain post-closing adjustments and indemnification claims, if any, and the issuance of 77,387 shares of our common stock valued at $6.9 million. Pursuant to the asset purchase agreement, the purchase price was subject to reduction by up to $0.5 million if a key customer relationship is not retained through March 27, 2024.  This key customer relationship was retained and, in the first quarter of fiscal year 2025 the $0.5 million in escrow was released and paid.  

 

The following is a summary of the purchase price allocation, in the aggregate, to the fair value, based on Level 3 inputs, of TIC-MS's assets and liabilities acquired on March 27, 2023 (in thousands):

 

Goodwill

  $ 7,218  

Intangible Assets – Customer Base & Contracts

    2,303  

Intangible Assets – Covenant Not to Compete

    132  
        9,653  

Plus:

Accounts Receivable

    502  
 

Property and Equipment

    356  

Less:

Current Liabilities

    (124 )
 

Deferred Tax Liability

    (712 )

Total Purchase Price

  $ 9,675  

 

During the first six months of fiscal year 2025, TIC-MS has contributed revenue of $1.8 million and operating income of $0.9 million, which includes the negative impact of amortization of the acquired intangible assets.

  

The results of acquired businesses are included in Transcat’s consolidated operating results as of the dates the businesses were acquired. The following unaudited pro forma information presents the Company’s results of operations as if the acquisitions of Becnel, Axiom, SteriQual and TIC-MS had occurred at the beginning of fiscal year 2024. The pro forma results do not purport to represent what the Company’s results of operations actually would have been if the transactions had occurred at the beginning of the period presented or what the Company’s operating results will be in future periods.

  

   

(Unaudited)

   

(Unaudited)

 
   

Second Quarter Ended

   

Six Months Ended

 

(in thousands except per share information)

 

September 28, 2024

   

September 23, 2023

   

September 28, 2024

   

September 23, 2023

 
                                 

Total Revenue

  $ 67,826     $ 68,948     $ 134,533     $ 137,828  

Net Income

  $ 3,286     $ 435     $ 7,545     $ 2,879  

Basic Earnings Per Share

  $ 0.36     $ 0.06     $ 0.83     $ 0.37  

Diluted Earnings Per Share

  $ 0.35     $ 0.05     $ 0.82     $ 0.37  

 

Certain of the Company’s acquisition agreements include provisions for contingent consideration and other holdback amounts. The Company accrues for contingent consideration and holdback provisions based on their estimated fair value at the date of acquisition and at subsequent remeasurement periods, as applicable.  As of September 28, 2024, $0.5 million of other holdback amounts unpaid are reflected in current liabilities on the Consolidated Balance Sheets and $0.8 million of contingent consideration and $1.6 million of other holdback amounts unpaid are reflected in other liabilities on the Consolidated Balance Sheets. During the first six months of fiscal year 2025, $0.5 million was paid to settle the earn-out obligation due to Cal OpEx Limited (d/b/a NEXA Enterprise Asset Management)(“NEXA”) for calendar 2023.  This amount was paid in 4,320 shares of Transcat common stock. During the first six months of fiscal year 2025, $2.3 million was paid to settle a holdback due to Axiom.  This amount was paid in 26,379 shares of Transcat common stock.  During the first six months of fiscal year 2025, $0.4 million was paid to settle a holdback to SteriQual.  This amount was paid in 4,763 shares of Transcat common stock.  During the first six months of fiscal year 2024, no contingent consideration and $0.3 million of other holdback amounts were paid.

 

During the first six months of fiscal year 2025 and fiscal year 2024, acquisition costs of $0.4 million and $0.2 million, respectively, were recorded as incurred as general and administrative expenses in the Consolidated Statements of Income.

v3.24.3
Note 6 - Subsequent Event
6 Months Ended
Sep. 28, 2024
Notes to Financial Statements  
Subsequent Events [Text Block]

NOTE 6  SUBSEQUENT EVENT

 

On October 30, 2024, the Company entered into an asset purchase agreement with Wiscale, LLC, a Wisconsin limited liability company and subsidiary of Nesnah Ventures, LLC (the “Purchaser”), pursuant to which the Company sold the assets, and certain liabilities, of the Company’s United Scale & Engineering division which is engaged in the business of selling, renting and servicing weighing systems, scales and balances, including truck scales, and related parts to the Purchaser. The aggregate consideration received by the Company for the sale was $1.1 million, subject to customary closing adjustments.

v3.24.3
Insider Trading Arrangements
3 Months Ended 6 Months Ended
Sep. 28, 2024
Sep. 28, 2024
Insider Trading Arr Line Items    
Material Terms of Trading Arrangement [Text Block]  

PART II. OTHER INFORMATION

Non-Rule 10b5-1 Arrangement Adopted [Flag] false  
Rule 10b5-1 Arrangement Adopted [Flag] false  
Rule 10b5-1 Arrangement Terminated [Flag] false  
Non-Rule 10b5-1 Arrangement Terminated [Flag] false  
v3.24.3
Significant Accounting Policies (Policies)
6 Months Ended
Sep. 28, 2024
Accounting Policies [Abstract]  
Basis of Accounting, Policy [Policy Text Block]

Basis of Presentation: Transcat’s unaudited Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the Securities and Exchange Commission (“SEC”). Accordingly, the Consolidated Financial Statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of the Company’s management, all adjustments considered necessary for a fair presentation (consisting of normal recurring adjustments) have been included. The results for the interim periods are not necessarily indicative of what the results will be for the fiscal year. The accompanying Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements as of and for the fiscal year ended  March 30, 2024 (“fiscal year 2024”) contained in the Company’s Annual Report on Form 10-K for fiscal year 2024 filed with the SEC.

 

Use of Estimates, Policy [Policy Text Block]

Use of Estimates: The preparation of Transcat’s Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States ("GAAP") requires that the Company make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions are used for, but not limited to, allowance for credit losses and returns, inventory reserves, estimated levels of achievement for performance-based restricted stock units, fair value of stock options, depreciable lives of fixed assets, estimated lives of intangible assets, fair value of the goodwill reporting units, and the valuation of assets acquired, liabilities assumed and consideration transferred in business acquisitions. Future events and their effects cannot be predicted with certainty; accordingly, accounting estimates require the exercise of judgment. The accounting estimates used in the preparation of the Consolidated Financial Statements may change as new events occur, as more experience is acquired, as additional information is obtained and as the operating environment changes. Actual results could differ from those estimates. Such changes and refinements in estimation methodologies are reflected in reported results of operations in the period in which the changes are made and, if material, their effects are disclosed in the Notes to the Consolidated Financial Statements.

 

Cash and Cash Equivalents, Policy [Policy Text Block]

Cash and Cash Equivalents:  Cash equivalents consist of highly liquid investments with an original maturity when purchased of three months or less and are stated at cost, which approximates fair value.

 

Marketable Securities, Policy [Policy Text Block]

Marketable Securities: Marketable securities consist of highly liquid investments with an original maturity when purchased of more than three months and are stated at fair value on the Consolidated Balance Sheets.  These securities are considered trading securities. Earnings on the marketable securities are included in interest income in the Consolidated Statements of Income.

 

Revenue [Policy Text Block]

Revenue Recognition:  Distribution non-rental revenue is recorded when an order’s title and risk of loss transfers to the customer, which is generally upon shipment. Distribution rental revenue is recognized over time using the time-elapsed output method as this portrays the transfer of control to the customer. The Company recognizes the majority of its Service revenue based upon when the calibration or other activity is performed and then shipped and/or delivered to the customer. The majority of the Company’s revenue generating activities have a single performance obligation and are recognized at the point in time when control transfers and/or our obligation has been fulfilled. Some Service revenue is generated from managing customers’ calibration programs in which the Company recognizes revenue over time using the time-elapsed output method as this portrays the transfer of control to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for product shipped or services performed. Sales taxes and other taxes billed and collected from customers are excluded from revenue. The Company generally invoices its customers for freight, shipping, and handling charges. Freight billed to customers is included in revenue. Shipping and handling is not included in revenue. Provisions for customer returns are provided for in the period the related revenue is recorded based upon historical data.

   

Under Accounting Standards Codification ("ASC") Topic 606, Revenue from Contracts with Customers, we use judgments that could potentially impact both the timing of our satisfaction of performance obligations. Such judgments include considerations in determining our transaction prices and when our performance obligations are satisfied for our standard product sales that include general payment terms that are between net 30 and 90 days.

 

Revenue recognized from prior period performance obligations for the second quarter of the fiscal year ending March 29, 2025 (“fiscal year 2025”) was immaterial. As of September 28, 2024, the Company had no unsatisfied performance obligations for contracts with an original expected duration of greater than one year. Pursuant to ASC Topic 606, the Company applied the practical expedient with respect to disclosure of the deferral and future expected timing of revenue recognition for transaction price allocated to remaining performance obligations. Deferred revenue, unbilled revenue and deferred contract costs recorded on our Consolidated Balance Sheets as of September 28, 2024 and March 30, 2024 were immaterial. See Note 4 for disaggregated revenue information.

 

  

% of Total Net Sales

 
  

Second Quarter Ended

  

Six Months Ended

 
  

September 28,

  

September 23,

  

September 28,

  

September 23,

 
  

2024

  

2023

  

2024

  

2023

 

Point-in-Time

  86.6%  90.4%  86.1%  90.5%

Over Time - Output Method

  13.4%  9.6%  13.9%  9.5%

Total

  100.0%  100.0%  100.0%  100.0%

 

Fair Value of Financial Instruments, Policy [Policy Text Block]

Fair Value of Financial Instruments:  Transcat has determined the fair value of debt and other financial instruments using a valuation hierarchy. The hierarchy, which prioritizes the inputs used in measuring fair value, consists of three levels. Level 1 uses observable inputs such as quoted prices in active markets; Level 2 uses inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, which is defined as unobservable inputs in which little or no market data exists, requires the Company to develop its own assumptions. The carrying amount of debt on the Consolidated Balance Sheets approximates fair value due to variable interest rate pricing on a portion of the debt with the balance bearing an interest rate approximating current market rates, and the carrying amounts for cash and cash equivalents, marketable securities, accounts receivable and accounts payable approximate fair value due to their short-term nature. Investment assets, which fund the Company’s non-qualified deferred compensation plan, consist of mutual funds and are valued based on Level 1 inputs.  At each of September 28, 2024 and March 30, 2024, investment assets totaled $0.1 million, and are included as a component of other assets (non-current) on the Consolidated Balance Sheets.

 

Share-Based Payment Arrangement [Policy Text Block]

Stock-Based Compensation:  The Company measures the cost of services received in exchange for all equity awards granted, including stock options and restricted stock units, based on the fair market value of the award as of the grant date. The Company records compensation cost related to unvested equity awards by recognizing, on a straight-line basis, the unamortized grant date fair value over the remaining service period for awards expected to vest. Excess tax benefits for share-based award activity are reflected in the Consolidated Statements of Income as a component of the provision for income taxes. Excess tax benefits are realized benefits from tax deductions for exercised awards in excess of the deferred tax asset attributable to stock-based compensation costs for such awards. The Company did not capitalize any stock-based compensation costs as part of an asset. The Company estimates forfeiture rates based on its historical experience. During the first six months of fiscal year 2025 and fiscal year 2024, the Company recorded non-cash stock-based compensation cost of $1.6 million and $2.2 million, respectively, in the Consolidated Statements of Income.

 

Foreign Currency Transactions and Translations Policy [Policy Text Block]

Foreign Currency Translation and Transactions:  The accounts of Cal OpEx Limited (d/b/a Transcat Ireland), an Irish company, and Transcat Canada Inc., both of which are wholly-owned subsidiaries of the Company, are maintained in their local currencies, the Euro and the Canadian dollar, respectively, and have been translated to U.S. dollars. Accordingly, the amounts representing assets and liabilities have been translated at the period-end rates of exchange and related revenue and expense accounts have been translated at an average rate of exchange during the period. Gains and losses arising from translation of Cal OpEx Limited’s and Transcat Canada Inc.’s financial statements into U.S. dollars are recorded directly to the accumulated other comprehensive loss component of shareholders’ equity.

 

Transcat records foreign currency gains and losses on business transactions denominated in foreign currency. The net foreign currency was a net loss of $0.4 million for the first six months of fiscal year 2025 and a net gain of less than $0.1 million for the first six months of fiscal year 2024. The Company continually utilizes short-term foreign exchange forward contracts to reduce the risk that its future earnings denominated in Canadian dollars would be adversely affected by changes in currency exchange rates. The Company does not apply hedge accounting and therefore the net change in the fair value of the contracts, which totaled a gain of less than $0.1 million during each of the first six months of fiscal years 2025 and 2024, was recognized as a component of Interest and Other Expenses, net in the Consolidated Statements of Income. The change in the fair value of the contracts is offset by the change in fair value on the underlying accounts receivables denominated in Canadian dollars being hedged. On September 28, 2024, the Company had a foreign exchange contract, which matured in October 2024, outstanding in the notional amount of $2.5 million. This contract was subsequently renewed and remains in place. The Company does not use hedging arrangements for speculative purposes.

 

Earnings Per Share, Policy [Policy Text Block]

Earnings Per Share: Basic earnings per share of the Company's common stock, par value $0.50 per share ("common stock"), are computed based on the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share of common stock reflect the assumed conversion of stock options, unvested restricted stock units using the treasury stock method and contingent consideration classified as equity in periods in which they have a dilutive effect. In computing the per share effect of assumed conversion, proceeds received from the exercise of options and unvested restricted stock units are considered to have been used to purchase shares of common stock at the average market prices during the period, and the resulting net additional shares of common stock are included in the calculation of average shares of common stock outstanding.

 

For the second quarter of fiscal year 2025, the net additional common stock equivalents had a ($0.01) effect on the calculation of diluted earnings per share.   For the second quarter of fiscal year 2024, the net additional common stock equivalents had no effect on the calculation of diluted earnings per share.  For the first six months of each of fiscal years 2025 and 2024, the net additional common stock equivalents had a ($0.01) effect on the calculation of diluted earnings per share. The average shares outstanding used to compute basic and diluted earnings per share are as follows (amounts in thousands):

 

  

Second Quarter Ended

  

Six Months Ended

 
  

September 28,

  

September 23,

  

September 28,

  

September 23,

 
  

2024

  

2023

  

2024

  

2023

 

Average Shares Outstanding – Basic

  9,160   7,819   9,107   7,732 

Effect of Dilutive Common Stock Equivalents

  122   129   115   108 

Average Shares Outstanding – Diluted

  9,282   7,948   9,222   7,840 

Anti-dilutive Common Stock Equivalents

  31   31   41   37 

 

Goodwill and Intangible Assets, Policy [Policy Text Block]

Goodwill and Intangible Assets: Goodwill represents the excess of the purchase price over the fair values of the underlying net assets of an acquired business. The Company tests goodwill for impairment for each reporting unit on an annual basis during the fourth quarter of its fiscal year, or immediately if conditions indicate that such impairment could exist. The Company is permitted, but not required, to qualitatively assess indicators of a reporting unit’s fair value to determine whether it is necessary to perform the two-step goodwill impairment test. If a quantitative test is deemed necessary, a discounted cash flow analysis is prepared to estimate fair value.

 

Intangible assets, namely customer base and covenants not to compete, represent an allocation of purchase price to identifiable intangible assets of an acquired business. Intangible assets are evaluated for impairment when events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. The allocation of goodwill and intangible assets by segment for the fiscal year 2025 additions are preliminary.  A summary of changes in the Company’s goodwill and intangible assets is as follows (amounts in thousands):

 

  

Goodwill

  

Intangible Assets

 
  

Distribution

  

Service

  

Total

  

Distribution

  

Service

  

Total

 

Net Book Value as of March 30, 2024

 $38,216  $67,369  $105,585  $6,993  $12,994  $19,987 

Additions

  21,685   10,847   32,532   5,360   2,680   8,040 

Amortization

  -   -   -   (1,443)  (2,222)  (3,665)

Currency Translation Adjustment

  -   10   10   -   -   - 

Net Book Value as of September 28, 2024

 $59,901  $78,226  $138,127  $10,910  $13,452  $24,362 

 

Other Liabilities Policy [Policy Text Block]

Other Liabilities: A summary of other current and non-current liabilities is as follows (amounts in thousands):

 

  

(Unaudited)

  

(Audited)

 
  

September 28,

  

March 30,

 
  

2024

  

2024

 

Current Liabilities:

        

Accrued Payroll and Employee Benefits

 $4,982  $5,508 

Accrued Incentives

  1,277   4,182 

Current Portion of Lease Liabilities

  3,201   2,510 

Accrued Acquisition Holdbacks

  514   2,577 

Accrued Sales Tax

  652   813 

Accrued Contingent Consideration

  -   529 

Income Taxes Payable

     2,926 

Other Current Liabilities

  466   620 

Accrued Compensation and Other Current Liabilities

 $11,092  $19,665 
         

Non-Current Liabilities:

        

Postretirement Benefit Obligation

 $1,132  $1,134 

Accrued Acquisition Holdbacks

  1,647   1,647 

Accrued Contingent Consideration

  806   - 

Other Non-Current Liabilities

  120   122 

Other Liabilities

 $3,705  $2,903 

 

New Accounting Pronouncements, Policy [Policy Text Block]

Recent Accounting Guidance Not Yet Adopted:  In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280).  The ASU requires disclosures, on an annual and interim basis, of significant segment expenses and other segment items that are regularly provided to the Chief Operating Decision Maker ("CODM") as well as the title and position of the CODM. ASU 2023-07 is effective for annual periods beginning in fiscal 2025 and interim periods in fiscal year 2026 with early adoption permitted.  The adoption of this ASU is expected to impact the Company's financial statement disclosures but have no material impact on our results of operations, cash flows or financial condition.

 

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures.  The ASU expands the income tax disclosure requirements, principally related to the rate reconciliation table and income taxes paid.  ASU 2023-09 is effective for annual periods beginning in fiscal 2026, with early adoption permitted.  The adoption of the ASU is not expected to have a material impact on the Company’s financial statement disclosures.

 

v3.24.3
Note 1 - General (Tables)
6 Months Ended
Sep. 28, 2024
Notes Tables  
Disaggregation of Revenue [Table Text Block]
  

% of Total Net Sales

 
  

Second Quarter Ended

  

Six Months Ended

 
  

September 28,

  

September 23,

  

September 28,

  

September 23,

 
  

2024

  

2023

  

2024

  

2023

 

Point-in-Time

  86.6%  90.4%  86.1%  90.5%

Over Time - Output Method

  13.4%  9.6%  13.9%  9.5%

Total

  100.0%  100.0%  100.0%  100.0%
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
  

Second Quarter Ended

  

Six Months Ended

 
  

September 28,

  

September 23,

  

September 28,

  

September 23,

 
  

2024

  

2023

  

2024

  

2023

 

Average Shares Outstanding – Basic

  9,160   7,819   9,107   7,732 

Effect of Dilutive Common Stock Equivalents

  122   129   115   108 

Average Shares Outstanding – Diluted

  9,282   7,948   9,222   7,840 

Anti-dilutive Common Stock Equivalents

  31   31   41   37 
Schedule of Intangible Assets and Goodwill [Table Text Block]
  

Goodwill

  

Intangible Assets

 
  

Distribution

  

Service

  

Total

  

Distribution

  

Service

  

Total

 

Net Book Value as of March 30, 2024

 $38,216  $67,369  $105,585  $6,993  $12,994  $19,987 

Additions

  21,685   10,847   32,532   5,360   2,680   8,040 

Amortization

  -   -   -   (1,443)  (2,222)  (3,665)

Currency Translation Adjustment

  -   10   10   -   -   - 

Net Book Value as of September 28, 2024

 $59,901  $78,226  $138,127  $10,910  $13,452  $24,362 
Schedule of Accrued Liabilities [Table Text Block]
  

(Unaudited)

  

(Audited)

 
  

September 28,

  

March 30,

 
  

2024

  

2024

 

Current Liabilities:

        

Accrued Payroll and Employee Benefits

 $4,982  $5,508 

Accrued Incentives

  1,277   4,182 

Current Portion of Lease Liabilities

  3,201   2,510 

Accrued Acquisition Holdbacks

  514   2,577 

Accrued Sales Tax

  652   813 

Accrued Contingent Consideration

  -   529 

Income Taxes Payable

     2,926 

Other Current Liabilities

  466   620 

Accrued Compensation and Other Current Liabilities

 $11,092  $19,665 
         

Non-Current Liabilities:

        

Postretirement Benefit Obligation

 $1,132  $1,134 

Accrued Acquisition Holdbacks

  1,647   1,647 

Accrued Contingent Consideration

  806   - 

Other Non-Current Liabilities

  120   122 

Other Liabilities

 $3,705  $2,903 
v3.24.3
Note 3 - Stock-based Compensation (Tables)
6 Months Ended
Sep. 28, 2024
Notes Tables  
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]
       

Total

   

Grant Date

 

Estimated

       

Number

   

Fair

 

Level of

Date

 

Measurement

 

of Units

   

Value

 

Achievement at

Granted

 

Period

 

Outstanding

   

Per Unit

 

September 28, 2024

October 2018

 

October 2018 – September 2028

  5     $ 20.81  

Time Vested

March 2022

 

March 2022 – March 2025

  1     $ 76.31  

Time Vested

May 2022

 

May 2022 – March 2025

  9     $ 63.17  

Time Vested

May 2022

 

May 2022 – March 2025

  8     $ 63.17  

0% of target level

August 2022

 

August 2022 – August 2025

  1     $ 78.04  

Time Vested

May 2023

 

May 2023 – March 2026

  8     $ 89.70  

150% of target level

May 2023

 

May 2023 – March 2026

  8     $ 89.70  

Time Vested

May 2023

 

May 2023 – May 2026

  13     $ 89.70  

Time Vested

April 2024

 

April 2024 - April 2027

  2     $ 107.13  

Time Vested

April 2024

 

April 2024 - April 2027

  1     $ 108.04  

Time Vested

May 2024

 

May 2024 - May 2027

  1     $ 119.45  

Time Vested

May 2024

 

May 2024 - May 2027

  1     $ 124.12  

Time Vested

May 2024

 

May 2024 - March 2027

  9     $ 124.12  

100% of target level

May 2024

 

May 2024 - March 2027

  10     $ 124.12  

Time Vested

July 2024

 

July 2024 - July 2027

  1     $ 116.91  

Time Vested

September 2024

 

September 2024 - September 2025

  6     $ 120.66  

Time Vested

September 2024

 

September 2024 - September 2027

  1     $ 123.33  

100% of target level

September 2024

 

September 2024 - September 2027

  1     $ 123.33  

Time Vested

Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   

Second Quarter Ended

   

Six Months Ended

 
   

September 28,

   

September 23,

   

September 28,

   

September 23,

 
   

2024

   

2023

   

2024

   

2023

 
                                 

Risk-Free Interest Rate

    4.09 %     4.38 %     4.35 %     3.82 %

Volatility Factor

    40.70 %     36.87 %     40.98 %     37.04 %

Expected Term (in Years)

    4.00       6.27       4.00       6.22  

Annual Dividend Rate

    0.00 %     0.00 %     0.00 %     0.00 %
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
           

Weighted

   

Weighted

         
           

Average

   

Average

         
   

Number

   

Exercise

   

Remaining

   

Aggregate

 
   

Of

   

Price Per

   

Contractual

   

Intrinsic

 
   

Options

   

Option

   

Term (in years)

   

Value

 

Outstanding as of March 30, 2024

    234     $ 63.43                  

Granted

    10     $ 112.93                  

Exercised

    (25 )   $ 23.02                  

Forfeited

    (12 )   $ 63.04                  

Outstanding as of September 28, 2024

    207     $ 70.67       6     $ 10,522  

Exercisable as of September 28, 2024

    72     $ 58.95       6     $ 2,838  
v3.24.3
Note 4 - Segment Information (Tables)
6 Months Ended
Sep. 28, 2024
Notes Tables  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
   

Second Quarter Ended

   

Six Months Ended

 
   

September 28,

   

September 23,

   

September 28,

   

September 23,

 
   

2024

   

2023

   

2024

   

2023

 

Revenue:

                               

Service

  $ 44,083     $ 41,431     $ 87,861     $ 81,284  

Distribution

    23,743       21,373       46,672       42,118  

Total

    67,826       62,804       134,533       123,402  
                                 

Gross Profit:

                               

Service

    14,591       14,084       29,474       27,055  

Distribution

    6,615       6,041       14,387       11,780  

Total

    21,206       20,125       43,861       38,835  
                                 

Operating Expenses:

                               

Service (1)

    10,887       13,342       21,680       23,121  

Distribution (1)

    6,584       5,140       13,347       9,431  

Total

    17,471       18,482       35,027       32,552  
                                 

Operating Income:

                               

Service

    3,704       742       7,794       3,934  

Distribution

    31       901       1,040       2,349  

Total

    3,735       1,643       8,834       6,283  
                                 

Unallocated Amounts:

                               

Interest and Other (Income)/Expense, net

    22       841       (107 )     1,719  

Provision for Income Taxes

    427       342       1,247       1,155  

Total

    449       1,183       1,140       2,874  
                                 

Net Income

  $ 3,286     $ 460     $ 7,694     $ 3,409  
                                 

Geographic Data:

                               

Revenues to Unaffiliated Customers (2)

                               

United States (3)

  $ 62,492     $ 57,119     $ 123,232     $ 111,376  

Canada

    3,794       3,896       8,266       8,143  

Other International

    1,540       1,789       3,035       3,883  

Total

  $ 67,826     $ 62,804     $ 134,533     $ 123,402  
v3.24.3
Note 5 - Business Acquisitions (Tables)
6 Months Ended
Sep. 28, 2024
Notes Tables  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]

Goodwill

 

$32,537

 

Intangible Assets – Customer Base & Contracts

    7,200  

Intangible Assets – Trademarks and Tradenames

    840  
        40,577  
         

Plus:

Cash

    214  
 

Accounts Receivable

    3,041  
 

Property and Equipment

    6,122  
 

Other Current Assets

    79  

Less:

Current Liabilities

    (210 )

Total Purchase Price

  $ 49,823  

Goodwill

  $ 26,758  

Intangible Assets – Customer Base & Contracts

    7,900  
        34,658  

Plus:

Cash

    161  
 

Accounts Receivable

    925  
 

Inventory

    1,796  
 

Other Current Assets

    40  
 

Property and Equipment

    4,965  

Less:

Current Liabilities

    (579 )
 

Deferred Tax Liability

    (3,242 )

Total Purchase Price

  $ 38,724  

Goodwill

  $ 2,175  

Intangible Assets – Customer Base & Contracts

    1,062  

Intangible Assets – Covenant Not to Compete

    392  

Intangible Assets – Sales Backlog

    95  
        3,724  

Plus:

Accounts Receivable

    666  

Less:

Current Liabilities

    (211 )
 

Deferred Tax Liability

    (395 )

Total Purchase Price

  $ 3,784  

Goodwill

  $ 7,218  

Intangible Assets – Customer Base & Contracts

    2,303  

Intangible Assets – Covenant Not to Compete

    132  
        9,653  

Plus:

Accounts Receivable

    502  
 

Property and Equipment

    356  

Less:

Current Liabilities

    (124 )
 

Deferred Tax Liability

    (712 )

Total Purchase Price

  $ 9,675  
Business Acquisition, Pro Forma Information [Table Text Block]
   

(Unaudited)

   

(Unaudited)

 
   

Second Quarter Ended

   

Six Months Ended

 

(in thousands except per share information)

 

September 28, 2024

   

September 23, 2023

   

September 28, 2024

   

September 23, 2023

 
                                 

Total Revenue

  $ 67,826     $ 68,948     $ 134,533     $ 137,828  

Net Income

  $ 3,286     $ 435     $ 7,545     $ 2,879  

Basic Earnings Per Share

  $ 0.36     $ 0.06     $ 0.83     $ 0.37  

Diluted Earnings Per Share

  $ 0.35     $ 0.05     $ 0.82     $ 0.37  
v3.24.3
Note 1 - General (Details Textual) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended
Sep. 28, 2024
Sep. 23, 2023
Sep. 28, 2024
Sep. 23, 2023
Mar. 30, 2024
Investments $ 0.1   $ 0.1   $ 0.1
Share-Based Payment Arrangement, Expense     1.6 $ 2.2  
Realized Gain (Loss), Foreign Currency Transaction, before Tax     (0.4) 0.1  
Unrealized Gain (Loss), Foreign Currency Transaction, before Tax     $ 0.1 $ 0.1  
Common Stock, Par or Stated Value Per Share (in dollars per share) $ 0.5   $ 0.5   $ 0.5
Dilutive Securities, Effect Per Share on Earnings (in dollars per share) $ 0.01 $ 0 $ 0.01 $ 0.01  
Foreign Exchange Contract [Member]          
Derivative Asset, Notional Amount $ 2.5   $ 2.5    
v3.24.3
Note 1 - General - Summary of Net Sales by Revenue Recognition Method as a Percentage of Total Sales (Details)
3 Months Ended 6 Months Ended
Sep. 28, 2024
Sep. 23, 2023
Sep. 28, 2024
Sep. 23, 2023
Revenue, percentage 100.00% 100.00% 100.00% 100.00%
Transferred at Point in Time [Member]        
Revenue, percentage 86.60% 90.40% 86.10% 90.50%
Transferred over Time [Member]        
Revenue, percentage 13.40% 9.60% 13.90% 9.50%
v3.24.3
Note 1 - General - Computation of Basic and Diluted Earnings Per Share (Details) - shares
shares in Thousands
3 Months Ended 6 Months Ended
Sep. 28, 2024
Sep. 23, 2023
Sep. 28, 2024
Sep. 23, 2023
Average Shares Outstanding – Basic (in shares) 9,160 7,819 9,107 7,732
Effect of Dilutive Common Stock Equivalents (in shares) 122 129 115 108
Average Shares Outstanding – Diluted (in shares) 9,282 7,948 9,222 7,840
Anti-dilutive Common Stock Equivalents (in shares) 31 31 41 37
v3.24.3
Note 1 - General - Summary of Changes in Goodwill and Intangible Assets (Details)
$ in Thousands
6 Months Ended
Sep. 28, 2024
USD ($)
Net Book Value, goodwill $ 105,585
Net Book Value, intangible assets 19,987
Additions, goodwill 32,532
Additions, intangible assets 8,040
Amortization, goodwill 0
Amoritization, intangible assets (3,665)
Currency Translation Adjustment, goodwill 10
Currency Translation Adjustment, intangible assets 0
Net Book Value, goodwill 138,127
Net Book Value, intangible assets 24,362
Distribution Segment [Member]  
Net Book Value, goodwill 38,216
Net Book Value, intangible assets 6,993
Additions, goodwill 21,685
Additions, intangible assets 5,360
Amortization, goodwill 0
Amoritization, intangible assets (1,443)
Currency Translation Adjustment, goodwill 0
Currency Translation Adjustment, intangible assets 0
Net Book Value, goodwill 59,901
Net Book Value, intangible assets 10,910
Service Segment [Member]  
Net Book Value, goodwill 67,369
Net Book Value, intangible assets 12,994
Additions, goodwill 10,847
Additions, intangible assets 2,680
Amortization, goodwill 0
Amoritization, intangible assets (2,222)
Currency Translation Adjustment, goodwill 10
Currency Translation Adjustment, intangible assets 0
Net Book Value, goodwill 78,226
Net Book Value, intangible assets $ 13,452
v3.24.3
Note 1 - General - Summary of Liabilities Current and Non-current (Details) - USD ($)
$ in Thousands
Sep. 28, 2024
Mar. 30, 2024
Accrued Payroll and Employee Benefits $ 4,982 $ 5,508
Accrued Incentives 1,277 4,182
Current Portion of Lease Liabilities 3,201 2,510
Accrued Acquisition Holdbacks 514 2,577
Accrued Sales Tax 652 813
Accrued Contingent Consideration 0 529
Income Taxes Payable 2,926
Other Current Liabilities 466 620
Accrued Compensation and Other Current Liabilities 11,092 19,665
Postretirement Benefit Obligation 1,132 1,134
Accrued Acquisition Holdbacks 1,647 1,647
Accrued Contingent Consideration 806 0
Other Non-Current Liabilities 120 122
Other Liabilities $ 3,705 $ 2,903
v3.24.3
Note 2 - Long-term Debt (Details Textual)
$ in Thousands
6 Months Ended 12 Months Ended
Sep. 28, 2024
USD ($)
Mar. 30, 2024
USD ($)
Jul. 07, 2021
USD ($)
Long-Term Debt, Current Maturities $ 2,386 $ 2,339  
The 2018 Term Loan [Member]      
Debt Instrument, Face Amount     $ 15,000
Long-Term Debt 3,000    
Long-Term Debt, Current Maturities 2,400    
Debt Instrument, Periodic Payment, Total $ 200    
Debt Instrument, Interest Rate, Stated Percentage 3.90%    
Revolving Credit Facility [Member]      
Line of Credit Facility, Maximum Borrowing Capacity     80,000
Debt Instrument, Covenant, Restriction to Repurchase Shares and Pay Dividends, Aggregate $ 25,000   10,000
Line of Credit Facility, Current Borrowing Capacity 80,000    
Long-Term Line of Credit $ 0    
LIBOR Floor 0.25%    
Debt Instrument, Covenant, Maximum Fixed Charge Ratio 1.15    
Debt Instrument, Covenant, Maximum Total Leverage Ratio 3    
Total Leverage Ratio 0.08 0.1  
Revolving Credit Facility [Member] | Maximum [Member]      
Debt Instrument, Permitted Acquisition, Aggregate Purchase Price $ 50,000    
Debt Instrument, Permitted Acquisition, Additional Aggregate Purchase Price $ 40,000    
Debt Instrument, Interest Rate, Effective Percentage 7.10%    
Letter of Credit [Member]      
Line of Credit Facility, Maximum Borrowing Capacity     $ 10,000
v3.24.3
Note 3 - Stock-based Compensation (Details Textual) - USD ($)
Pure in Thousands, $ in Millions
3 Months Ended 6 Months Ended
Sep. 28, 2024
Sep. 23, 2023
Sep. 28, 2024
Sep. 23, 2023
Jun. 29, 2024
Share-Based Payment Arrangement, Expense, Tax Benefit     $ 1.1 $ 0.6  
Share-Based Payment Arrangement, Expense     $ 1.6 2.2  
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate     0.00%    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)     10,000    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value     $ 2.4 0.3  
Proceeds from Stock Options Exercised     $ 0.6 $ 0.1  
Individual Employee [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)       5 years  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)       10,000  
Director [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)       5 years  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)       10,000  
Performance-based Restricted Stock Units [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)     3 years    
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $ 6.4   $ 6.4    
Restricted Stock Units (RSUs) [Member]          
Share-Based Payment Arrangement, Expense     0.9 $ 1.5  
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount 5.0   $ 5.0    
Share-Based Payment Arrangement, Option [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)     5 years    
Share-Based Payment Arrangement, Expense     $ 0.7 $ 0.6  
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $ 2.1   $ 2.1    
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate 0.00% 0.00% 0.00% 0.00%  
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)     3 years    
Share-Based Payment Arrangement, Option [Member] | Share-Based Payment Arrangement, Employee [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)     10,000 7,000  
Share-Based Payment Arrangement, Option [Member] | Share-Based Payment Arrangement, Employee [Member] | Share-Based Payment Arrangement, Tranche One [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)     3 years 3 years  
Share-Based Payment Arrangement, Option [Member] | Minimum [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)     5 years    
Share-Based Payment Arrangement, Option [Member] | Maximum [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)     10 years    
The 2021 Plan [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares)         600,000
v3.24.3
Note 3 - Stock-based Compensation - Summary of Non-vested Restricted Stock Units (Details) - Performance-based Restricted Stock Units [Member]
shares in Thousands
Sep. 28, 2024
$ / shares
shares
October 2018 [Member]  
Total number of units outstanding (in shares) | shares 5
Grant date fair value per unit (in dollars per share) | $ / shares $ 20.81
March 2022 [Member]  
Total number of units outstanding (in shares) | shares 1
Grant date fair value per unit (in dollars per share) | $ / shares $ 76.31
May 2022, First Issuance [Member]  
Total number of units outstanding (in shares) | shares 9
Grant date fair value per unit (in dollars per share) | $ / shares $ 63.17
May 2022, Second Issuance [Member]  
Total number of units outstanding (in shares) | shares 8
Grant date fair value per unit (in dollars per share) | $ / shares $ 63.17
Estimated level of achievement 0.00%
August 2022 Issuance [Member]  
Total number of units outstanding (in shares) | shares 1
Grant date fair value per unit (in dollars per share) | $ / shares $ 78.04
May 2023 First Issuance [Member]  
Total number of units outstanding (in shares) | shares 8
Grant date fair value per unit (in dollars per share) | $ / shares $ 89.7
Estimated level of achievement 150.00%
May 2023 Second Issuance [Member]  
Total number of units outstanding (in shares) | shares 8
Grant date fair value per unit (in dollars per share) | $ / shares $ 89.7
May 2023 Third Issuance [Member]  
Total number of units outstanding (in shares) | shares 13
Grant date fair value per unit (in dollars per share) | $ / shares $ 89.7
April 2024 First Issuance [Member]  
Total number of units outstanding (in shares) | shares 2
Grant date fair value per unit (in dollars per share) | $ / shares $ 107.13
April 2024 Second Issuance [Member]  
Total number of units outstanding (in shares) | shares 1
Grant date fair value per unit (in dollars per share) | $ / shares $ 108.04
May 2024 First Issuance [Member]  
Total number of units outstanding (in shares) | shares 1
Grant date fair value per unit (in dollars per share) | $ / shares $ 119.45
May 2024 Second Issuance [Member]  
Total number of units outstanding (in shares) | shares 1
Grant date fair value per unit (in dollars per share) | $ / shares $ 124.12
May 2024 Third Issuance [Member]  
Total number of units outstanding (in shares) | shares 9
Grant date fair value per unit (in dollars per share) | $ / shares $ 124.12
Estimated level of achievement 100.00%
May 2024 Fourth Issuance [Member]  
Total number of units outstanding (in shares) | shares 10
Grant date fair value per unit (in dollars per share) | $ / shares $ 124.12
July 2024 [Member]  
Total number of units outstanding (in shares) | shares 1
Grant date fair value per unit (in dollars per share) | $ / shares $ 116.91
September 2024, First Issuance [Member]  
Total number of units outstanding (in shares) | shares 6
Grant date fair value per unit (in dollars per share) | $ / shares $ 120.66
September 2024 Second Issuance [Member]  
Total number of units outstanding (in shares) | shares 1
Grant date fair value per unit (in dollars per share) | $ / shares $ 123.33
Estimated level of achievement 100.00%
September 2024 Third Issuance [Member]  
Total number of units outstanding (in shares) | shares 1
Grant date fair value per unit (in dollars per share) | $ / shares $ 123.33
v3.24.3
Note 3 - Stock-based Compensation - Weighted Average Assumptions (Details)
3 Months Ended 6 Months Ended
Sep. 28, 2024
Sep. 23, 2023
Sep. 28, 2024
Sep. 23, 2023
Annual Dividend Rate     0.00%  
Share-Based Payment Arrangement, Option [Member]        
Risk-Free Interest Rate 4.09% 4.38% 4.35% 3.82%
Volatility Factor 40.70% 36.87% 40.98% 37.04%
Expected Term (in Years) (Year) 4 years 6 years 3 months 7 days 4 years 6 years 2 months 19 days
Annual Dividend Rate 0.00% 0.00% 0.00% 0.00%
v3.24.3
Note 3 - Stock-based Compensation - Summary of Options (Details)
$ / shares in Units, shares in Thousands, $ in Thousands
6 Months Ended
Sep. 28, 2024
USD ($)
$ / shares
shares
Outstanding, number of options (in shares) | shares 234
Outstanding, weighted average exercise price (in dollars per share) | $ / shares $ 63.43
Granted, number of options (in shares) | shares 10
Granted, weighted average exercise price (in dollars per share) | $ / shares $ 112.93
Exercised, number of options (in shares) | shares (25)
Exercised, weighted average exercise price (in dollars per share) | $ / shares $ 23.02
Forfeited, number of options (in shares) | shares (12)
Forfeited, weighted average exercise price (in dollars per share) | $ / shares $ 63.04
Outstanding, number of options (in shares) | shares 207
Outstanding, weighted average exercise price (in dollars per share) | $ / shares $ 70.67
Outstanding, weighted average remaining contractual term (Year) 6 years
Oustanding, aggregate intrinsic value | $ $ 10,522
Exercisable, number of options (in shares) | shares 72
Exercisable, weighted average exercise price (in dollars per share) | $ / shares $ 58.95
Exercisable, weighted average remaining contractual term (Year) 6 years
Exercisable, aggregate intrinsic value | $ $ 2,838
v3.24.3
Note 4 - Segment Information (Details Textual)
6 Months Ended
Sep. 28, 2024
Number of Reportable Segments 2
v3.24.3
Note 4 - Segment Information - Schedule of Segment Reporting Information, by Segment (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Sep. 28, 2024
Jun. 29, 2024
Sep. 23, 2023
Jun. 24, 2023
Sep. 28, 2024
Sep. 23, 2023
Revenue [1] $ 67,826   $ 62,804   $ 134,533 $ 123,402
Gross Profit 21,206   20,125   43,861 38,835
Operating Expenses 17,471   18,482   35,027 32,552
Operating Income 3,735   1,643   8,834 6,283
Interest and Other (Income)/Expense, net 22   841   (107) 1,719
Provision for Income Taxes 427   342   1,247 1,155
Total 449   1,183   1,140 2,874
Net Income 3,286 $ 4,408 460 $ 2,949 7,694 3,409
UNITED STATES            
Revenue [1],[2] 62,492   57,119   123,232 111,376
CANADA            
Revenue [1] 3,794   3,896   8,266 8,143
Other International [Member]            
Revenue [1] 1,540   1,789   3,035 3,883
Service Segment [Member] | Operating Segments [Member]            
Revenue 44,083   41,431   87,861 81,284
Gross Profit 14,591   14,084   29,474 27,055
Operating Expenses [3] 10,887   13,342   21,680 23,121
Operating Income 3,704   742   7,794 3,934
Distribution Segment [Member] | Operating Segments [Member]            
Revenue 23,743   21,373   46,672 42,118
Gross Profit 6,615   6,041   14,387 11,780
Operating Expenses [3] 6,584   5,140   13,347 9,431
Operating Income $ 31   $ 901   $ 1,040 $ 2,349
[1] Revenues are attributed to the countries based on the destination of a product shipment or the location where service is rendered.
[2] United States includes Puerto Rico.
[3] Operating expense allocations between segments are based on actual amounts, a percentage of revenues, headcount, and management’s estimates.
v3.24.3
Note 5 - Business Acquisitions (Details Textual)
$ in Thousands
3 Months Ended 5 Months Ended 6 Months Ended
Apr. 15, 2024
USD ($)
shares
Dec. 23, 2023
USD ($)
Aug. 08, 2023
USD ($)
Jul. 12, 2023
USD ($)
Mar. 27, 2023
USD ($)
shares
Sep. 28, 2024
USD ($)
Sep. 23, 2023
USD ($)
Jun. 24, 2023
USD ($)
Sep. 28, 2024
USD ($)
Sep. 28, 2024
USD ($)
shares
Sep. 23, 2023
USD ($)
Mar. 30, 2024
USD ($)
Revenues [1]           $ 67,826 $ 62,804     $ 134,533 $ 123,402  
Operating Income (Loss)           3,735 $ 1,643     8,834 6,283  
Payments for Other Holdbacks                     300  
Business Combination, Contingent Consideration, Liability, Current           500     $ 500 500    
Business Combination, Contingent Consideration, Liability, Noncurrent           806     806 806   $ 0
Unpaid Amounts for Other Holdbacks           1,600     1,600 1,600    
Payment for Contingent Consideration Liability, Financing Activities                     0  
Business Combination, Acquisition Related Costs                   400 $ 200  
Becnel Rental Tools, LLC [Member]                        
Revenues                 4,700      
Operating Income (Loss)                 (200)      
Axiom [Member]                        
Revenues                   4,700    
Operating Income (Loss)                   300    
SteriQual, Inc. [Member]                        
Revenues                   1,100    
Operating Income (Loss)                   (200)    
TIC-MS, Inc. [Member]                        
Revenues                   1,800    
Operating Income (Loss)                   900    
Becnel Rental Tools, LLC [Member]                        
Business Combination, Consideration Transferred $ 49,800                      
Payments to Acquire Businesses, Gross 17,500                      
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 32,300                      
Business Combination, Payment Withheld for Potential Post-closing Adjustments 2,500                      
Business Combination, Consideration Held Back 500                      
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High 2,000                      
Business Combination, Contingent Consideration, Liability $ 1,500         1,600     $ 1,600 1,600    
Business Combination, Contingent Consideration, Liability, Payable in Cash, Percentage 50.00%                      
Business Combination, Contingent Consideration, Liability, Payable in Shares, Percentage 50.00%                      
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low $ 0                      
Becnel Rental Tools, LLC [Member] | Revenue Target Achievement [Member]                        
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares) | shares 9,283                      
Becnel Rental Tools, LLC [Member] | Measurement Input, Discount Rate [Member]                        
Business Combination, Contingent Consideration, Liability, Measurement Input 0.11                      
Becnel Rental Tools, LLC [Member] | Measurement Input, Risk Free Interest Rate [Member]                        
Business Combination, Contingent Consideration, Liability, Measurement Input 0.05                      
Becnel Rental Tools, LLC [Member] | Measurement Input, Price Volatility [Member]                        
Business Combination, Contingent Consideration, Liability, Measurement Input 0.30                      
Becnel Rental Tools, LLC [Member] | Maximum [Member]                        
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life (Year) 11 years                      
Axiom [Member]                        
Business Combination, Consideration Transferred     $ 38,700                  
Payments to Acquire Businesses, Gross     10,000                  
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable     28,600                  
Business Combination, Payment Withheld for Potential Post-closing Adjustments     $ 3,900                  
Payments for Other Holdbacks                   $ 2,300    
Stock Issued During Period, Shares, Acquisitions (in shares) | shares                   26,379    
SteriQual, Inc. [Member]                        
Business Combination, Consideration Transferred   $ 3,800   $ 4,300                
Business Combination, Consideration Held Back       900                
Business Combination, Consideration Subject to Reduction       $ 500                
Payments for Other Holdbacks           $ 400       $ 400    
Stock Issued During Period, Shares, Acquisitions (in shares) | shares                   4,763    
TIC-MS, Inc. [Member]                        
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life (Year)         15 years              
Business Combination, Consideration Transferred         $ 9,700              
Payments to Acquire Businesses, Gross         2,900              
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable         $ 6,900              
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares) | shares         77,387              
Business Combination, Consideration Subject to Reduction               $ 500        
Escrow Deposit         $ 500              
Business Combination, Potential Purchase Price Adjustment for Failure to Retain Key Customer Relationships         $ 500              
NEXA [Member]                        
Payment for Contingent Consideration Liability, Financing Activities                   $ 500    
Stock Issued During Period, Shares, Acquisitions (in shares) | shares                   4,320    
[1] Revenues are attributed to the countries based on the destination of a product shipment or the location where service is rendered.
v3.24.3
Note 5 - Business Acquisitions - Summary of Purchase Price Allocation (Details) - USD ($)
$ in Thousands
Sep. 28, 2024
Apr. 15, 2024
Mar. 30, 2024
Aug. 08, 2023
Jul. 12, 2023
Mar. 27, 2023
Goodwill $ 138,127   $ 105,585      
Becnel Rental Tools, LLC [Member]            
Goodwill   $ 32,537        
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, Intangibles and Deferred Taxes   40,577        
Cash   214        
Accounts Receivable   3,041        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory   6,122        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other   79        
Current Liabilities   (210)        
Total Purchase Price   49,823        
Becnel Rental Tools, LLC [Member] | Customer-Related Intangible Assets [Member]            
Intangible Assets   7,200        
Becnel Rental Tools, LLC [Member] | Trademarks and Trade Names [Member]            
Intangible Assets   $ 840        
Axiom [Member]            
Goodwill       $ 26,758    
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, Intangibles and Deferred Taxes       34,658    
Cash       161    
Accounts Receivable       925    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory       1,796    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other       40    
Current Liabilities       (579)    
Total Purchase Price       38,724    
Property and Equipment       4,965    
Deferred Tax Liability       (3,242)    
Axiom [Member] | Customer-Related Intangible Assets [Member]            
Intangible Assets       $ 7,900    
SteriQual, Inc. [Member]            
Goodwill         $ 2,175  
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, Intangibles and Deferred Taxes         3,724  
Accounts Receivable         666  
Current Liabilities         (211)  
Total Purchase Price         3,784  
Deferred Tax Liability         (395)  
SteriQual, Inc. [Member] | Customer-Related Intangible Assets [Member]            
Intangible Assets         1,062  
SteriQual, Inc. [Member] | Noncompete Agreements [Member]            
Intangible Assets         392  
SteriQual, Inc. [Member] | Sales Backlog [Member]            
Intangible Assets         $ 95  
TIC-MS, Inc. [Member]            
Goodwill           $ 7,218
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, Intangibles and Deferred Taxes           9,653
Accounts Receivable           502
Current Liabilities           (124)
Total Purchase Price           9,675
Property and Equipment           356
Deferred Tax Liability           (712)
TIC-MS, Inc. [Member] | Customer-Related Intangible Assets [Member]            
Intangible Assets           2,303
TIC-MS, Inc. [Member] | Noncompete Agreements [Member]            
Intangible Assets           $ 132
v3.24.3
Note 5 - Business Acquisitions - Pro Forma Results (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Sep. 28, 2024
Sep. 23, 2023
Sep. 28, 2024
Sep. 23, 2023
Total Revenue $ 67,826 $ 68,948 $ 134,533 $ 137,828
Net Income $ 3,286 $ 435 $ 7,545 $ 2,879
Basic Earnings Per Share (in dollars per share) $ 0.36 $ 0.06 $ 0.83 $ 0.37
Diluted Earnings Per Share (in dollars per share) $ 0.35 $ 0.05 $ 0.82 $ 0.37
v3.24.3
Note 6 - Subsequent Event (Details Textual)
$ in Millions
Oct. 30, 2024
USD ($)
Subsequent Event [Member]  
Proceeds from Sale of Productive Assets $ 1.1

Transcat (NASDAQ:TRNS)
過去 株価チャート
から 11 2024 まで 12 2024 Transcatのチャートをもっと見るにはこちらをクリック
Transcat (NASDAQ:TRNS)
過去 株価チャート
から 12 2023 まで 12 2024 Transcatのチャートをもっと見るにはこちらをクリック